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ABSTRACT 
Physical and Chemical Mechanisms of Direct and Controllable  
Plasma Interaction with Living Objects 
Danil Dobrynin 
 
 
The number of potential applications of non-equilibrium atmospheric pressure discharges 
in biology and medicine has grown significantly in recent years; in fact, the activity in 
this direction lead to the formation of a new field in plasma chemistry titled `Plasma 
Medicine'. It is now clear that these plasmas can have not only physical (e.g. tissue 
cutting and cauterization), but medically relevant therapeutic effects — plasmas can 
trigger a complex sequence of biological responses in tissues and cells.  To move ahead 
in further development of actual commercial tools that will enter the hospital, and in 
finding novel and perhaps even unexpected uses of these plasmas an understanding of 
mechanisms of interaction of non-equilibrium gas discharges with living organisms, 
tissues, and cells becomes essential. 
This thesis is focused on understanding of the mechanisms of plasma interaction with 
living objects using a threefold approach: physical, chemical, and biological. First, a 
physical characterization of a novel microsecond spark discharge ignited in a pin-to-hole 
electrode configuration is performed. This provides ground for deeper understanding of 
the physical mechanisms of plasma effects of biological objects, and further adjustment 
of the discharge for specific applications. A series of in vitro and in vivo experiments on 
inactivation of bacteria and spores using various types of plasma discharges adds 
understanding of physicochemical plasma biodecontamination mechanisms. Based on the 
xvi 
 
results of this study, an initial model of such mechanisms is proposed. Results of in vitro 
and ex vivo experiments show that plasmas are able to produce a number of various 
reactive species in gas phase, as well as deliver these species into liquid phase and into 
tissues. Depth of plasma effect penetration is shown to be on the order of several 
millimeters. Based on these results, an in vitro physicochemical model of tissue is 
proposed. Biological safety of plasma treatment is revealed through a series of 
differential skin toxicity trials on live mouse and rat skin tissue, live pig skin tissue, 
and in an open wound model on pigs. Plasma ability to coagulate blood, 
decontaminate and accelerate wound healing is shown in a series of in vivo 
experiments using live rat animal models. The first invasive plasma application for 
treatment of gastroenterological diseases is presented.  
 
 
1 
 
 
 
CHAPTER 1. PLASMA MEDICINE: BACKGROUND 
 
Progress in various engineering technologies and physical sciences, for example, 
microelectronics, optics, material sciences, and nanotechnology, resulted in development 
of new methods and directions in life sciences. In the last decade, plasma technology is 
emerging worldwide as an independent medical field— Plasma Medicine, which now 
may be compared to the launch of laser technology into medicine years ago. Plasma 
medicine can be subdivided into three main fields: plasma-assisted modification of 
biorelevant surfaces, plasma-based biodecontamination and sterilization, and direct 
therapeutic plasma application. 
Surface modification and decontamination are more or less indirect medical plasma 
applications where plasma technology is used to process material or devices for 
subsequent medical applications. In contrast to that, the aim of therapeutic plasma 
application as the central field of plasma medicine is to bring physical plasmas directly 
on or in a human (or animal) body. Particularly for this very innovative field, the 
fundamental knowledge of the mechanisms of plasma interaction with living cells and 
tissue is essential as a scientific basis. Worldwide, it is the aim of several research 
institutes and associations (INP Greifswald, Germany, Max-Plank Institute, Germany, 
McGill University, Canada, University of California, Berkley, CA, Montreal University, 
Canada, Osaka University, Japan, Old Dominion University, VA, Loughborough 
University, UK, and others)  to put forward therapeutic applications of physical plasma in 
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different fields of medicine, like dermatology, dentistry, surgery, traumatology, internal 
medicine, oncology, and several others. 
In the view of the field of Plasma Medicine, development of plasma sources and plasma-
based medical devices becomes extremely important, and therefore an overview of major 
types of plasmas used for biomedical purposes will open this chapter. It will be followed 
by a review of the current states of the sub-fields of plasma biodecontamination and 
sterilization, plasma-cell interaction and therapeutic plasma applications. 
1.1. Plasma sources for biomedical applications 
Biomedical application of plasmas is not only a task for medicine; it is a challenge for 
plasma physics as well. Therapeutic applications of plasmas assume that the plasma 
discharges are ignited in open air atmospheres and thus at atmospheric pressures. 
Adjusted plasma sources for different applications are required, and the proposed 
selectivity of plasma action implies a thoughtful control of the performance parameters of 
the plasma sources. Widely used cold plasma discharges at atmospheric pressures are still 
a challenge for plasma diagnostic. Usually they are small-scale (due to the Paschen law 
with the pressure × distance scaling), constricted or filamentary (i.e., consisting of 
distinct microdischarges due to the streamer-breakdown process) and transient (due to 
high collision rates and quenching). Additional challenge occurs due to an input of 
nitrogen, oxygen, and water, implying complex plasma chemistry. 
 During recent years, a broad spectrum of plasma sources dedicated for biomedical 
applications has been reported, for example, plasma needle [1], atmospheric-pressure 
plasma plume [2], floating-electrode dielectric barrier discharge (FE-DBD) [3,4,5,6], 
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atmospheric-pressure glow discharge torch [7], microhollow cathode discharge air 
plasma jet [8], microwave plasma torch [9], helium plasma jets [10,11,12], dielectric 
barrier discharge (DBD) [13], and nanosecond plasma gun [14]. Although this list is far 
from being comprehensive, below we will focus on the following main types of the 
discharges: DBD and plasma jets. 
1.1.1. Dielectric Barrier Discharges 
Dielectric barrier discharges are characterized by the presence of at least one isolating 
layer in the discharge gap [15,16]. The classical configuration is the so-called volume 
barrier discharges (VBD), where one or two electrodes with an isolating layer form the 
discharge gap. The VBD enables direct treatment of the object to be treated, i.e., the 
object with stray capacity is the second electrode. Since the local current is limited by the 
capacity of the discharge configuration, a painless treatment is possible. Special 
configurations of the DBD are the so-called surface discharge and the coplanar discharge. 
In a surface barrier discharge (SBD), both electrodes are in direct contact with the 
isolator. In this geometry, the plasma is formed around the electrodes on the isolator 
surface. 
Direct application of VBDs for skin and wound treatment has been demonstrated by 
means of so-called floating electrode DBD (FE-DBD) plasma [3,4,5,17,18,19] by 
Fridman et al (Figure 1).  The discharge is operated in atmospheric air, without additives 
of noble gases. Usually the discharge is ignited as a number of microdischarges, they 
tipical characteristics are shown in Table 1.  
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Figure 1 General schematic of a DBD setup (left), and a photograph of FE-DBD plasma in operation 
(right). 
 
Uniformity of the plasma could be improved in two ways: 1) increasing uniform pre-
ionization of the gas to initiate more avalanches or 2) shortening the voltage rise time 
[20,21] to avoid growth of highly inhomogeneous electric field that promotes growth of 
some avalanches at the expense of others. If the number of primary avalanches is high 
enough before the accumulation of the critical space charge, the discharge is likely to 
remain uniform even if streamers do occur. The resulting discharge will resemble ‗pulsed 
avalanche‘ regime [22]. In addition, under these conditions, the shape of the electrodes 
does not affect the location of the avalanches and streamers making the discharge more 
independent of the topography. A fast rising driving voltage can also shift electron energy 
distribution function to higher values. Nanosecond-pulsed DBD with glass test tube 
electrode is shown in Figure 2. This discharge typically appears dim. Nevertheless, it can 
be seen in Figure 2(a-b) that plasma is spread all over the spherical tip of the electrode. 
Figure 2a is taken in the presence of background light and Figure 2b is taken in a dark 
room. 
 
 
5 
 
 
 
Table 1 Typical microdischarge parameters in a 1-mm gap in atmospheric-pressure air [23,24] 
Lifetime 1 – 20 (100) ns Filament radius 50 – 100 m 
Peak current 0.1 A Current density 0.1 – 1 kA cm-2 
Electron density 10
14 – 1015 cm-3 Electron energy 1 – 10 eV 
Total transported 
charge 
0.1 – 1 nC Overheating 5K 
Total dissipated energy 5 J Gas temperature ~300 K 
 
 
Figure 2 Side view of nanosecond-pulsed DBD between test tube electrode and ground metal electrode (a) 
with background light and (b) in a complete dark room for the same exposure time (bottom halves of the 
images are due to reflection from the ground plate electrode surface) [25,26,27] 
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1.1.2. Plasma jets 
Plasma jets consist of a gas nozzle applied with one or two electrodes. The plasma is 
generated inside the nozzle and transported to the object to be treated by a gas flow. 
There are numerous plasma jets available and described in literature 
[8,10,12,28,29,30,31,32,33,34,35]. They mainly differ in electrode configuration, type of 
gas, and frequency of applied voltage. In general, one must distinguish between remote 
plasma jets (i.e., the plasma is potential free and consists of relaxing and recombining 
active species from inside the nozzle) and active plasma jets (i.e., the expanding plasma 
contains free and high energetic electrons). In the latter case, the substrate must be 
considered as a second or third electrode, i.e., the plasma is not potential free. Plasma jets 
enable direct and indirect treatment.  
One of the first plasma jets, the so-called plasma needle, was used for a broad range of 
biomedical applications, including tissue treatment, cell manipulation, and dental 
applications [1,36,37,38,39,40,41,42,43] by Stoffels et al (Figure 3).  Atmospheric 
plasma is generated by applying radio-frequency voltage to a tungsten wire (50 mm long, 
1mm diameter) inserted in a quartz tube. Frequency generator (fixed 13.56 MHz 
frequency), matching network and power meter are home-built. The plasma is ignited in a 
gas mixture, directed through the tube at a flow rate of about 1 l min−
1
. Gas composition 
is determined from mass spectra; the feed gas contains 15% He, 12% O2 and 73% N2. 
The temperature in the plasma can rise up to 150 ◦C (Figure 4). These results are in very 
good agreement with previous measurements involving optical emission spectroscopy 
[1]. For medical applications, such a temperature is generally too high, unless tissue de-
vitalization is desired. However, this problem can be solved by operating downstream, 
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increasing gas flowrate (only in external operations), reducing plasma power (using 
thinner electrodes) and shortening treatment times (e.g. pulsing the plasma). Plasma 
needle production of NO as measured by means of mass spectroscopy is shown on Figure 
5. The density of NO may thus reach up to 20% of the ambient density. Besides nitric 
oxide, other reaction products must be present in this region. The product gases may 
contain N2O and also some NO2 due to NO oxidation. 
Sakiyama and Graves presented various models of the plasma needle [44]. They used a 
fluid code in 1- or 2-D axially symmetric coordinates for the description of the 
atmospheric plasma needle interacting with different surfaces, and they modeled the 
transition between the unipolar and bipolar modes (Figure 3). The former was referred to 
as the ―corona‖ and the latter as the ―glow,‖ and the transition corona-to-glow, with 
increasing plasma power, was studied. These simulation results were supported by the 
experimental observation of light emission spatial profiles, and a good qualitative 
agreement was obtained. Furthermore, ion fluxes toward and energy distributions at the 
grounded surface were simulated. Ion fluxes ranged from 10
17
 m−
2
 s−
2
 (corona) to 10
22
 
m−
2
 s−
2
 (glow with a conductive surface). Typical ion energies at the considered power 
levels were up to 5 eV in the glow mode with conducting surfaces. 
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Figure 3 General schematic of the plasma needle setup (top), and two operation modes of the radio-
frequency plasma needle (bottom): (Left) Unipolar ―stand-alone‖ mode (corona). (Right) Bipolar plasma-
to-surface mode (glow) [1,43] 
 
Figure 4 Gas temperature as a function of input power at various positions [45] 
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Figure 5 Scaled NO density and product gas density in fractions of ambient atmospheric density, at 1.5mm 
from the needle tip, as a function of plasma power [45] 
 
Another plasma jet which is recently used for numerous biomedical investigation is the 
atmospheric pressure plasma jet (APPJ) which is shown in Figure 6. Recently, the device 
has got the CE marking, i.e., it fulfills the EU consumer safety, health or environmental 
requirements [46]. It consists of a hand-held unit (dimensions: length = 170 mm, 
diameter = 20 mm, weight = 170 g) for the generation of a plasma jet at atmospheric 
pressure, a DC power supply (system power: 8 W at 220 V, 50/60 Hz), and a gas supply 
unit. The principal scheme of the plasma source is shown in the right part of Figure 6. In 
the center of a quartz capillary (inner diameter 1.6 mm) a pin-type electrode (1 mm 
diameter) is mounted. In the continuous working mode, a high-frequency (HF) voltage 
(1.1 MHz, 2–6 kVpp) is coupled to the pin-type electrode. The plasma is generated from 
the top of the centered electrode and expands to the surrounding air outside the nozzle. 
The whole system works with all rare gases (especially argon) with gas flow rates 
between 5 and 10 slm. Small admixtures (1%) of molecular gases to the feed gas are 
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possible. At maximal input DC power of 3.5 W to the hand-held unit, the ignited plasma 
jet has a length of up to 12 mm. 
 
Figure 6 Atmospheric-pressure plasma jet (APPJ; INP Greifswald, Germany) for experimental biomedical 
applications (left: CE approved device; right: schematic set-up) [46]. 
 
A detailed characterization of the macroscopic parameters of the plasma jet and profound 
analysis of the main risk factors is given elsewhere [29]. The axial temperature profile of 
the plasma jet revealed plasma jet temperatures between 63 and 46 °C. Radiation emitted 
from the plasma contains molecular bands of OH-radical and lines of excited argon atoms 
between 500 and 1000 nm. In the UV-A region between 350 and 400 nm, bands of 
nitrogen emission have been measured because of increasing mixing of the feed gas 
argon with the surrounding ambient air. There was no detectable emission in the UV-C 
range between 200 and 280 nm. The plasma jet emits significant amount of VUV 
radiation, mainly the 2nd continuum of the argon excimer Ar2* between 120 and 135 nm. 
Since the plasma jet is operated in its own argon atmosphere, considerable amount of 
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VUV radiation can reach the object to be treated. The irradiance in the 260–360 nm UV 
range was about 5 mW/cm
2
 at minimal distance of 5 mm and maximum power of 6 W. 
With increasing distance from the capillary outlet, drastic reduction of irradiance was 
detected reaching values between 1 and 2 mW/cm
2
. Thus, UV-caused problematic side 
effects of the plasma jet can be avoided in principle. The absolute VUV radiance of the 
APPJ reaches maximum values of 2.2 mW mm
–2
 sr
–1
. 
Besides (V)UV and heat radiation, the plasma jet provides a mixture of charged and non-
charged reactive species, above all reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) and other toxic gases. Maximum concentrations of ozone between 0.10 
and 0.13 ppm have been measured in the close proximity of the plasma jet. 
1.2.  Plasma biodecontamination and sterilization 
Plasma sterilization is one of the oldest and best established applications related to 
biomedical technology. The antimicrobial properties of plasmas have been thoroughly 
described in the literature [4,47,48,49,50,51,52,53,54,55,56,57,58]. Low-pressure as well 
as atmospheric sources have been used in direct and in indirect exposures, and chemical 
systems such as air, oxygen, nitrogen, and noble gases have been studied. Samples of 
different types, with various bacterial species (Gram positive and negative, aerobic and 
anaerobic [4,47,48,49,50,51,52,53,54,55,56,57,58]) and spores [59,60,61], have been 
subjected to plasma treatment. The nature of plasma interactions with bacteria is rather 
complex; the dose-dependent effects range from lethal (cell death, eradication [49]) 
through sublethal (bacteriostatic action due to slight damage followed by cell cycle arrest 
[41]) to nonlethal metabolic changes [62]. 
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Obviously, plasma interactions with biological objects are very complex; the results 
depend on the manner of treatment and on the nature of the object (bacterium, cultured 
cell, tissue, etc.). From the physical point of view, one can distinguish between two 
manners of plasma exposure.  
1) Direct: The active plasma is in direct contact with the surface [4,26,36,38,40,41]. In 
this arrangement, the (most reactive) short-living species have the highest chance to reach 
the surface. The energy transfer to the surface is optimal, and the fluxes of species are 
highest. A sheath is formed at the treated object, which allows surface bombardment with 
energetic positive ions. There is a physical current transfer to the object. Direct treatment 
is commonly acknowledged as the most effective one in regard to surface modification 
and sterilization. However, the effects can be quite drastic (cell necrosis or devitalization) 
when aggressive plasma sources are used. 
2) Indirect: This is also called afterglow or postdischarge treatment [4,26,36,38,40,41]. In 
this arrangement, only the effluents from the plasma are directed onto the surface, usually 
by introducing a vigorous gas flow. Short-living particles such as charged species and 
certain radicals are unable to reach the treated objects; there is also no current transfer. 
The active factors are long-living products of plasma chemical reactions, e.g., in air 
plasmas, the afterglow is dominated by nitric oxide or ozone. Indirect plasma treatment is 
preferred for in vivo medical applications because of its relative safety. However, the 
efficacy is much lower than in case of direct exposure.  
There are many factors that determine the efficacy of bacterial inactivation. First, direct 
treatment is always more effective than remote exposure; although in the latter case, 
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significant killing can be obtained as well [9,63]. From the plasma (chemical) point of 
view, agents that cause bacterial death or injury can be roughly classified as follows: 
1) heat; 
2) shear stress and desiccation; 
3) UV radiation; 
4) free radicals (OH, NO, ONOO, etc.); 
5) charging (positive and negative ions, electrons). 
Thermal damage is usually not an important mechanism of injury, considering that most 
cold atmospheric plasmas are designed to operate at ambient temperature. However, 
sample exposure to vigorous gas flows from several types of plasma jets may contribute 
to killing. Therefore, in such cases, it is always recommended to take control samples 
which are exposed only to gas jet without the ignition of the plasma. UV radiation is a 
very potent disinfectant [39,49,59,64], but its role in atmospheric plasma sterilization is 
said to be modest. Besides, UV poses a danger of cell injury (DNA damage), and 
therefore, many plasma sources are specially designed so as to limit the UV emission. 
Short-living free radicals, particularly the reactive oxygen species (ROS, e.g., O, , O2
-
OH), are considered to be the prime plasmaborne disinfectants 
[4,17,25,38,40,41,49,51,52,65,66,67]. The role of oxygen radicals in plasma sterilization 
has been also demonstrated: the rate of inactivation in air or oxygen plasmas is decades 
faster than in noble gases.  
The aforementioned effects can contribute to cell death in cold atmospheric plasma 
treatment. As said before, the results depend on many factors, such as the sample type 
and bacterial species. However, one can make a few general statements with regard to the 
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efficacy of plasma inactivation. These statements are rather easy to predict a priori, 
keeping in mind the superficial nature of plasma action and the structure of bacterial 
cells. 
1) Spores are more difficult to destroy than the vegetative forms. 
2) Gram positive species are more difficult to deactivate than the Gram negative 
ones. This is easy to understand when chemical etching or charge-induced 
damage is taken as the prime injury mechanism. The membrane of G+ species is 
much thicker and harder to penetrate. However, the difference in the killing 
efficiency is not very large; the effects of the sample thickness seem to be of a 
higher order. 
3) Anaerobic species are easier to kill than aerobes. This is because the anaerobes 
are more sensitive to ROS, and they generally cannot withstand oxygen-rich 
conditions. 
4) Direct exposure is more effective than indirect treatment. 
5) There may be a contribution of charged species in bacterial inactivation, but only 
in direct plasma treatment (no postdischarge) and only for the vegetative bacteria 
that are on or close to the sample surface. 
1.3.  Plasma-cell interaction 
The interactions of cold plasma with eukaryotic cells are much more complex than with 
bacteria, which are simply due to a greater complexity in the behavior and reactions of 
the cells. Just like bacteria, eukaryotic cells react to heat, shear stress, ROS, UV, and 
charged species. The effects on cells can be lethal (necrosis) or nonlethal (detachment 
[42,68,69]) but also triggeredlethal (programmed cell death, apoptosis [5,68,70]). 
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Considering that eukaryotic cells have much more advanced defense systems against 
hostile factors and much better repair possibilities, the induction of lethal effects in cells 
usually requires higher doses of treatment than in the case of killing bacteria. This is valid 
both for the administration of reactive chemicals (e.g., ROS; after all, inflammatory cells 
use ROS to inactivate bacteria in the body) and for UV irradiation. This means that a 
certain selectivity in plasma treatment can be obtained; the bacteria can be lethally 
harmed, whereas the damage to body cells remains tolerable. This natural selectivity is, 
of course, very favorable for all in vivo plasma applications, particularly for wound or 
dental treatment. In this sense, plasma can be seen as a ―topical antibiotic.‖ 
1.3.1. Reversible (repairable) DNA damage following plasma treatment 
If the plasma treatment is able to penetrate tissues and cells, what is the effect it has on 
the cells?  The effect is, indeed, non-trivial, but does seem to involve DNA.  We have 
measured the extent of DNA damage in mammalian cells using immunofluorescence and 
western blot techniques with hydrogen peroxide as a positive control as it is known to 
induce DNA damage.  Experiments show that phosphorylation of γ-H2AX histone does 
occur following plasma treatment which is indicative of thymine cross-linking and DNA 
double strand breaks (DSBs) or DNA single strand breaks.  The amount of DSBs depends 
on the plasma dose and it was shown that this effect is reversible for lower plasma doses 
(which are, interestingly, still high-enough for complete inactivation of high 
concentration of bacteria); in other words, at plasma doses below 1 J/cm
2
 we observe 
minimal effects on DNA, at higher doses of 2 to 6 J/cm
2
 we observe DBSs but they are 
repaired by the cell within 24 hours, and at doses above 7 J/cm
2
 amount of DNA damage 
is sufficient for the cell to go into apoptosis[71].  These effects are somehow related to 
16 
 
 
 
reactive oxygen species generated in plasma as DSBs can be blocked by intracellular and 
extracellular anti-oxidants [72]. 
1.3.2. Cell proliferation and release of growth factors 
Oxidative stress on mammalian cells may not be as detrimental as it initially seems.  
Indeed, ROS induce stress in mammalian cells and while in some cases it may lead to 
apoptosis in other cases this stress can actually promote or control angiogenesis, the 
growth of new blood vessels or repair/regeneration of existing ones [73,74,75].  In our 
experiments we show that plasma treatment increases proliferation of porcine aortic 
endothelial cells.  Fold growth, determined by counting attached cells seven days 
following the treatment, shows a two-fold increase in proliferation compared to untreated 
cells.  Initial results indicate that this phenomenon is due to release of fibroblast growth 
factor 2 (FGF-2) by these cells as was confirmed with FGF-2 inhibitors [76,77]. 
Plasma treatment can apparently have variable effect on cells.  We can categorize these 
effects into non-damaging treatment where all cells survive, medium level treatment 
where cells are affected but some therapeutic effects are observed, and high doses where 
cell growth is impaired  
(Figure 7) [72,76,77,78,79].   
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Figure 7.  Summary of effects of varying doses of plasma on mammalian cells. 
 
1.4.  Therapeutic plasma applications 
The most prominent effect of atmospheric plasmas on tissues is (blood) coagulation. 
Blood coagulation is readily achieved in a thermal way [80], but recently, it has been 
shown that cold atmospheric plasma treatment can produce this effect by pure chemical 
interactions, without heat. Recently, Fridman et al. [3,17,81] described a novel method of 
blood coagulation by means of a cold dielectric barrier discharge in air. Plasma treatment 
was shown to coagulate large bleeding areas (e.g., surgical cuts in human spleen) without 
inducing additional necrosis. This is an essential finding, because other methods (APC 
and coblation) always produce a necrotic zone around the treated spot. Nonthermal 
coagulation was ascribed to calcium-cation (Ca2+)-initiated release of thrombin that 
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induced precipitation of insoluble fibrin from soluble fibrinogen. The extra calcium 
cations were supplied by a charge exchange reaction with positive ions from the plasma; 
in other words, plasma shifted the pH toward more acidic. Acidic conditions are 
favorable for clot formation, because acids neutralize negatively charged colloidal protein 
suspensions and promote their precipitation (as in the case of bacteria, where acidic 
conditions reduced the negative charge on the cell and led to cell death). 
A special micro-plasma jet system has been developed by Dr. Gostev at Petrozavodsk 
State University for local medical treatment of skin diseases, and especially for treatment 
of corneal infections (see [82,83,84,85,86,87,88]). Ability of the medical microplasma 
system to sterilize surface has been demonstrated by Misyn et al. [82,83,84,85,86,87,88] 
Staphylococcus cultures in liquid media (~10
6
 cfu mL
-1
) have been treated by the air 
plasma plume of 3 mm diameter, incubated for 24 h, and counted (Table 2). 
A 6-log reduction in viable bacteria is achieved in 25 s of treatment; however the 
sterilization efficiency drops off with increase in volume of liquid which inhibits UV 
penetration and diffusion of active species generated in plasma. Nevertheless, the 
microplasma system should be a good solution for the treatment of living human and 
animal skin as the bacteria are normally at much lower concentrations on skin. 
A series of in vitro experiments on bacterial cultures and in vivo experiments on rabbit 
eyes [83,85,86,88] affirm the strong bactericidal effect of the micro-discharge with 
minimal and reversible changes, if any, in biological tissues, even in such delicate tissues 
as cornea. During the investigation of plasma treatment of ulcerous dermatitis of rabbit 
cornea two important observations were made: 1) plasma treatment has a pronounced and 
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immediate bactericidal effect, and 2) the treatment has an effect on wound pathology and 
the rate of tissue regeneration and wound healing process. 
Table 2 Results of Staphylococcus inactivation by air plasma 
Culture 
volume, ml 
Plasma exposure time, s 
0 (control) 25 50 100 
1 2×106 cfu 0 cfu 0 cfu 0 cfu 
2 4×106 cfu 25 cfu 0 cfu 0 cfu 
3 6×106 cfu 1×106 cfu 680 cfu 460 cfu 
 
These results offered a strong ground for application of the medical micro-plasma system 
for treatment of human patients with complicated ulcerous eyelid wounds, which is 
shown in Figure 5 [84,88]. Necrotic phlegm on the surface of the upper eyelid was 
treated by air plasma plume of 3 mm diameter for 5 seconds once every few days. By the 
5th day of treatment (two 5-second plasma treatment sessions) the eyelid edema and 
inflammation were reduced; and by the 6th day (third session) the treated area was free of 
edema and inflammation and granular tissue appeared. Three more plasma treatments 
were administered (six total), and the patient was discharged from the hospital six days 
following the last treatment. The micro-plasma treatment is being further developed for 
stimulation of reparative processes in various topical wounds, tropic ulcers, chronic 
inflammatory complications, and other diseases of soft tissues and mucous membrane 
[84,88,89]. 
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Figure 8 Result of six sessions of plasma treatment of the complicated ulcerous eyelid wound. 
 
Thesis outline 
The thesis is organized in the following manner:  
- first (Chapter 2), a physical characterization of a novel microsecond spark 
discharge plasma in pin-to-hole electrode geometry is presented;  
- the second part is dedicated to the studies on plasma sterilization and 
biodecontamination via in vitro experimental work with bacteria (Chapter 3) and 
spores (Chapter 4) and in vivo inactivation of bacteria on skin surface (Chapter 
5);  
- the third part is related to the problem of plasma-tissue interaction studied by in 
vitro measurement of plasma delivery of active species into liquid media (Chapter 
6) and wounds followed with development of a physicochemical model of tissue 
(Chapter 7), in vivo studies of plasma toxicity (Chapter 8), wound healing and 
blood coagulation (Chapter 9), and treatment of gastroenterological diseases 
(Chapter 10).  
These findings on the mechanisms of plasma interaction with living objects are 
summarized in Chapter 11.  
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CHAPTER 2. MICROSECOND PIN-TO-HOLE SPARK DISCHARGE (PHD) 
 
The first successful application of cold plasma for treatment of a eyelid wounds in human 
described in previous chapter offer a strong ground for further development of the newly 
formed field of Plasma Medicine. The discharge used by Dr. Gostev and colleagues was 
never physically characterized, and in order to understand the mechanisms of plasma 
interaction with living tissues, its role in wound healing and to optimize the efficiency 
discharge, an extensive study on plasma diagnostics has been performed. 
2.1. Experimental setups 
The microsecond spark discharge characterized in this study is ignited in a pin-to-hole 
electrode configuration (PHD, figure 1), and is based on the original schematic proposed 
by Gostev and colleagues [88]. A needle anode (1.5 mm diameter) is coaxially fixed in an 
insulator with gas inlet openings (air, ~0.5 L/min), which is surrounded by an outer 
cylindrical cathode (7 mm diameter) with an axial opening (2 mm diameter) for plasma 
outlet; the interelectrode gap was set to 1.6 mm, and the cathode wall thickness was 0.8 
mm. Both electrodes are made of stainless steel. The plasma discharge was ignited by 
applying an 8 kV positive potential to the central electrode. To provide high discharge 
energy while keeping average gas temperature low (a little above room temperature), the 
electrode system was powered through a 0.33 µF capacitor. This formed a 35 µs dense 
energetic discharge with average energy of ~1.8 J/pulse.  
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Figure 9 Pin-to-Hole spark Discharge (PHD) plasma system schematic and in operation, demonstrating that 
the plasma discharge is safe to the touch. 
 
Typical PHD plasma voltage and current waveforms are shown in Figure 10, top. Due to 
lane inductance, the discharge appears as a series of microdischarges, in which the first 
one is the most energetic with ~1 µs duration and 0.6 J energy (Figure 10, bottom, where 
the current oscillations are numerically eliminated knowing line inductance of L=5.4 H, 
and corresponding period of oscillations of T=7 s). Measurements of the light intensity 
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at 310 nm wavelength using photomultiplier also showed the series of microdischarges 
(Figure 11). 
The average gas temperature was measured using a K-type thermocouple as a function of 
distance from the cathode. Due to low frequency and short duration, the penetrating 
plasma temperature is relatively low, and can be decreased to be less than 50°C by 
introducing airflow through the discharge cell (Figure 12). 
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Figure 10 Typical PHD plasma voltage and current waveforms (top), and corrected current 
oscillogramm (bottom).  
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Figure 11 Discharge emission intensity at 310 nm wavelength measured with photomultiplier. 
 
Figure 12 Penetrating plasma afterglow average gas temperature, with and without airflow, as a 
function of distance from the discharge. 
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In order to study the discharge development, a modified experimental setup which allows 
generation of a single discharge was used (Figure 13). Here, a 150 m long coaxial cable 
was used as a charging capacitor with capacitance of 0.33 F. The discharge was initiated 
by separate air spark gap charged with 1.2 F capacitor. Typical voltage and current 
oscillograms are shown on Figure 14: the peak discharge voltage was approximately 8 
kV, and the peak current – 130 A with the pulse duration of about 140 ns. 
 
Figure 13 Modified setup for study of the discharge development.  
 
Figure 14 Typical waveforms of the discharge voltage and current. 
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2.2 Discharge characterization: OES 
The spark discharge emission spectrum was measured using an Acton SpectraPro 500i 
spectrophotometer (Figure 15). Plasma temperature was estimated using the Boltzmann 
plot method, which uses the relative ratio of emission intensities on multiple spectra lines 
to estimate the spark gas temperature. At local thermal equilibrium, the plasma 
temperature can be derived from the following equation: 
   
   
    
   
 
 
         
where I is the relative emission intensity ratio,  is the wavelength, A is the transition 
probability, gu is the upper level statistical weight, Eu is the upper level energy, and C is a 
constant for various atoms. Iron and oxygen spectral lines were used to estimate the 
temperature in the discharge center. Although the average gas temperature of the 
penetrating plasma was slightly above room temperature, the discharge temperature itself 
must be high to produce a significant amount of NO. A Boltzmann plot of iron and 
oxygen spectral lines is shown in Figure 16. By this method, a time-averaged plasma 
excitation temperature of 9030±320 K was estimated.  
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Figure 15 The spark discharge emission spectrum. 
 
Figure 16 Boltzmann plot of iron and oxygen spectral lines 
Plasma UV radiation with and without air flow was measured using an IL1700 
photometer (International Light Technologies) with SED(SEL)220 detector (spectral 
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range 160-320 nm, 220 nm peak). The PHD plasma discharge radiates intensively in the 
UV range (Figure 15). The measured total plasma UV irradiation with and without gas 
feeding was 90 and 140 µW/cm2 respectively. DNA damage by UV-C and UV-B 
radiation occurs after about 0.4 mJ/cm
2
 and 10 mJ/cm
2
 respectively. 
By using the linear Stark effect of lines broadening it is possible to estimate electron 
concentration in the discharge. The determination of the electron density using Stark-
broadening has the advantage of not requiring the validity of LTE conditions. LTE 
conditions require that the collision excitation and deexcitation processes predominate 
over the radiative processes, i.e. that the electron number density is sufficiently high. The 
corresponding lower limit of electron density is given by the criterion: Ne ≥ 
1.6·1012·T1/2·(Е)3 = 1.3e15 cm-3. Here, broadening of hydrogen (656.2 nm) and oxygen 
(645, 926, 615 and 605 nm) lines were used. The hydrogen line profile is mainly 
broadened due to the linear Stark effect: 
3/29
2/1 105.2 eH n
 . Oxygen O I 
broadening: eeee wnTnn
162/16/14/14
2/1 10)]068.01(1075.11[2.0
   , where where w 
is the electron impact width parameter and γ is the ion-broadening parameter; both weak 
functions of temperature. Stark broadening parameters for the selected line were taken 
from Griem‘s tables. The average electron density was calculated to be ne = (7.8 ± 
4.2)E+16 cm
-3
 (Figure 17). 
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Figure 17 H line profile used for determination of electron density in the discharge using Stark 
broadening. 
 
2.3 Discharge characterization: jet formation (imaging and gas 
dynamic modeling) 
The measurements were performed using 4Picos ICCD camera and quartz lens with focal 
distance of 16 mm. Camera spectral response range was 220-750 nm. Camera gate was 
equal to 5 ns and was synchronized with the high-voltage current pulse with the accuracy 
of about 10 ns. These measurements allowed us to trace the spark stage of the discharge 
(Figure 18). Here one can notice, that the discharge is started as a classical high voltage 
arc, which then, as the energy stored in the capacitor is discharged, extinguished, and the 
plasma is propagating in both directions as a result of high temperature and pressure in 
the discharge cell with formation of the ―plasma jet‖.  
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2.4 Discharge characterization: strimer and spark stages modeling 
The numerical modeling of gas discharge development was made based on the fluid 
model approximation. The motion of species is described by the balance equation within 
hydrodynamic (drift-diffusion) approximation: 
   
  
     
 
    
                    
            
Here, Ns is the species density; flux js consists of an advective part with drift velocity Vs 
and diffusion part with coefficient D. The right part in the balance equation Qs 
corresponds to various plasma-chemical processes like ionization, recombination, 
electron attachment, and photoionization, etc. Electron transport parameters, namely, 
mobility and diffusion coefficients, are calculated with BOLSIG+ solver as a part of 
ZDPlasKin module integrated into the code. These transport coefficients for other species 
(ions mainly) have to be taken from somewhere. Electric field distribution E can be 
expressed vie the electric potential ϕ which in its turn obeys Poisson‘s equation: 
    
 
   
      
       
Where ε and ε0are the dielectric permittivity of the media and of free space, respectively, 
and qs is the charge of species (s). In presence of an interface dielectric-gas or dielectric-
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metal, the later relation has to be corrected due to for surface charge and different 
permittivity. Processes leading to production of electrons far from the region of discharge 
and close to surfaces have a great importance in the development of pulsed discharges, 
especially of positive polarity. 
   
  
        
Emission of electrons from a metal or dielectric surface due to bombardment by ions is 
expressed as: 
        
       
Here, j is the transport flux of incident species (s) and emitted electrons (e). The 
coefficient of ionelectron emission γ depends not only on the type of ions but also on the 
material of the surface. At the present, two values are used in the code: γm and γd 
corresponding to emission from metal (m) and dielectric (d) surfaces for any positive ion. 
Identically, two coefficients of electron emission by photons from metal and dielectric 
surfaces are used. 
The results of modeling experiments are shown in Figure 19 and Figure 20. Pulsed 
discharge develops in two stages. First stage is a streamer stage. During this stage the 
streamer crosses the gap and bridges the electrodes. Streamer starts when the voltage on 
the gap reaches 5-7 kV/cm at atmospheric pressure air. Electric field in the streamer head 
is several times higher than the breakdown threshold while the field in the channel is 5-6 
times lower the breakdown limit. When streamer reaches the opposite electrode the 
reverse stoke re-distributes the potential across the gap. Electric filed becomes lower than 
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the breakdown threshold in all points of the gap and plasma recombination prevails on 
the ionization. Channel‘s plasma degradation occurs simultaneously with  
 
 
 
Figure 18. Here: number is time when picture is taken (in microseconds) after the discharge starts. 
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gas heating due to joule heating of the gas, and, more important, continuous voltage 
increase on the high-voltage electrode. As a result of gas density decrease and voltage 
increase, reduced electric field E/n reaches the breakdown threshold in all points of the 
gap and gas ionization starts again [90]. Now the gas ionization leads to fast formation of 
hot conductive channel. Discharge power reaches its maximum when the channel‘s 
conductivity is equal to the power supply‘s resistance. Further gas ionization leads to 
conductivity increase and decreases the voltage across the discharge gap. Hot pressurized 
channel formed during the discharge phase starts the gasdynamic expansion with shock 
waves formation. Gas dynamic motion in the discharge chamber leads to the hot jet 
formation through the nozzle. Let‘s consider this sequence of events in more details. 
Streamer starts from the conical tip of the high-voltage electrode (Figure 19) and 
propagates across the gap with velocity u ~ 1 mm/ns.  After 1.5 ns it reaches the central 
point of the gap (Figure 19, b). Typical channel diameter is d ~ 0.2 mm. 
When streamer head becomes close to the low-voltage electrode, the electrical field 
ahead of the ionization wave becomes sensitive to the shape of the electrode (cylindrical 
hole on the axis). Streamer‘s shape changes (Figure 19, d) and the channel touches the 
edge of the low-voltage electrode (Figure 19,e). The streamer phase takes approximately 
2 ns from the streamer start to the conductive bridge formation between the electrodes.  
Continuous voltage increase leads to breakdown development (spark phase of the 
discharge). Energy release during this stage leads to formation of fast hot channel 
formation (Figure 20, a). Further modeling was performed using Euler‘s equations, 
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including mass, momentum and energy conservation equations, as well as the equation of 
state.  
     
a    b       c   d     e 
Figure 19 Air, P = 1 atm. U = 8 kV. a) – e): t = 1, 1.5, 1.7. 1.9 and 2 ns 
 
The gas temperature in the pulsed spark channel can reach 10-20 kK because of high rate 
of energy release. Short time of the hot channel formation lead to pressure increase in the 
discharge. Hot gas from the spark channel expands from the region of discharge energy 
release, forming shock waves and complex gasdynamic motion in the discharge chamber 
(Figure 20, b,c). It should be noted that during initial stage of the expansion there is no 
gas motion along the discharge axis because of almost symmetrical conditions of gas 
expansion in both directions (Figure 20, d, e, f).  At time t = 3.2 s shock wave appears 
on the nozzle exit and starts to propagate into free space (Figure 20, f). Shock wave 
propagates also in the discharge chamber and after t = 7 s reaches the closed end of the 
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chamber (Figure 20, g). Reflected shock wave appears and propagated toward the nozzle 
(Figure 20, h, t= 12.8 s). Until this time only small portion of the gas from plasma 
channel penetrates through the hole. Reflected shock reaches the nozzle after t = 20 ms 
and increases the pressure near it (Figure 20, t = 25.6 s). Gas acceleration through the 
nozzle forms the high-speed jet which propagates several centimeters from the nozzle 
(Figure 20, t = 51.2s). Almost all discharge products (O3, NO, etc) produced during the 
discharge stage are pushed away from the discharge chamber at this time. Inertia of the 
jet formed creates the negative pressure in the discharge chamber after t ~ 100 s after 
the discharge. A suction stage appears and the discharge cavity fills with a fresh portion 
of air.  
2.5 Bacteria inactivation in vitro 
The efficiency of microsecond spark discharge in inactivation of bacteria was tested in 
vitro. In this study an Escherichia coli suspension in phosphate buffered saline (PBS) at 
initial concentration of about 3·109 cells/ml was used. Bacteria were treated on brain 
heart infusion (BHI) agar: 400 µl of bacteria solution were inoculated on BHI agar 
prepared Petri dishes and spread on agar surface to obtain uniform layer of bacteria. After 
inoculation plates were allowed to dry in room air for about 30 minutes to allow 
evaporation of excess water. To quantify the number of bacteria per unit area of agar, the 
bacteria solution was properly diluted, inoculated on agar surface as described above, and 
after incubation at 37⁰C for 15 hours resulting colonies were counted. In order to check 
the role of UV radiation produced by the discharge as a mechanism of bacteria 
inactivation, treatment was done either with or without 0.5 mm quartz glass placed in 
between the discharge and bacteria (Figure 21). 
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a  f  
b  g  
c  h  
d  j  
e  k  
Figure 20. Spark channel expansion and plasma jet formation. 
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Figure 21. PHD treatment of bacteria on agar. 
 
The results of experiments are shown on Figure 22: the clear circles correspond to 
absence of bacteria growth (inactivation area). Here we show, that even after 1 pulse (~35 
s) bacteria are inactivated (~107 cells). At the same time it is clear that the dominant 
mechanism of inactivation in the case of spark discharge is probably UV radiation.  
 
Figure 22. The results of PHD treatment of bacteria on agar: without (left) and with (right) quartz. Numbers 
indicate number of pulses used for treatment. 
Quartz
1
 m
m
1
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m
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2.6 Microsecond spark in a pins-to-hole discharge cell 
configuration  (PsHD) 
As it was shown above, PHD plasma is a powerful source of UV radiation which plays 
the major role in the process of bacteria inactivation. The measured total plasma UV 
irradiation with and without gas feeding was 90 and 140 µW/cm2 respectively. DNA 
damage by UV-C and UV-B radiation occurs after about 0.4 mJ/cm
2
 and 10 mJ/cm
2
 
respectively. This means that the safe treatment dose for the PHD is on the order of 5 – 
90 s. In order to decrease the amount of UV exposure produced by the discharge during 
treatment, the discharge was ignited in a different geometry (Figure 23). Measured UV 
was 5 µW/cm2, i.e. 20 times lover than in the case of original PHD configuration.  
 
 
Figure 23. Spark discharge cell for reduced UV generation: discharge cell schematic (top), discharge in 
operation (bottom) 
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The bacteria inactivation experiment was conducted in the same way as described above. 
The results (Figure 24) show that although the efficiency of bacteria inactivation 
significantly decreased, the effect of UV no longer plays a significant role. 
 
Figure 24. The results of bacteria inactivation by microsecond spark plasma in pins-to-hole discharge cell 
configuration. 
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CHAPTER 3. DIRECT PLASMA INACTIVATION OF BACTERIA: IN VITRO 
STUDIES 
 
One of the first and probably the simplest from the point of view of practical realization 
application of atmospheric pressure plasmas is inactivation of bacteria on various 
surfaces, in air and liquids. In medicine, obviously, the primary focus would be 
decontamination and sterilization of tissues: skin and wounds, i.e. primary target is 
usually surface. Although a large number of experimental data has been obtained in last 
decade by researchers from various research centers and laboratories, the basic 
mechanisms of plasma inactivation of bacteria are still poorly understood. The main 
focus of this chapter is to indicate the role of major plasma components in the process of 
plasma ―sterilization‖. For this purpose, two types of discharges were used as a plasma 
source: floating electrode dielectric barrier discharge (FE-DBD) and atmospheric 
pressure corona discharge. The spark discharge (―PHD‖) was not used since the major 
factor in this case is powerful UV radiation, and separation of other components seems to 
be rather difficult. 
3.1 Role of charged species in direct plasma interaction with bacteria 
Floating electrode dielectric barrier discharge (FE-DBD) system is based on a 
conventional dielectric barrier discharge and is basically a system driven by alternating 
current high voltage applied between two conductors where one or both are covered with 
a dielectric to prevent transition to arc.  In this setup, amplitude and waveform of the high 
voltage signal are quite important.  It is widely known that damage to a surface being 
treated is related to the temperature of the filaments, their density, and the energy per 
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filament [26,27,91,92].  Uniformity of FE-DBD treatment was discussed elsewhere and 
can range from a rather non-uniform continuous wave discharge to a uniform nanosecond 
pulsed plasma [27,93].  Continuous wave system can have different waveforms (sin, 
triangle, etc), 1 to 30 kHz, 10 to 40 kV peak-to-peak; microsecond pulse system: single 
polarity positive pulse, 2 µsec duration, 5 V per nsec rise time, 120 Hz to 4 kHz pulse 
frequency; nanosecond pulse system: 40 nsec duration, 1 to 3 kV per nsec rise time, 
single pulse to 2 kHz [26,27,78,94].  The continuous wave discharge has the lowest 
number of filaments while operating at highest power and temperature; and this was 
shown to significantly damage biological tissues being treated [26,94].  Electrical safety 
of application of plasma to living tissue has been discussed in detail previously 
[2,78,94,95]; however, toxicity of such treatment, or the extent of immediate or long term 
damage, remains an open question. 
There are two modes of application of FE-DBD to the surface being treated: 1) where the 
tissue or cells are used as a second active electrode — plasma then is bound between the 
dielectric surface of the powered electrode and the surface of the tissue being treated; or 
2) where plasma is separated from the tissue by a grounded metal mesh and gas is blown 
through the discharge to carry active species outside of the plasma.  The first method is 
called a ―direct‖ and the second - an ―indirect‖ application of plasma to tissue.  Fridman 
et al. have previously shown that direct application of plasma yields to roughly a two 
orders of magnitude improvement in rate of bacteria inactivation as compared to indirect 
application, even when the plasma is removed from the tissue by a fraction of a 
millimeter [79].  All the effects of direct plasma on bacteria are negligible compared to 
the effects of charges.  In short, leaving only UV radiation (removing plasma by use of 
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quartz (UV) or magnesium fluoride (VUV) windows) removes the ability of plasma to 
sterilize.  Global gas temperature and applied electric fields are also negligible as the gas 
temperature rise is insufficient to achieve sterilization and the frequency and waveform 
utilized is out of the range for effective electroporation (see [78,96,97,98] for further 
details).  Effects of neutral active species cannot be ignored.  Neutrals by themselves, 
given enough time, are able to sterilize as well as direct plasma treatment and they are 
also responsible for many interesting biological effects; e.g. effect of NO in tissue 
regeneration [78,99,100].  It is important to note here that the effect of plasma is on 
bacteria and not on the substrate: a) agar treated by plasma for up to 1 hour remains able 
to grow bacteria the same way untreated agar does and bacteria appear unaffected; and b) 
bacteria treated on one Petri dish and transferred to another one immediately following 
the treatment remain inactivated and do not grow. 
3.1.1 Comparison of direct plasma treatment to indirect treatment with and 
without ion flux 
In this section three sets of experiments are discussed: comparison of direct and indirect 
plasma treatment of bacteria, and investigation of the effect of ions of both polarities in 
the process of bacteria sterilization. In the case of direct plasma treatment the discharge is 
ignited on the treated surface with 1.5 mm discharge gap.  For indirect plasma treatment a 
grounded metal mesh is used as a second electrode (22 wires per cm, 0.1 mm wire 
diameter, 0.35 mm openings, 60% open area, weaved mesh). The gap between the mesh 
and the quartz dielectric is set to 1.5 mm, just as in the case of the direct treatment setup.  
To ensure that both FE-DBD setups, with and without the mesh, produce the same 
amount of UV radiation, we correct for the UV transparency of the mesh using separate 
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measurements. The spectrum is measured using TriVista Spectrometer System with 
Princeton Instruments PIMAX intensified CCD camera with and without mesh. It turns 
out that the mesh cuts off only about 20-40% of UV light depending on UV wavelength 
(Figure 25). 
 
Figure 25 Results of measurement of light intensity from FE-DBD in the ultraviolet spectrum measured at 
three peaks (239.5 nm, 263.54 nm, and 284.03 nm) without mesh (taken as 100% for each wavelength) and 
with mesh: a representative spectra and averaged data for the three peaks. 
 
To investigate the effect of charged species agar prepared in metal dishes was used. 
These dishes are then biased with unipolar potential to extract charges from the 
discharge. The fact of charge extraction is confirmed by current measurements in ―dish – 
ground‖ circuit (Figure 26). The plasma is ignited in the same electrode-mesh 
configuration as in the indirect plasma treatment experiment. Distances between the 
powered electrode and the mesh, and between the mesh and the agar, both are set to 1.5 
mm. 
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Figure 26 The results of current measurements in experiments with ion flow. 
 
The results of direct, indirect, and bias experiments are shown in Figure 27.  When E. coli 
are treated with plasma directly they are exposed simultaneously to charged particles, 
UV, and all active plasma components such as ozone (O3), hydroxyl radicals (OH), and 
other excited molecular and atomic species, and thus maximum inactivation effect is 
obtained in this case.  The results of indirect plasma treatment show that it is significantly 
less effective, probably due to absence of charged species in plasma afterglow as was 
previously reported with skin flora (mix of staphylococci, streptococci, and yeast) [79].  
Applying bias potential to the agar leads to an increase in inactivation efficiency.  These 
results show that presence of charged species may lead to a significant increase of plasma 
treatment efficiency.  Although in Figure 27 it may appear that there is some observable 
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difference between positive and negative bias we did not observe this statistically.  
Careful quantitative analysis of these results will be discussed below. 
 
Figure 27.  Results of inactivation of E. coli on agar surface by direct (a, b) and indirect (c-h) plasma 
treatment.  In the case of indirect treatment the agar was either grounded (c, d) or DC-biased with 1 kV 
positive polarity (e, f) or 1 kV negative polarity (g, h).  For all cases, the plasma dose was kept at 2 (a, c, e, 
g) and 5 J/cm2 (b, d, f, h). 
 
3.1.2 Effect of positive and negative ions on inactivation of E. coli in nitrogen 
corona discharge 
To study the role of ions alone, we use DC corona discharge in flow of dry nitrogen at 0.5 
slpm.  A stainless steel needle electrode is placed inside of ceramic tube with inner 
diameter of 5 mm and is powered through a 10 MOhm resistor to produce ion flow with 
average current of approximately 20 µA for both positive and negative polarities; voltage 
is then varied around 1 kV to produce the same current for both polarities.  Grounded 
metal dish of 60 mm diameter with agar and E. coli is then used as a second grounded 
electrode, completing the circuit.  There is also a 2 mm gap between end of the tube and 
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agar surface to provide gas output from the system.  Nitrogen (99.999% pure) is used to 
ensure that concentration of reactive oxygen species is reduced in the discharge.  The 
results show that ions of both polarities are able to inactivate bacteria.  The effect 
becomes visible after ~25 seconds of treatment for both cases and positive ions show 
slightly higher efficiency; however, the difference between positive and negative ions is 
no more than ~10-15% (Figure 28).  No water evaporation was observed for treatment 
times below 1 hour and the effect of gas flow alone was analyzed and shown to have no 
effect on bacteria (results not shown, but see [79] for similar experiment).  This 
experiment serves as a second indication of the potential importance of ions in the 
inactivation of bacteria; however it does not completely eliminate the role of UV and 
ROS since even in high purity Nitrogen minute amounts of water and oxygen are present. 
 
Figure 28.  Schematic and results of E. coli inactivation on agar surface by negative and positive polarity 
corona discharge in nitrogen. 
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3.1.3 Inactivation of bacteria using DC corona discharge: role of ions and 
humidity 
Here the results of an experimental study of the effect of ions produced in a DC corona 
discharge on inactivation of bacteria on the surface of agarose gel are discussed.  Both 
positive and negative corona discharges in various gases at varied humidity were studied.  
The measurements in N2-O2-H2O mixtures show that there is no inactivation in pure N2, 
pure O2, and N2-H2O mixture.   The best results were achieved in the case of direct 
treatment when discharge was ignited in oxygen and water containing mixtures.  It is 
shown that neither UV radiation, ozone, or H2O2, nor other neutral active species alone 
produced by corona have an effect on bacteria viability. It is shown that the main role of 
charged particles may be related to the faster transport of active peroxide species – cluster 
ions OH
-
(H2O)n and  H3O
+
(H2O)n.  The efficiency of these radicals is much higher, than 
of the oxygen radicals and ions (including O2
-
, O4
+
 and O3) and of nitrogen and argon 
ions. 
Corona discharge setup 
Experiments were conducted using DC corona discharge at atmospheric pressure. 
Seventeen needles were uniformly fixed in cylindrical plastic enclosure with inner 
diameter of 5 cm (Figure 29, a).  Grounded metal plates filled with agar or grounded 
metal coupons were placed 4 cm below the needles, and played the role of a second 
electrode. The corona needles were powered with either positive or negative DC voltage 
through a 10 MOhm resistor to produce ion flux. The current associated with the charge 
impinging on the agar plate was measured by an amperemeter connected in series with 
the grounding connection. By variation of applied voltage from 5 to 30 kV, the current of 
49 
 
 
 
ions was varied from 10 to 250 µA. In order to check inactivation efficiency of neutral 
active species generated by the discharge, a grounded metal mesh was introduces into the 
system in the same way as in [4,101]. Mesh was placed between the high voltage 
electrodes and the treated surface. In these set of experiments corona current was kept at 
100 µA, while the distance between mesh and bacteria was 2 mm. In addition, effect of 
neutral radicals was studied by corona treatment in reverse room air flow (vacuuming the 
system) at rate of 1 slpm. The effects of gas composition and presence of water were 
studied by introducing either dry or wet (gases were bubbled through distilled water, 
which was boiled prior the experiment for ~20 min and then cooled to room temperature) 
air, O2, N2, Ar, and He into the discharge volume at rate of 10 slpm.  
Preparation of bacteria 
In this study an Escherichia coli suspension in phosphate buffered saline (PBS) at initial 
concentration of about 3·109 cells/ml was used. Bacteria were treated either on brain 
heart infusion (BHI) agar or on aluminum coupons after ~60 minutes of drying at room 
air. In the first case 400 µl of bacteria solution were inoculated on BHI agar prepared in 
aluminum plates (plate diameter 6.5 cm) and spread on agar surface to obtain uniform 
layer of bacteria. After inoculation plates were allowed to dry in room air for about 30 
minutes to allow evaporation of excess water. In such a case, bacteria were never 
completely dry and were covered by a minute amount of water, a condition which we 
refer to as ―moist‖ [101].  To quantify the number of bacteria per unit area of agar, the 
bacteria solution was properly diluted, inoculated on agar surface as described above, and 
after incubation at 37⁰C for 15 hours resulting colonies were counted (see Figure 29, b). 
For air-dried bacteria treatment experiments, 100 µl drops of bacteria solution were 
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placed on sterile aluminum coupons. Due to relatively low wetability of coupons, drops 
always had round shape at base with diameter of about 8 mm. Then, inoculated drops 
were dried at room air for about 1 hour, and treated with corona discharge or left 
untreated as controls. After the treatment, bacteria were washed out with ~1 ml of PBS, 
and incubated on BHI agar. Here it is necessary to mention that some number of E. coli 
after drying were probably killed and number of colonies observed after incubation 
decreased for about 90%. Therefore, this loss of bacteria was accounted in our further 
experiments, and actual number of treated bacteria was recalculated correspondingly. 
 
Figure 29 Schematic of the DC corona experimental setup (a), and representative picture of bacteria treated 
by corona discharge in air after incubation (b). 
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Results 
Initial experiments were done with bacteria of various initial concentrations dried on agar 
(―moist‖ condition) utilizing corona discharge in room air (~60% humidity) with constant 
current of 100 µA. Resulting numbers of colonies  on treated area after incubation were 
recalculated to a number of colony forming units (CFU) per cm
2 
assuming that area of 
treatment was about 19.5 cm
2
 . Because it is almost impossible to count relatively large 
number of colonies after the treatment with low doses, here we considered colony 
numbers less than ~150 CFU per treated area. To be able to study inactivation kinetics at 
lower doses we have used initial bacteria surface densities from 10
7
 cm
-2
 to ~150 cm
-2
. 
Results for corona of both positive and negative polarities of applied voltage are shown 
on Figure 30 in terms of colony number density as a function of dose, where exposure 
time of treatment area at constant current was recalculated to charge density (µC/cm2). It 
is shown that positive corona discharge treatment of bacteria dried on agar surface at 
constant current of 100 µA permits up to about 6 log reduction of viable bacteria in about 
90 seconds of treatment. Interestingly, negative corona has in general the same effect on 
bacteria viability, however the same level of inactivation may be achieved at 1.5 – 3 
times higher doses of treatment.  
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Figure 30 Bacteria inactivation on agar by positive and negative corona discharges in room air 
 
Although corona discharge used in this study is expected to be relatively weak in terms of 
production of active neutral species, compared to, for example, dielectric barrier 
discharges (first of all, due to low discharge power), and to produce mostly ionic flows, 
here we also studied the effect of neutral radicals. In this set of experiments corona was 
ignited in room air between powered needle electrodes and grounded metal mesh placed 
2 mm above bacteria layer dried on agar. The discharge current was kept at 100 µA. The 
results (Figure 31) show that, indeed, in the present discharge conditions neutral radicals 
alone probably do not play the major role: no visible effect was observed in the case of 
indirect treatment. Similar results (Figure 32) were achieved by introducing a reverse air 
flow through the discharge system (air flow direction was opposite to the ion flux). In this 
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case a large portion of neutral active radicals was carried out by the air flow, which did 
not result in significant reduction of bacteria inactivation.  
 
Figure 31 Bacteria inactivation on agar by direct and indirect treatment with positive and negative corona 
discharges in room air 
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Figure 32 Bacteria inactivation on agar by positive and negative corona discharges in room air with and 
without reverse gas flow 
 
In order to study the effects of different sorts of ions, a series of experiments on bacteria 
treatment dried on surface of agar was performed. Here we used He, Ar and N2 flow 
through the system at rates of 10 slpm. High flow rates and ~60 second exposition prior 
to treatment (setup volume is ~0.2 l) ensured the full gas replacement before the 
experiment. Bacteria were treated with 100 µA corona for up to 60 seconds, and then 
immediately exposed to room air and incubated at standard conditions. After the 
incubation, no visible decrease in viability was noticed, as expected. Similar experiments 
were done using oxygen and dry air with the same treatment doses. Surprisingly, in these 
last two cases, no inactivation was observed also. Compared to room air, these 
experiments were done using dry gases at zero humidity, therefore next was to check the 
effect of water on inactivation efficiency of corona discharge. To do that, in three 
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separate experiments nitrogen, argon or oxygen was fed through bubbler contained 
distilled water at flow rate of 10 slpm. The results of the experiments are shown on 
Figure 33. Compared to room air (~60% RH), only in O2/H2O mixture the same 
inactivation efficiency was achieved, while no visible inactivation was observed in all 
other cases. These results show that neither UV radiation, ozone, H2O2, nor other neutral 
active species alone produced by corona in dry oxygen or other gases with water have an 
effect on bacteria viability. Also, it is clear that non-oxygen charged species alone or in 
combination with water do not provide any bacteria inactivation. 
 
Figure 33 Effect of gas composition on bacteria inactivation on agar by positive and negative corona 
discharges 
 
Possible effects of ions on bacteria inactivation may be divided in two groups: physical 
effect (e.g. membrane disruption due to accumulation of charges), and chemical (e.g. 
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catalysis of membrane peroxidation) [38,101,102].  In the first case, there should be a 
strong dependence on dose rate – time, which is required to accumulate certain number of 
charges on bacteria outer surface, probably should be relatively short, given that agar is a 
conductive media. In contrast, chemical mechanism is likely to be much slower. In order 
to separate these two possibilities, the following experiment was carried out. 400 µl of 
bacteria solution were dried on surface of agar and then exposed to positive corona 
discharge. Discharge current varied in the following ranges: 10, 50, 100 and 250 µA, 
with maximum treatment time from 700 to 30 seconds in order to provide same dose of 
treatment (number of charges). The results (Figure 34) make it possible to suggest, that 
inactivation mechanism is provided by chemical effects rather than physical.  
 
Figure 34 Effect of dose rate on bacteria inactivation on agar positive corona discharge in room air 
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Another important question is the role of water layer which covers bacteria: in all 
experiments described above, bacteria were dried on agar (hydrogel) at room air, and 
therefore were covered by minute amount of water (―moist‖). To study the effect of this 
water layer, the experiment, similar to the first described in this paper, was performed. To 
minimize the layer of water covering bacteria, bacteria contained solution was dried on 
stainless-steel coupons as described in section above. Then bacteria were exposed to 
either positive or negative corona discharge at constant current of 100 µA. The results are 
shown on Figure 35, where it was taken into account that total treated area was 19.5 cm
2
, 
but only 0.5 cm
2
 were covered with bacteria. From these results one may conclude, that 
the actual difference between inactivation efficiency of ―moist‖ bacteria is about 2-4 
times higher than that of ―dry‖ ones, which is in good correlation with our previous 
observations, when bacteria were treated with dielectric barrier discharge plasma [101]. 
However, given that the last experiment (treatment of ―dry‖ bacteria) was done in humid 
room air, presence of water is still important, and optimal amount of water would lead to 
higher efficiency (as in a case of so-called ―water chemistry‖), and vice versa, excess 
water leads to dilution of the effect. 
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Figure 35 Inactivation of bacteria by positive and negative corona discharges dried on metal in room air 
 
Using linear parts of inactivation curves from Figures 2 and 7, we have recalculated 
charge doses required for inactivation of ―moist‖ and ―dry‖ bacteria obtained for both 
positive and negative corona to obtain required dose per one log reduction and number of 
ions (assuming that each ion carries a single charge) per bacteria for different initial 
concentrations. These curves are shown in Figure 36.  
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Figure 36. Dose per one log reduction and number of ions per inactivated bacteria for corona discharge 
treatment. Solid symbols – charge density, open symbols – specific charge per bacteria. 
3.2 Role of ultraviolet light, hydrogen peroxide, and ozone on plasma 
inactivation 
3.2.1 Effect of ultraviolet radiation in bacteria inactivation by direct dielectric 
barrier discharge 
The mechanism of UV-based sterilization is widely studied, and indeed in many cases it 
plays major role [64,103], therefore experiment that analyzes the role of UV radiation 
produced by direct plasma was carried out.  One way to protect bacteria from everything 
that is generated in plasma, except for the UV photons, is to place a quartz glass on top of 
the treated surface.  In our experiments we have used quartz, which is transparent to UV 
photons of >200 nm wavelengths, and MgF2, which is transparent to VUV photons of 
>140 nm wavelengths [92].  This way only UV/VUV photons generated in plasma reach 
bacteria.  As can be seen in Figure 37, bacteria that are protected from direct discharge by 
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a 10 mm square MgF2 slide are unaffected (highest dose used was 600 J/cm
2
 with no 
observed difference between untreated bacteria and MgF2-protected bacteria); thus we 
can conclude that the action of ultraviolet radiation for our case can be neglected.  
However, even though we observe no visible effect on bacteria by UV/VUV photons, it 
should not be discounted completely as UV, especially VUV, is known for its synergetic 
effect in interaction and destruction of model polymers [91,92,104]. 
 
Figure 37.  Emission from DBD plasma over the cell surface in UV range (right) and results of inactivation 
of bacteria by direct plasma contact compared with only UV (left).  No effect on bacteria protected from 
plasma by MgF2 slide (10 mm square in the center) is observed.  In this image the plasma surface power 
density was 0.6 Watt/cm2 and the treatment dose was 108 J/cm2. 
 
3.2.2 Effect of hydrogen peroxide produced by plasma on bacteria inactivation 
In the presence of water molecules in room air, a certain amount of OH molecules is 
produced in DBD plasma. Although this highly reactive radical probably does not play a 
key role in inactivation process by itself, as was discussed above, the product of 
recombination of two polar OH molecules on charge centers, a hydrogen peroxide 
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molecule, may relatively easy pass cell membrane and later cause lethal effects (for 
example, fatal DNA damage [105,106]).  The ability of hydrogen peroxide to sterilize is 
widely used and well studied, and therefore an experiment that helps analyze the role of 
hydrogen peroxide in DBD plasma inactivation of bacteria was carried out.  Because 
measurement of H2O2 concentration on the surface of agar is a challenging problem, this 
concentration was estimated using approximation of the dependence of measured amount 
of H2O2 produced in liquid.  Concentration of H2O2 was measured in distilled water and 
phosphate buffered saline (PBS) with H2O2 specific test strips (Emd Chemicals, 
No.:10081/1).  Dependence of peroxide concentration on treated volume is almost linear, 
and increases approximately three times when amount of treated liquid is decreased 10 
times (Figure 38).  The estimated amount of liquid under the electrode (surface area of ~5 
cm
2) in the case of ―moist‖ agar is a few microliters; therefore, we can expect the 
concentration of peroxide is on the order of a few tens of mmol/L for plasma dose of 
several J/cm
2
. 
 
Figure 38.  Dependence of peroxide concentration on volume of liquid for water and PBS. 
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To determine the concentration of H2O2 which causes the same sterilization effect on 
agar in direct plasma treatment, we use 50 volume percent water solution of H2O2, further 
diluted with distilled de-ionized water.  The 0.1 ml droplet of the solution is poured onto 
bacteria dried on agar and spread over the whole agar surface.  The results show that 
concentration of H2O2 that corresponds to 0.5 J/cm
2
 of direct DBD plasma is more than 
200 mmol/L (Table 3).  As can be seen from Figure 38, in the best case direct DBD 
plasma produces 6.5 mmol/L H2O2 at plasma dose more than an order of magnitude 
higher than that required for inactivation by plasma; thus we conclude that while 
hydrogen peroxide may have some effect it is not the key mechanisms by which direct 
plasma inactivation occurs. 
Table 3.  Effect of hydrogen peroxide on inactivation of E. coli. 
H2O2 volume % H2O2 mmol/L Inactivation result 
50 20,000 Complete inactivation 
5 2,000 
0.5 200 Some visible disinfection 
5·10-2 20 No visible result 
5·10-3 2 
5·10-4 0.2 
3.2.3. Effect of ozone produced in plasma on inactivation of bacteria 
Bactericidal effect of ozone is well known and has already been utilized in industry for 
some time [107,108,109].  In room air, dielectric barrier discharge generates ozone which 
may be responsible for the observed bacterial inactivation.  We assess the effect of ozone 
in two ways.  First, dielectric barrier discharge in room air at ~60% relative humidity 
produces 28 ppm of ozone measured outside of the discharge zone (recorded by ozone-
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specific spectrophotometer MedOzon 254/5, MedOzon, Russia).  We then use ozone 
generator (~500 ppm max output, Quinta Inc) to produce same concentration of ozone in 
room air without plasma [50,51,52].  No inactivation effect was observed on E. coli and 
on skin flora (mix of streptococci, staphylococci, and yeast) in as much as 30 minutes of 
treatment.  However, ozone meter measures ozone concentration downstream of plasma 
so the concentration inside plasma may be significantly different.  For this reason we use 
nitric oxide to remove ozone [110,111,112]: 
         
     
   
         
DBD plasma in gas produced by diluting a stock 700 ppm NO in N2 with oxygen leads to 
the same inactivation efficiency as when pure N2 with O2 mixture is used while the 
measured ozone concentration is zero in the first case and 28 ppm in the second.  Thus 
we can conclude that, as with UV and H2O2, ozone does not play a major role in 
inactivation of bacteria, at least in the case of E. coli or skin flora on agar surface. 
3.3. The role of water in inactivation of bacteria 
3.3.1 The role of water in direct plasma inactivation of bacteria 
Water is present in all the plasma treatment cases discussed above.  However, the effect 
of water and the amount required is not clear; and to analyze it we separate our treatment 
conditions into three groups: a) dry treatment, when a droplet with bacteria is placed on a 
glass slide and then dried in a desiccator in a biological hood until droplet appears 
completely dry (~1 hour); b) moist treatment, when droplet with bacteria is placed on 
agar surface and left to dry until agar appears dry (~1 hour); and c) wet treatment, when a 
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droplet with bacteria is placed in a cavity on a glass hanging drop slide and treated 
immediately, before water evaporates.  Plasma treatment is then performed in direct or 
indirect conditions described above.  There is a significant difference between these three 
cases: while on agar bacteria are covered with extremely thin, probably on the order of 
microns, layer of free water and the loss of charges in volume is small, in solution 
bacteria are covered with thick layer of water and therefore the effect of charged particles 
may be significantly diluted.  In case of bacteria dried on glass slides, free water is 
evaporated almost completely, and bacteria are covered with layer of water molecules 
bound by van der Waals forces.  In this last case, a priori, the result is not clear: the effect 
of plasma treatment may be enhanced due to energetic ion bombardment, or may be 
lowered due to the lack of free water which is required for effective oxidation processes. 
Results of comparison of dry, moist, and wet treatment in direct and indirect setup are 
shown in Figure 39.  For all the cases, a 0.2 ml of 10
8
 CFU/ml E. coli solution was used 
and treated with plasma in ~1 J/cm
2
 increments.  It is clear that, as was previously shown 
by the authors [79], direct plasma treatment achieves inactivation at lower doses than 
indirect.  Interestingly, this remains the case for all types of treatment regardless of the 
amount of water.  While the difference in dose required for inactivation of bacteria in 
moist and wet conditions may be attributed to the amount of water protecting the 
organism, the case of dried bacteria is not as clear.  The clear conclusion we can draw 
from this experiment is that presence of water and direct plasma treatment are both 
required to achieve fast inactivation and this inactivation is highly dependent on the 
amount of water. 
65 
 
 
 
 
Figure 39.  Results of comparison of dry, moist, and wet treatment in direct and indirect setup. 
3.4. Discussion 
In this chapter we address a problem of direct plasma interaction with bacteria, 
particularly, inactivation of viable bacteria. Plasma is a complex medium with the 
following major active components: charged particles (i.e. electrons and ions), electric 
fields (both global applied electric field and those associated with charges), photons (and 
first of all, energetic ones – UV photons), and neutral active species (free radicals, e.g. 
OH radical, and stable active products, e.g. O3). It was noticed [4,38,101,102] that in the 
case of direct contact of plasma with the treated sample, i.e. when there is a physical 
charge transfer from plasma to surface, effect of plasma treatment is always the highest 
(here it is necessary to note, that this is true for treatment of surface, and not for treatment 
of  liquid in volume [101]). In contrast, indirect plasma treatment, or treatment with 
afterglow, when only long-living species and in some cases active radicals are able to 
react with the sample, provides much lower efficiency. The mechanism of inactivation of 
microorganisms by cold atmospheric pressure plasmas is undoubtedly complex in nature, 
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and should be studied from both biological (i.e. processes that occur in microorganism 
after plasma treatment which lead to lethal or sub-lethal effects), and plasma-chemical 
(i.e. generation of active components in plasma, determination of major ones, an study of 
chemical and physical processes in water layer surrounding microorganism) sides. Here 
we are focused on inactivation of viable bacteria (not bacteria in spore form) using direct 
atmospheric pressure DC corona discharge and DBD plasma treatment because of 
possibility to separate the effects of different components. 
In low pressure discharges UV radiation often plays a major role in sterilization, however 
in atmospheric pressure cold plasmas (such as DBD, corona, ―plasma needle‖, etc.) it is 
usually not the case [36,38,41,101,102]. For corona discharge this suggestion is 
confirmed by the results of bacteria treatment in various gases, including dry air and 
oxygen (see Figure 33). Also, these results show that global electric fields in our 
experimental setup also have no effect on inactivation of viable E. coli. 
A common hypothesis of bacterial inactivation mechanism by air plasmas is related to 
oxidative damage by neutral active species, either stable ones, e.g. ozone and hydrogen 
peroxide, or short living reactive oxygen species (ROS), like hydroxyl radical and atomic 
oxygen. These neutrals may be formed directly in plasma, in water layer surrounding 
bacteria, or inside of bacteria. DC corona discharges were studied to produce ROS, 
ozone, H2O2, etc., however, it was shown that ozone and H2O2 alone require much longer 
treatment times than direct plasma treatment (see, for example, [101]),. Our experiments 
show that the treatment of bacteria with corona discharge ignited in oxygen, where ozone 
is formed, resulted in no visible inactivation.  
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Hydroxyl radicals (and hydrogen peroxide as a result of recombination of two OH 
molecules) are formed in discharges ignited in humid atmosphere (for example, Ar/H2O 
mixture): 
            
  
   
         
     , 
where M+ is any ion. Hydroxyl radicals can then react with nearby organics leading to 
chain oxidation and thus damage of cellular membranes and other cell components (here 
R is any organic molecule): 
             
          
               
Hydrogen peroxide can travel trough liquid and relatively easy transferred though cell 
membrane, and at appropriate conditions inside the cell is converted back to hydroxyl 
radicals through a natural reaction chain termed Fenton mechanism: 
       
               
       
          
Bacteria are known to have protective mechanisms to ―inactivate‖ hydrogen peroxide 
through enzymes, for example, catalase and peroxidase, which convert H2O2 into water 
and oxygen:              .             . Here we have experimentally 
shown that these two active species, OH and H2O2, alone do not play a major role in the 
process of bacteria inactivation. 
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Charged species were shown to have a great influence on efficiency of bacteria 
inactivation, and several hypotheses were proposed. First, it should be mentioned that 
energetic ions may be responsible for membrane etching, however, this probably happen 
mostly in low pressure plasmas or in streamers of direct DBD. Another possible effect of 
ions is traditionally associated with superoxide (O2
-
), which in presence of superoxide 
dismutase (SOD) is readily converted into hydrogen peroxide: 
   
     
     
           , causing oxidative damage to the cell. Positive ions, as it was 
mentioned above, also may be converted into OH and hydrogen peroxide directly on the 
bacterial membrane. Third hypothesis is related to mechanical stress caused by 
electrostatic charging of bacteria [38,102]. It was considered, that bacteria charged in 
plasma (analogously to particle charging in ―dusty‖ plasmas) under certain conditions 
may be ruptured due to mechanical stress. Although in this model only spherical gram-
negative bacteria were considered, proposed electrostatic rupture mechanism possibly 
may be applied to nonspherical objects, which may be killed even easier. Another 
hypothesis is related to neutralization of bacteria surface charge which leads to cytoplasm 
leakage and cell death (analogously to surface disinfectants) [38]. These two last physical 
mechanisms of electrostatic inactivation of microorganisms may take place under 
condition of electrically isolated surface, where there is no leakage of transferred charge, 
but accumulation of these charges. In the present work, bacteria were placed on the 
surface of conductive agar which was grounded, and therefore no charge accumulation 
may be expected. The results of our study clearly show that inactivation of bacteria 
cannot be explained by the effect of only neutral active species or charged particles acting 
independently. Moreover, presence of oxygen and water molecules in the discharge is 
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absolutely necessary. Therefore a mechanism of peroxidation of bacterial membrane 
catalyzed by charges is proposed [101], where: 
 both positive and negative ions have relatively the same effect; 
 effect of charged species is chemical and not related to such physical phenomena 
as sheer stress, ion bombardment damage, or thermal effects; 
 ions catalyze peroxidation processes of bacterial membrane composed of 
polysaccharides ; 
 presence of oxygen and water is necessary and reactive oxygen species play a 
crucial intermediate role. 
A multitude of ions may be produced in air plasma.  Their concentration is lower than 
that of active neutral species but their effect may be stronger due to their ability to 
catalyze complex biochemical processes.  Positive nitrogen or oxygen ions can be 
produced in a three-body collision:          
      or           
     .  
Superoxide anion can be produced in a similar collision with another molecule, at the 
wall, or at a charge center:            
-
  .  These ions are well known to create or 
catalyze chain oxidation processes in presence of organic molecules; for example, 
oxidation of aldehydes catalyzed by negative ions or oxidative hydrolysis catalyzed by 
positive ions (Figure 40) [113,114,115]: 
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Figure 40.  Oxidation reactions catalyzed by positive or negative ions that may take place in solution. 
 
It is well known that these reactions can create long chains for both positive and negative 
ions and these chains may be much longer than the OH oxidation of organic molecules 
discussed in the previous section.  In other words, charges may have an effect on bacteria 
and cells in solution due to the oxidation and peroxidation chain reactions they can 
catalyze; the same may be a reason for difference in doses required to inactivate bacteria 
versus achieve cellular damage which will be discussed in the next section. 
The role of water vapors in the plasma system may be related to charged water clusters 
which carry both charge and radicals (e.g., OH and H2O2), resulting in simultaneous 
delivery of all active components to bacteria. Another possibility is related to production 
of highly reactive HO2 ions which are effectively transported to the target inside of 
protective water clusters. 
In summary, it is shown that for an effective and fast inactivation of bacteria on a surface 
by a plasma discharge simultaneous presence of oxygen and hydrogen contained 
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compounds (e.g. water vapor) is required. It is well known, that in a discharge ignited in 
this atmosphere highly biologically active peroxides, peroxide radicals and their ions (e.g. 
H2O2, HO2, OH
-
, H3O
+
) are produced. The significant difference in the inactivation 
efficiency observed in the experiments with the direct and indirect plasma treatment 
setups demonstrates the importance of charged particles. Through, the efficiency does not 
strongly depend on the polarity of ions: both positive and negative charges are important. 
In the O2-H2 system, these may be cluster ions OH
-
(H2O)n and H3O
+
(H2O)n. We show in 
experiments of pure oxygen (mainly O2
-
 and O4
+
 ions) and pure nitrogen (electrons and 
N4
+
 ions) atmospheres that ions probably play a secondary role, and the chemical 
composition in the most important factor. Therefore we come to the conclusion that the 
role if charge in the process of bacteria inactivation is probably related to the active 
radical transport to the treated surface.  
Our estimations show, that in an electric field of about E/n ~ 30 Td that is created in the 
discharge gap, the ion (mainly OH
-
(H2O)n and  H3O
+
(H2O)n) drift time to the surface is 
about 100-200 s. In contrast, convective transport with a typical speed of about 1 cm/s 
for the same distance of 4 cm requires about 4 seconds. Therefore, presence of charged 
particles provides about 4 orders of magnitude faster transport of active radicals to the 
treated surface, while the transport does not depend on polarity of ions. Thus, 
recombination losses are significantly reduced and the inactivation efficiency is 
increased.  
This mechanism explains that the bacteria inactivation efficiency does not depend on the 
discharge polarity (in fact, the difference between positive and negative coronas is related 
to different peroxide radical ions – H3O
+
 and OH
-
), the low effect of the treatment with 
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the discharge ignited in a dry atmosphere (the role of ions is related to fast radical 
transport to the surface), and the difference between direct and indirect treatment 
(charged radical clusters OH
-
(H2O)n and  H3O
+
(H2O)n are effectively trapped by the 
grounded metal mesh which prevents their transport to the bacteria). 
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CHAPTER 4. COLD PLASMA INACTIVATION OF BACILLUS CEREUS AND 
BACILLUS ANTHRACIS (ANTHRAX) SPORES 
 
The mechanisms of non-thermal plasma inactivation of viable bacteria were discussed in 
the previous chapter. However, bacteria in spore form seem to be inactivated by plasma 
in a different way, first of all because of multiple protective layers and low metabolism. 
Here the results of experimental study on inactivation of Bacillus spores by FE-DBD 
plasma are presented and possible mechanisms are discussed. 
Bacillus species, which are ubiquitous in the environment, are aerobic or facultative 
anaerobic, gram-positive bacteria [116,117,118]. The genus Bacillus is divided into three 
broad groups, depending, amongst other characteristics, on the morphology of the spore. 
B. cereus, B. anthracis (anthrax) and B. thuringiensis belong to the B. cereus group 
[116,119].  Moreover, morphological and chromosomal similarities between these 
species have prompted the view that B. anthracis, B. thuringiensis, and B. cereus are all 
varieties of a single species [116]. Bacilli can produce a dormant cell type called a spore 
in response to nutrient-poor conditions. Bacterial spores have little or no metabolic 
activity and can withstand a wide range of environmental assaults including heat, UV and 
solvents [120,121,122,123]. To kill or inactivate Bacillus spores one can apply 0.88 mol/l 
hydrogen peroxide, pH 5.0 for 3 hours to sterilize a spore suspension of 10
6
 spores per 
ml, 5107 W/cm2 of UV radiation for 30 hours to achieve 0.67 log reduction in  0.1 ml 
of 10
8 
spores per ml placed on a wood carrier, or 10
6
 rad of gamma irradiation to sterilize 
10
6
 spores per ml [123]. 
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B. anthracis spores, as opposed to vegetative cells, are the infectious form and cause 
anthrax. Spores of B. anthracis represent a noteworthy bioterrorism agent, and can be 
easily distributed in dry form in parcels and letters via postal service, as occurred in 2001, 
when anthrax-contaminated letters sent through the US postal service killed five people 
and sickened 23 others [124], in aerosols or in contaminated water, for instance. In 
response to these possibilities, an effective, low-energy and cost effective method of 
spore inactivation or sterilization is required. An attractive method of spore inactivation 
is plasma treatment. Low temperature plasma at low pressure, arc discharge plasma, 
microwave plasma, and other plasmas are effective in sterilization of spores 
[59,61,125,126,127]. For example, Kuo et al. reported that a 3 to 5 log reduction of B. 
cereus spores in aqueous suspension can be achieved after several seconds of treatment 
with arc-seed microwave (2.45 GHz, 700W) plasma torch [61]. Several systems based on 
different types of discharge have been reported [59,61,126,127]. In most of these systems 
spores were treated either at low pressure, or with relatively high power discharges, and 1 
to 5 log reduction of germinated spores was achieved within a few minutes of treatment.  
In the present study we were interested in inactivating Bacillus spores in both dry form 
and suspended in water with use of atmospheric pressure Dielectric Barrier Discharge 
(DBD) plasma on surfaces, as well as inside of closed volumes, e.g. envelopes.  We 
reported previously on sterilization of bacteria and yeast, including skin flora such as 
streptococcus and staphylococcus, on agar surfaces with atmospheric pressure DBD 
plasma [128]. It took 5 -10 seconds in the case of direct DBD treatment to achieve up to 
an 8 log reduction of a mixture of staphylococci, streptococci and Candida yeast species. 
The results of the present study show that inactivation of bacteria in spore form both in 
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liquid or air-dried on surface requires higher doses of DBD plasma treatment, and up to 5 
log reduction can be achieved within a minute of exposure to plasma. It is also shown 
that the mechanisms by which direct plasma inactivates spores and vegetative bacteria 
may be quite different. 
 
4.1. Materials and Methods 
The atmospheric pressure DBD plasma was used to treat Bacillus spores at room 
temperature in air. The powered electrode was made of a 2.5 cm diameter solid copper 
disc covered by a 3.5 cm diameter 1 mm thick quartz dielectric. The discharge gap was 
kept at 1.5 mm. The microsecond-pulsed DBD discharge was ignited by applying AC 
pulsed high voltage of 30 kV in magnitude (peak to peak) and 1.3 kHz frequency 
between the electrodes. Current peak duration was 1.2 μs, and corresponding plasma 
surface power density was 0.3 W/cm
2
. 
Spores were treated in either dry form or in aqueous suspension on glass slides (Figure 
41). The slides were placed on top of grounded metal and plasma was ignited directly 
between the powered electrode and treated spores.  For treatment of spores in water, in 
order to avoid splashing of the solution due to charging during plasma treatment, we used 
hanging drop slides with well diameters of 15 mm and 20 µl capacity (Fischer Scientific). 
To prevent loss of spores due to disbursement during treatment of air-dried spores, spores 
were dried in a plastic chamber (Figure 42) placed on a grounded metal surface, and 
covered with a glass cover slide. The chamber was ventilated with air for faster drying of 
samples; and was washed with water to collect spores after treatment.  
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Figure 41  Principal schematic of the DBD plasma treatment setup with removable mesh, used for indirect 
treatment.  Additional flow of ethanol vapor may be provided as shown by gas flow arrows. 
 
Another set of experiments was carried out using indirect plasma treatment. In this case 
we used a modified plasma system (Figure 41), where grounded metal mesh (22 wires 
per cm, 0.1 mm wire diameter, 0.35 mm openings, 60% open area, weaved mesh) was 
used as a second electrode. The gap between the mesh and the second electrode was kept 
at 1.5 mm, the same in the direct treatment setup. The distance between mesh and treated 
surface was also kept at 1.5 mm. 
In this study we used B. cereus (ATCC 6464, B. cereus Frankland and Frankland) and B. 
anthracis (Sterne strain 7702) spores suspended in distilled water at 10
5
 to 10
8
 spores per 
ml. These experiments were first done using B. cereus spores as a surrogate for B. 
anthracis spores, and then repeated with B. anthracis species.  Spores were prepared 
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according to standard protocol [129], [130]. Each experiment was repeated three times. 
Treated spores were diluted and plated on Brain Heart Infusion (BHI, Fisher Scientific) 
agar, incubated at 37⁰C overnight, and colony forming units (CFUs) were counted. All 
work with B. anthracis was done in BSL 2 laboratory, certified by Drexel University and 
by the CDC. 
 
Figure 42 Schematic of the setup for treatment of air-dried spores with direct DBD plasma. 
 
Treatment of spores in suspension 
Ten μl of B. cereus or B. anthracis spores in distilled water at concentrations of 107, 106, 
and 10
5
 spores per ml, were placed in hanging drop glass slide wells and treated for 5 to 
45 sec with direct DBD plasma. After treatment, bacteria were appropriately diluted and 
plated, as above.  Experiments were done in duplicate on 3 different days.    
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Treatment of dried spores in room air 
Spores were placed inside a plastic chamber (see Figure 42), covered with a glass cover 
slide and dried for about 30 minutes with constant air flow of about 0.1 l/min (control 
experiments with only gas flow through the chamber showed no loss of collected spores). 
10 μl of B. cereus at 108, 107, and 106 spores per ml in distilled water were used. Dried 
spores were treated with direct DBD plasma for 5 to 45 sec, and then washed out of the 
chamber with 30 ml of distilled water, appropriately diluted and plated, as above.  Similar 
experiments were done using B. anthracis spores, except 10 µl of B. anthracis spores 
were placed inside of either plastic or paper envelopes, dried in room air for 1 hour and 
treated with DBD plasma. In these experiments, the discharge was ignited in the volume 
of either plastic chamber, or paper or plastic envelope (envelopes were slightly inflated to 
assure that walls are in contact with powered and grounded electrodes (Figure 43)). 
 
Figure 43 The setup for DBD plasma treatment of air-dried spores contained inside a closed envelope 
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Direct versus indirect treatment of spores in room air 
 We compared the effects of direct and indirect DBD plasma treatment on B. cereus spore 
viability.  Ten μl of spores in water at 105 spores per ml were treated with direct or 
indirect plasma for 10 to 60 seconds, and appropriately diluted and plated.   
4.2. Results and Discussion 
In the first series of experiments, the spores of two Bacillus species, B. cereus and B. 
anthracis, were treated in water droplets on the surface of glass slides using atmospheric 
pressure DBD plasma in room air. The inactivation kinetics of these Bacillus spores of 
three different concentrations after DBD plasma treatment are shown in Figure 44. The 
number of colonies after treatment is plotted on a logarithmic scale as a function of 
treatment dose and time, which are directly related.  Although spores of both species 
were effectively inactivated (up to 5 log reduction in less than a minute of treatment), log 
N, i.e., killing kinetics, was quite different for B. cereus vs. B. anthracis spores; 2-step vs. 
linear, respectively. In addition, anthrax spores appeared to be slightly more resistant to 
plasma treatment (see inset in Figure 44).  These species have similar morphology, 
metabolism and physiology, and similar behavior of inactivation kinetics was reported 
previously, for example when aqueous spore suspensions were treated with UV254 
irradiation (see Figure 6 in [131]). It was noted by the authors that this difference may be 
related to virulence plasmids that may influence UV sensitivity of B. cereus and B. 
anthracis spores. 
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Figure 44 Inactivation of various concentrations of B. cereus (filled squares) and B. anthracis (filled 
circles) spores in water on glass slides using direct DBD plasma treatment.  
 
In contrast to inactivation of spores suspended in distilled water, inactivation by plasma 
treatment of air-dried B. cereus and B. anthracis spores both appear to be linear. Figure 
45 shows the results of plasma inactivation of three different concentrations of B. cereus 
spores dried inside a plastic chamber (see Figure 42).  Inactivation of 10
7
 per ml
 
anthrax 
spores inside of a closed paper envelope is shown in Figure 46. Similar results were 
obtained in the case of plastic envelope (data not shown). These results are interesting, as 
they show the high efficiency of DBD-plasma based systems to sterilize within 
temperature sensitive materials.  This is important in view of the 2001 bioterrorism 
attacks when anthrax spores in envelopes were distributed through the U.S. postal 
service, resulting in illness and death [124]. 
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Figure 45  Inactivation by direct DBD plasma of various concentrations of dry B. cereus spores contained 
inside a closed plastic chamber.  
 
Figure 46 Inactivation by direct DBD plasma of dry B. anthracis spores contained inside a paper envelope. 
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Fridman et al [128] observed a significant difference (a few orders of magnitude) in 
killing of  bacteria (streptococcus and staphylococcus) and yeast when charged species 
were excluded from plasma by introducing a grounded metal mesh between the powered 
electrode and the treated surface. In this case plasma is generated remotely (indirectly) 
and active neutral species and radiation are delivered to the object with the plasma 
afterglow. In our previous experiments [28] we observed that in the case of direct plasma 
treatment of bacteria on agar with an initial concentration of 10
8 
CFU per ml in 
phosphate-buffered saline (PBS), complete sterilization was achieved in 5 to 10 seconds, 
and in more than 15 minutes in the case of indirect plasma treatment. To determine the 
role of charged species (electrons, ions and associated electric fields) on inactivation of 
spores we performed similar experiments using B. cereus spores in distilled water (Figure 
47). The difference in spore inactivation, about 1.5 log, appears to be not as large as for 
vegetative bacteria, however, it is still significant.  Moreover, in the case of indirect 
plasma treatment, the inactivation process clearly consists of 2 stages, with about the 
same inactivation rate in the first stage as we observed for direct plasma treatment. The 
effect of charged species, electron and ions, may be related to production of hydrogen 
peroxide in liquid phase (similar reactions may take place in the gas phase; all 
experiments were done in room air at about 60% relative humidity): 
 
      
                 
 
   
             
  
 
            
 
   
         
    
          
  
where M
+
 is any positively charged ion. Hydrogen peroxide is readily soluble in water 
and is relatively easily transported through outer spore coats [132]. At appropriate 
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conditions, hydrogen peroxide may be converted inside of spores to hydroxyl radicals 
through a natural reaction chain termed Fenton mechanism: 
 
       
              
       
         
  
To determine the role of neutral OH radicals, which may react directly with spores due to 
their extremely high reactivity, or which may be converted into hydrogen peroxide, we 
introduced ethanol vapors into indirect DBD plasma discharge, and treated B. cereus 
spore suspensions in water (in plasma, ethanol is easily decomposed with formation of 
OH radicals and hydrogen peroxide [133], [134]). There was no decrease in spore 
viability in control experiments where only ethanol vapor flowed through the system 
(data not shown).  The results (Figure 48) show that additional production of OH radicals 
allows greater inactivation of spores.   
 
Figure 47 Inactivation of B. cereus spores in water using direct and indirect DBD plasma  
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To see if morphological differences occurred, we analyzed spore morphology before and 
after DBD plasma treatment. Bacillus cereus spores were deposited onto stainless steel 
coupons and were observed by scanning electron microscopy (SEM). Samples were then 
exposed to DBD plasma for 1 minute (corresponding to a dose of 18 J/cm
2
), and SEM 
photomicrographs of the same spores were taken again. As can be seen when comparing 
the photomicrographs of spores before and after treatment (Figure 49), the inactivation 
mechanism is not erosion of the spores, since their protective coats appear to be 
undamaged. Therefore, we believe that diffusion of chemically active oxygen species 
(e.g. H2O2) into spores followed by damage of internal macromolecules or molecular 
systems may be the primary mechanism of spore inactivation. 
 
Figure 48 The effect of ethanol vapor on inactivation of aqueous suspensions of B. cereus spores by 
indirect DBD discharge. 
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Figure 49 SEM photomicrographs of B. cereus spores on a stainless steel coupon before (top) and after 
(bottom) exposure to direct DBD plasma (same spot of one sample in both photos)  
4.3. Conclusion 
In summary, the mechanism by which DBD plasma kills Bacillus spores appears to be 
quite different from the mechanism by which it kills vegetative bacilli. As indicated 
above, a 2-stage process occurs in killing of spores by DBD plasma: the first stage, which 
is not sensitive to the presence of charged particles, may be dominated by the effect of 
UV radiation generated by the plasma. This supposition comes from the following 
observations: 1) the initial rate of inactivation of spores is about the same for direct and 
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indirect plasmas (slightly less for indirect, since the metal mesh allows less radiation to 
access the sample); 2) difference in inactivation rate of B. cereus and B. anthracis spores, 
which may be related to different sensitivity due to differences in, for example, plasmid 
and surface content. The second stage appears related to production of neutral reactive 
oxygen species that are transported inside the spore to cause damage to biomolecules 
critical to cell‘s survival or germination.  One possible effect may be related to oxidation 
of germination proteins located in spore coats, or inactivation of germination receptors 
which are located on inner spore membrane [135,136].  Both germination proteins and 
germination receptors are required for successful germination [135,136].  Hydrogen 
peroxide is one possible agent responsible for such effects, as it is known to inactivate 
spores at low concentrations [120]. It was suggested that lethal action occurs through 
inactivation of enzymes which are mainly located in the spore protoplast, and of the 
germination apparatus, while no lysis of spores is noticed [120]. 
We have demonstrated that DBD plasma is able to effectively inactivate Bacillus spores 
both in liquid and in dry forms: up to 5-log reduction of spores was observed after less 
than a minute of treatment.  We also showed that active oxygen radicals play a significant 
role in the inactivation process.  
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CHAPTER 5. PLASMA STERILIZATION OF LIVING TISSUE: IN VIVO 
STUDIES 
 
One of the most widely discussed potential applications is plasma treatment of wounds 
for the purpose of reducing microbial load and enhancing healing processes 
[55,79,137,138,139].  Two major types of plasma treatment have been discussed in 
connection with wound disinfection (see Chapter 3).  One is indirect treatment using gas 
flow through plasma which brings mostly neutral active species in contact with living 
tissue. The other is direct application of non-thermal plasma to living tissues.  Indirect 
treatment permits to decouple plasma system design from constraints related to applying 
the treatment to living tissues.  For example, it permits to employ thermal plasma for 
generation of active species including substantial quantities of NO [63,88,140,141]. 
Indirect plasma treatment of skin and wounds has been investigated over the last several 
years demonstrating a significant effect [137].  On the other hand, applying non-thermal 
plasma directly to living tissue makes it possible to employ charges and short living 
neutral species [94,142].  It has been demonstrated above that bacterial inactivation on 
surfaces of agar and even skin can be achieved significantly faster with direct exposure to 
non-thermal plasma such as the Dielectric Barrier Discharge (DBD). No significant 
toxicity was observed during relatively low power and duration plasma exposure which is 
typically sufficient to achieve significant reduction in the bacterial load [94,137,140,143].  
However, effects of direct DBD plasma treatment on bacterial inactivation in real wounds 
have not been reported so far. 
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In this chapter, a study where open wounds contaminated with bacteria are treated with 
Floating Electrode DBD plasma directly is presented.  Rat is employed as the animal 
model.  Although bleeding is stopped and most of the excess wound fluid is removed 
prior to plasma application, the wound remains moist.  The results demonstrate that over 
3-log reduction (over 1000 times) of bacteria occur following only 1 min of DBD plasma 
treatment without any visible tissue damage. 
5.1. Materials and methods 
Floating electrode dielectric barrier discharge 
In this study we have used a floating electrode dielectric barrier discharge (FE-DBD) 
generated between an insulated high voltage electrode and the sample (FE) undergoing 
treatment.  Half millimeter thick polished clear fused quartz (Technical Glass Products, 
Painesville, OH), was used as an insulating dielectric barrier.  The setup and high voltage 
electrode schematic is shown in Figure 50. The discharge was generated by applying high 
voltage pulses with the following characteristics: 20 kV (p-p), 1.6 s pulse duration, 1 
kHz frequency.  The average power density for the active area of the high voltage 
electrode was kept at the level of approximately 0.5 W/cm
2
, i.e. 0.74 Watt for 15 mm 
electrode diameter.  The electrode was specifically designed to fit into the Polycarbonate 
holder as is shown in Figure 50 and a set of spacers of 0.5 mm thickness was provided to 
the operator to allow for controlled application of plasma for every wound. 
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Figure 50.  Schematic of the FE-DBD plasma electrode that fits into the plastic ring sutured to the wound. 
 
All procedures were performed in compliance with the animal welfare and protection act 
following the Drexel University‘s Institutional Animal Care and Use Committee 
(IACUC) approval. 
Animal model 
Thirty hairless Sprague-Dawley rats, weighing approximately 250 g, arrived and 
acclimated for 3-5 days in the facility.  Animals were transferred from the viviarium to 
the approved surgical suite.  Animals were continuously anesthetized with inhalational 
gas anesthetic, Isoflurane (Vedco, St. Joseph, MO) at 2-3% induction plus oxygen 
2L/min then 1.5-2% maintenance administered via a face mask for the appropriate length 
of time and placed in the supine position.  Animals received analgesia (Meloxicam, 
Boehringer-Ingelheim, Germany) at 1 mg/kg, subcutaneous, Bupivicaine 25% (Hospira, 
Lake Forest, IL) 0.5 ml/site intradermally and Normosol R (Baxter, Deerfield, IL) 
crystalloid parenteral fluid therapy at 10ml/kg subcutaneous bolus at the onset of 
anesthesia but prior to surgery.  The ventral surface of the rat was prepared in sterile 
surgical fashion: the surgical area was gently washed and sanitized with chlorhexidine 
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scrub solution; the area underwent an initial contact scrub of 5 minutes, rinsed with 
normal saline solution and repeated second time; a preparatory solution of diluted 
chlorhexidine with isopropyl alcohol (1:8) was lightly sprayed onto the surgical area.    
Approximately 2 cm incisions along the right and left side of the thoracic region were 
inflicted and plastic rings were inserted into the subcutaneous layer of the skin (ring size 
was equivalent to the size of the plasma probe) and restricted the bacteria to the affected 
area only, Figure 51). The skin was sutured with 3-0 nylon around the ring in a continous 
suture pattern.  Twenty l drops of PBS solution containing S. aureus at concentration of 
10
5 
or 10
6
 ml
-1
 were applied to the wounds and covered and secured with sterile 
Tegaderm dressing (3M, St. Paul, MN).   Animals were recovered from anesthesia in a 
pediatric warming incubator and bacteria incubated for four hours.  Upon completion of 
bacterial incubation, animals were re-anesthetized, wounds were opened and treated with 
DBD or untreated controls.  After treatment, wounds were swabbed using sterile 
technique and transferred into PBS for further dilution and plating and plated directly 
onto BHI agar. Bacteria inactivation efficiency by DBD plasma treatment was analyzed 
after 14 hours of incubation on BHI agar.  Figure 51 shows the sequence of steps taken 
during the animal procedure. 
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Figure 51.  Steps taken during the animal procedure: (a) a cut is made; (b) plastic ring is inserted into the 
skin and (c) sutured in place; (d) wound area is inoculated with known concentration of S. aureus and (e) 
covered with sterile dressing; 4 hours following inoculation the sterile covering is removed and (f) wound 
area is treated with plasma; after the treatment (g) the wound area is thoroughly swabbed and (h) plated for 
bacterial counts. 
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All data is reported with 95% confidence interval (p < 0.05) and the number of samples 
in each experiment is identified. 
5.2. Results and discussion 
The results of viable Staphylococcus aureus inactivation in living tissue of experimental 
wound using FE-DBD plasma for initial concentration of bacteria of 10
5 
or 10
6
 cells per 
ml of PBS are shown in Figure 52.  We observed a 3-log reduction of bacteria after a one 
minute exposure to plasma, and the results are similar for the both initial concentrations 
of bacteria. 
 
Figure 52.  Results of wound sterilization with 103 and 104 starting bacterial load. 
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Interestingly, the inactivation efficiency of plasma treatment in the wound is about an 
order of magnitude less than that for the agar surface [94,137].  Here we propose two 
possible explanations of this effect.  First, it is necessary to mention that even under 
assumption of discharge uniformity (i.e. discharge was covering the whole surface of the 
electrode, which in present setup was impossible to control), direct plasma exposure has 
provided only at ~75% of the wound surface due to presence of dielectric enclosure 
around central copper.  Therefore, it is possible that the remaining ~25% of bacteria, 
which were relatively uniformly distributed over the wound, were treated indirectly. 
Indirect plasma exposure, i.e. when there is no direct exposure of the treated bacteria to 
charged species, was previously shown to be about an order of magnitude less effective 
in bacteria inactivation on agar than direct treatment.  The second hypothesis is related to 
the presence of wound liquids – compared to almost dry, covered with a minute amount 
of water, ―moist‖ surface of agar. Again, as we have previously shown,  liquid water 
plays as a ―protective‖ layer, preventing direct delivery of charges to the bacteria surface, 
and significantly dilutes the inactivation effect of active neutral particles [79,142].  At the 
same time, this wound liquid, which contains high amount of organic molecules, and 
wound itself may also react with plasma produced reactive species, resulting in decreased 
activity of plasma treated medium.  
5.3. Conclusion 
While we have previously shown effective inactivation of pathogenic organisms in many 
regimes of plasma and on various surfaces (see [137,142] for examples) we have not 
previously addressed sterilization of living open wound tissue such as would be present 
during surgery.  Here, it is shown that sterilization is possible and is quite effective of an 
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open wound area of bacteria that was allowed to ―settle‖ in the wound for 4 hours.  While 
the treatment appears to not have any adverse or toxic effect on the wound tissue (as was 
previously the case with intact skin [94]) an open question remains of the effect of 
plasma on the wound itself and on the wound healing rate.  Since plasma was previously 
shown in-vitro to generate reactive oxygen species (ROS) which were shown to promote 
cell proliferation [143] and in this work was confirmed in-vivo to produce bacterial 
inactivation similar to in-vitro studies we may assume that wound healing time will be 
reduced following the treatment.  This, however, remains to be verified and is the subject 
of the follow-on studies. 
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CHAPTER 6. DIRECT AND CONTROLLABLE PRODUCTION AND 
DELIVERY OF ACTIVE SPECIES BY PLASMA 
 
Cold atmospheric pressure plasma discharges have been shown to be effective when 
applied for wound sterilization and decontamination purposes and wound healing. Action 
of specific charged or neutral active species or radiation is frequently associated with the 
corresponding specific effect (e.g., anti-inflammatory effect of nitric oxide (NO), and 
highly oxidative hydroxyl radical and other reactive oxygen species (ROS)). 
Traditionally, production of these biologically extremely important reactive species has 
been measured in gas phase, i.e. at the production point – plasma itself or plasma 
afterglow. Although these measurements are undoubly necessary and useful, the real 
effect of plasma treatment is almost never ―direct‖ (except for special cases of, for 
example, low pressure sterilization of surfaces or polymer treatment), and is often 
associated with so-called ―water chemistry‖. Indeed, in the case of wounds, where a large 
amount of various biological liquids (e.g. blood, pus) is present, plasma produced 
reactive species are first react and diffuse in media, and then for successful activation of 
signaling pathways of healing mechanism have to be delivered even further – deep into 
tissues and cells. Therefore, measurements of production and delivery of plasma 
produced ROS, followed by numerical modeling of these processes linked to the plasma 
source, seem to be extremely important for the development of fundamental 
understandings of the plasma-tissue interaction. 
In this chapter we discuss the results of experimental studies on plasma delivery of 
reactive oxygen and nitrogen species (ROS and RNS) into liquid media.  
96 
 
 
 
6.1. Detection and measurement of ROS and RNS produced in liquid 
media by microsecond spark discharge in a pin-to-hole electrode 
configuration (PHD) 
Reactive oxygen and nitrogen species play an extremely important role in many 
biological processes, and depending on concentration of these species one may expect 
different effects on cells – from accelerated cell growth to apoptosis and necrosis. 
Therefore it is important to control amount of ROS and RNS produced by plasma in a 
treated biological object. Since almost always these objects (cells and tissues) are 
surrounded by certain liquid media, as a first step we chose detection and, if possible, 
measurement of ROS and RNS in a solution. One of the easiest way to do that is utilizing 
a widely used among biologists, well studied and readily available fluorescent technique, 
where a certain fluorescent dye reacts with a specific molecule of interest and as a result 
of this reaction its fluorescent properties are changed. One of drawbacks of this method is 
that it is difficult to synthesize a dye which would react only with specific specie of 
interest (because of highly reactive nature of these species), and usually manufacturers 
indicate ―preferred‖ reactive specie. However, by blocking (scavenging) other possible 
reactants it is possible to measure the concentration of specie of interest with little error. 
Here we focused on detection and measurement of the following species: hydrogen 
peroxide, superoxide (O2
-), peroxynitrite and ―singlet‖ oxygen. It is necessary to mention, 
that although the manufacturer specifically indicated that it is possible to measure singlet 
oxygen, it is still not clear in which state exactly the molecular oxygen is detected.  
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6.1.1. Materials and methods 
Microsecond spark discharge plasma in a pin-to-hole spark discharge configuration 
(PHD) was used in all experiments. Measurements of hydrogen peroxide (H2O2), 
superoxide (O2
-
), peroxynitrite (ONOO
-) and ―singlet‖ oxygen produced by plasma were 
done in phosphate buffered saline (PBS), since according to the manufacturers‘ protocols 
fluorescent properties of dyes highly depend on pH of the solution, while PBS provides 
necessary pH buffer properties. Measurements of H2O2 were done using 100 mM 
Amplex UltraRed reagent (Invitrogen) fluorescent dye with addition of 200 U/ml 
horseradish peroxidase (MP Biomedicals) according to the manufacturer‘s protocol. The 
reagent is a fluorogenic substrate for horseradish peroxidase (HRP) that reacts with 
hydrogen peroxide (H2O2) in a 1:1 stoichiometric ratio to produce Amplex®  UltraRed, a 
brightly fluorescent and strongly absorbing reaction product (excitation/emission maxima 
~568/581 nm). To obtain calibration curves for hydrogen peroxide in the plasma treated 
samples a standard stabilized 3% H2O2 (Fisher) water solution properly diluted to obtain 
various concentrations was used. Superoxide (O2
-
) was measured indirectly by H2O2 
concentration increase in presence of superoxide dismutase (SOD, 3 U/mL, Fisher): 2 O2
- 
+ 2 H
+
 [+SOD]  H2O2  + O2 [+SOD]. Peroxynitrite, which is not a free radical, but also 
a powerful oxidant and is product of reaction of superoxide
 
with nitric oxide:   
      
     
 , was measured using 2,7-Dichlorodihydrofluorescein (DCDHF, Ex/Em: 
502/523 nm) (Cayman Chem, 300 mM in DMSO). Singlet oxygen was measured using 
10 mM Singlet Oxygen Sensor Green Reagent (Ex/Em: 504/525 nm, Invitrogen) solution 
in PBS. According to the manufacturer‘s protocol, the Singlet Oxygen Sensor Green 
reagent is highly selective for 
1
O2; unlike other available fluorescent and 
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chemiluminescent singlet oxygen detection reagents, it does not show any appreciable 
response to hydroxyl radical or superoxide. To check that, we have used singlet oxygen 
and OH scavengers, sodium azide NaN3 (Fisher Sci, 600mM in PBS) and D-mannitol 
(Fisher Sci , 300 mM in PBS) respectively, added to the dye containing solution right 
before the treatment.  In order to ensure that UV radiation produced by the discharge does 
not result in increased fluorescence, the solutions were first treated through a 0.5 mm 
quartz glass placed in front of the discharge. Fluorescence was measured using an LS55 
(Perkin Elmer) fluorescent spectrometer equipped with well plate reader accessory.  
6.1.2. Results and discussion 
H2O2 concentration in PHD plasma treated PBS (Figure 53) increased up to 60 µM with 
30 seconds of direct plasma treatment, while no significant effect was measured due to 
UV radiation. In terms of H2O2 concentration, superoxide O2
-
 radical was detected in 
about the same amount – roughly twice higher signal was detected in the presence of 
superoxide dismutase.  
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Figure 53 Measured H2O2 and O2
- concentration in PHD plasma treated PBS 
 
When measured singlet oxygen, the results obtained appear to be quite confusing: 
although there is definite dependence of the dye fluorescence on the distance from the 
plasma source (Figure 54), but addition of OH and singlet oxygen scavengers resulted in 
comparable fluorescent intensities. These results indicate that the Singlet Oxygen Sensor 
Green reagent may be sensitive to both of them and also depends on presence of other 
reactive species. 
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Figure 54 Detected ―singlet‖ oxygen in PHD treated water (left), and effects of scavengers on ―singlet‖ 
oxygen detection signal. 
 
In contrast, measurements of peroxynitrite were fairly consistent (Figure 55), and 
addition of superoxide dismutase, which prevents formation of ONOO
-
 by reacting with 
O2
-
, resulted in significantly lower fluorescent signal. 
 
Figure 55 Detected peroxynitrite in PHD treated water. 
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6.2. Direct and controllable nitric oxide delivery into biological media 
and living cells by a pin-to-hole spark discharge (PHD) plasma 
Nitric oxide (NO) is a short-lived bioactive molecule critical to inflammatory and 
vascular processes, in particular wound healing. In the early wound, high NO levels are 
produced by inflammatory cells such as neutrophils and macrophages to fight infection 
[144]. As the wound heals, endothelial cells, fibroblasts and keratinocytes produce lower 
sustained NO amounts to stimulate angiogenesis and new tissue formation. The critical 
role of NO in wound healing is evidenced by poor wound healing in animals with 
decreased NO production, which was reversed by exogenous NO application [145]. 
Various local topical NO delivery systems have been developed to promote wound 
healing in NO-deficient wounds, such as diabetic ulcers [145,146,147,148]. However, the 
success of these treatments was limited by short NO half-life, rapid or inconsistent NO 
release over a limited timeframe, and NO donor instability [145,149,150]. Any NO 
therapy for wound healing should have simple administration with minimal side effects. 
Ideally, the approach should address both the wound inflammatory and healing stages. 
NO treatment from thermal plasmas has previously been shown to enhance wound and 
skin disease treatment. The ―Plazon‖ system, a rapidly quenched hot air plasma jet, can 
provide a relatively high NO concentration with significant therapeutic effect [17,151]. 
This plasma device was used in two modes. In ―hot mode,‖ the plasma jet was used to 
rapidly coagulate and sterilize wound surfaces, as well as to remove, dissect, or desiccate 
dead tissue and pathologic growths. In ―cold mode,‖ the NO-rich plasma gas flow (20–
40°C) was used to stimulate regenerative processes and wound healing. Additional NO 
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plasma sources include a pulsed arc discharge, a high frequency discharge, and an 
atmospheric pressure plasma jet [152,153,154].  
An alternative NO producing plasma, a pin-to-hole spark discharge (PHD), has also been 
reported to sterilize liquids and surfaces (including living tissue) and may stimulate 
wound healing. The advantages of this plasma include that it is small and portable, uses a 
low voltage power supply, operates in room air, can be applied directly to tissue without 
measurable damage, and can deliver both reactive oxygen species (e.g., hydrogen 
peroxide) and UV radiation. However, this spark discharge and its cellular effects have 
never been characterized.  
In this study, we measured the PHD plasma NO production in gas, and NO delivery into 
liquid and cells. We further investigated plasma NO effects on cell viability and 
intracellular signaling. It is shown that the PHD plasma effectively produces and delivers 
NO, which results in a functional cellular response with minimal cell toxicity. 
6.2.1. Materials and methods 
Spark discharge plasma in a pin-to-hole spark discharge configuration (PHD) was used in 
all experiments. To prevent cell effects due to plasma discharge UV emission and 
reactive oxygen species (ROS) production (e.g. hydrogen peroxide), either straight or 
curved 50 mm Tygon tube extensions were attached to the cathode (Figure 56). 
103 
 
 
 
 
Figure 56 Probe extensions used in the study: direct treatment at 3 mm distance, straight and curved 50 mm 
tube extensions. 
 
Endothelial cell culture and plasma treatment 
Porcine aortic endothelial cells (PAEC) were isolated from swine aorta by the 
collagenase dispersion method [155]. Cells were cultured in low glucose Dulbecco‘s 
modified Eagle‘s medium (DMEM, Mediatech) supplemented with 5% fetal bovine 
serum (Hyclone), 1% penicillin-streptomycin, and 1% glutamine (Invitrogen). Cells 
between passages 4 and 9 were maintained in a humidified incubator at 37°C and 5% 
CO2 with a media change every two days.   
4,5-diaminofluorescein (DAF-2), 4,5-diaminofluorescein diacetate (DAF-2 DA), 3-
isobutyl-1-methylxanthine (IBMX) and cGMP Enzyme Immunoassay (EIA) kit were 
purchased from Cayman Chemicals. Diethylamine NONOate (DEA NONOate, Cayman 
Chemicals) and sodium nitroprusside (SNP, Sigma) were used as NO donors. Sodium 
pyruvate (SP, Sigma) was used as the ROS scavenger. 
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Phosphate buffered saline (PBS) and endothelial cells were plasma treated with either the 
straight or curved tube extension. All NO measurements were carried out in PBS (pH 7.4) 
while cell viability assays were in both PBS and serum-free media. The cGMP assay was 
carried out in serum-free media.  
Nitric oxide and hydrogen peroxide measurement in gas, liquid, and cells 
NO production in gas phase was measured using a gas chromatograph (Agilent 3000 
MicroGC) calibrated with 700 ppm NO balanced with nitrogen. The discharge cell was 
inserted inside a syringe tip, and plasma treated room air was collected by slowly pulling 
the plunger during plasma treatment. The collected air was then analyzed 
chromatographically.  
The fluorescent dye DAF-2 is widely used for quantitative NO measurement in liquids 
and biological tissues. DAF-2 does not interact with reactive nitrogen and oxygen 
species, such as nitrates (NO3
-
) and nitrites (NO2
-
), superoxide (O2
-
), hydrogen peroxide 
(H2O2), or peroxynitrite (ONOO
-
) [156]. DAF-2 detects NO by reacting with an active 
intermediate, N2O3, formed during oxidation of NO to nitrite, yielding a fluorescent 
compound DAF-2 triazole (DAF-2T) [156]. 
All reagents were freshly prepared prior to each experiment. 100 µl PBS containing 1 µM 
DAF-2 was added to a 96-well plate (Corning).  The solution was treated with plasma for 
0 - 240 pulses, using either the straight or curved tube extension. Fluorescence was 
measured at ex/em: 485/538 nm using an Infinite 200 Tecan microplate reader. 
Fluorescence was converted to NO concentration using a standard curve developed using 
the NO donor, DEA NONOate. DEA NONOate dissociates with a half life of 2 minutes 
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at 37°C to liberate 1.5 moles of NO per molecule NONOate [157]. To obtain the standard 
curve, DEA NONOate (0 – 667 nM) dissolved in 0.01 N NaOH was incubated with 
DAF-2 (1 µM) for 30 min at 37°C and fluorescence was measured using the microplate 
reader as described. 
The cell permeant version of DAF-2, DAF-2 diacetate, was used to measure NO 
concentration in an endothelial cell monolayer. DAF-2 DA is a non-fluorescent cell 
permeable molecule, which upon entry into the cell is cleaved by cellular esterases into 
the less permeable DAF-2 [156]. PAEC were seeded near confluence in a 96-well plate 
(30,000 cells/well) and incubated for 24 h. Prior to plasma treatment, cells were loaded 
with DAF-2 DA (10 µM) for 45 min. The wells were washed once and 100 µl PBS was 
added. The cells were treated with plasma for 0 - 240 pulses, using the curved tube 
extension. Fluorescence was measured at ex/em: 485/538 nm in a microplate reader. 
DAF-2T (fluorescent compound) stability was tested by plasma treating samples (60 
pulses) and measuring fluorescence at regular intervals up to 30 min after treatment. The 
measured fluorescence was stable for up to 15 min, after which a 7% decrease was 
observed at 30 min. Hence, all plasma treatments and fluorescence measurements were 
carried out in less than 15 min for repeatability.  
Hydrogen peroxide (H2O2) was measured in PBS after PHD plasma treatment using the 
fluorescent Amplex UltraRed probe (Invitrogen) according to the manufacturer‘s 
protocol. 75 µL PBS containing 100 µM Amplex UltraRed with 200 U/µL horseradish 
peroxidase (MP Biomedicals) was PHD plasma treated either directly at 3 mm distance 
or with straight or curved tube extensions. Calibration curves were obtained using 
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stabilized 30% hydrogen peroxide (Fisher Scientific) diluted in PBS.  Fluorescence was 
measured at ex/em: 530/590 nm using an LS55 fluorescent spectrometer (Perkin Elmer). 
NO concentrations in liquid and cells were numerically calculated based on measured 
NO gas concentration, with the assumption that only diffusion occurred and no NO was 
lost to reactions in the gas or liquid phase. The diffusion equations from the gas to the 
liquid are: 
             
  
 
     
 
                  
 
        
  
 
     
 
                      
where Co, Cgas/surf and CH2O are NO concentrations at the plasma discharge cell, at the 
liquid surface, and in the water respectively; Dgas and DH2O are NO diffusion coefficients 
in gas and water; kh is the Henry constant for NO in water, L is the tube length, and d is 
the liquid depth with surface area S. The plasma discharge NO production was simulated 
with a linear dependence on time until the saturation concentration was reached:       
               A similar diffusion equation was used for calculation of NO diffusion 
into cells, assuming that cells uniformly covered the well bottom in a single layer. The 
values used for calculation are listed in Table 4. 
Cell viability 
Cell viability following plasma treatment was measured via cell counts and a Live/Dead 
assay (Invitrogen). PAEC were seeded near confluence in a 24-well plate (200,000 
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cells/well) and incubated for 24 h. Supplemented media in the wells was replaced with 
200 µl serum-free media or PBS, and samples were treated with plasma for 0 – 240 
pulses using the 50 mm curved tube extension. Following plasma treatment, PAEC were 
returned to supplemented media and incubated at 37°C for 3 or 24 hours. 5 mM SNP was 
used as the positive control. Cells were washed once in PBS to remove detached cells, 
trypsinized and counted using a Coulter counter (Beckman Coulter).  
Table 4 Experimental parameters and constants used for numerical modeling of NO diffusion from gas into 
liquid and cells. 
Quantity value Reference 
Tube length, L 5 cm  
Liquid depth, d 0.3 cm  
Liquid surface area, S 0.3 cm
2
  
NO diffusion coefficient in gas, Dgas 0.3 cm
2
/sec [158] 
NO diffusion coefficient in water, 
DH2O 
2
.
10
-5
 cm
2
/s [159] 
Henry constant for NO in water, kh 1.9
.
10
-3
 M/atm [160] 
Cell membrane permeability 0.9 m/s [161] 
Intracellular NO diffusivity 0.9
.
10
-9
 m
2
/s [161] 
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For the Live/Dead assay, PAEC were seeded near confluence in a 96-well plate (30,000 
cells/well) and incubated for 24 h. 100 µl serum-free media was added to each well, after 
which cells were treated with plasma for 0-240 pulses using the 50 mm straight or curved 
tube extension and incubated for 24 h. Cells were then washed to remove detached cells, 
labeled with 2 µM calcein AM and 4 µM ethidium homodimer-1 (EthD-1) and incubated 
for 45 min at room temperature. Live cells convert non-fluorescent cell permeant calcein 
AM into highly fluorescent calcein by intracellular esterase activity. EthD-1 binds to 
nucleic acids in membrane damaged cells to undergo a 40-fold increase in fluorescence, 
and is excluded by cells with intact membranes. Thus calcein is retained by live cells and 
produces green fluorescence (ex/em: 485/530 nm), while EthD-1 produces red 
fluorescence in dead cells (ex/em: 530/645 nm). Fluorescence was measured using a 
microplate reader as described.  
For Live/Dead imaging using a fluorescent microscope, PAEC were seeded near 
confluence in a 24-well plate (200,000 cells/well) and incubated for 24 h. Supplemented 
media in the wells was replaced with 200 µl serum-free media, and samples were treated 
with plasma for 0-240 pulses using the 50 mm curved extension. Cells were then labeled 
with calcein AM and EthD-1 as described previously and imaged by fluorescent 
microscopy (Olympus) with a digital high performance CCD camera (Diagnostic 
Instruments).  
NO intracellular cGMP induction 
Nitric oxide diffuses freely through biological membranes into the cytoplasm [162], 
where it stimulates soluble guanylyl cyclase (sGC) to convert guanosine triphosphate 
(GTP) into 3, 5-cyclic guanosine monophosphate (cGMP) [163]. Many of the biological 
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effects of NO are mediated through the second messenger, cGMP. Hence, the cGMP 
assay is widely used for the indirect NO measurement. Guanylyl cyclase can be activated 
by nanomolar concentrations of intracellular NO [164]. 
Nitric oxide induced cGMP accumulation was measured using a cGMP competitive EIA. 
In this assay, a constant cGMP tracer concentration competes with free cGMP in the 
sample for cGMP-specific binding sites in the well. The sample cGMP concentration is 
therefore inversely proportional to the bound cGMP tracer amount (measured well color). 
PAEC were seeded near confluence in a 24-well plate (200,000 cells/well) and incubated 
for 24 h. Prior to plasma treatment, cells were incubated with IBMX (0.5 mM) for 30 min 
at 37°C to prevent cGMP degradation by phosphodiesterases [165]. Cell medium was 
then replaced with 200 µl serum-free medium containing IBMX, and cells were plasma 
treated for 0-240 pulses using the curved tube extension. Media was aspirated and 0.1 N 
HCl was added to each well. The cells were then scraped off the surface, samples were 
centrifuged at 1000g for 10 min, and the supernatant was assayed as per manufacturer‘s 
instructions.  
Statistical analysis 
Statistical analysis was performed using Prism software (Graphpad). Data are expressed 
as mean ± SD. Data were analyzed with one-way or two-way ANOVA. Individual groups 
were evaluated by Bonferroni‘s multiple comparison test and p values < 0.05 were 
considered significant.   
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6.2.2. Results and discussion 
H2O2 concentration in PHD plasma treated PBS (Figure 57) increased up to 60 µM with 
30 seconds of direct plasma treatment (210 pulses). However, the PBS H2O2 
concentration was significantly reduced when either a straight or curved tube extension 
was used. In these configurations, H2O2 reached a stable concentration of 1.5 - 2 µM in 5 
-10 seconds of treatment at 7 Hz (35-70 pulses), which was nearly 30 times lower than 
H2O2 measured in the direct treatment configuration. H2O2 is formed by water vapor in 
the air flow (relative humidity ~60%) around the discharge cell, as well as by interaction 
of ions with the liquid. These ions, which do not travel far, would not be able to reach the 
liquid in the tube configurations. Once formed, H2O2 in the gas may react with the Tygon 
tubing walls in the straight and curved tube extension configurations. This would 
dramatically reduce the amount of H2O2 that reaches the liquid. 
 
Figure 57 Hydrogen peroxide in PHD plasma treated PBS decreased in the straight and curved tube 
configurations, as measured by Amplex Ultrared probe. 
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PHD plasma H2O2 production is also of interest in wound healing applications. In early 
wound healing, H2O2 activates cell surface tissue factor to restore hemostasis and 
modulates both leukocyte adhesion and motility in inflammation [166,167,168]. Reactive 
oxygen species are also important in wound re-vascularization, since H2O2 induces 
vascular endothelial growth factor expression and is critical in its signaling [169,170]. 
Finally, in late wound healing, H2O2 promotes re-epithelialization by activating matrix 
metalloproteinases and promoting epithelial cell motility [171]. Thus a plasma device that 
can deliver defined doses of H2O2 and NO individually or in combination may be useful 
throughout the wound healing process.  
Nitric oxide in gas, liquid, and cells after PHD plasma treatment  
We determined NO concentrations in gas, liquid, and cells following PHD plasma 
treatment and compared experimental results to numerical simulations of NO 
concentrations in liquid and cells under diffusion-only conditions (Figure 58). In gas, NO 
concentration rapidly increased with plasma treatment and reached a stable level of 
1980±50 ppm NO by around 50 seconds. In the liquid (PBS), NO concentration increased 
linearly up to 240 plasma pulses, as measured by DAF-2 dye. Approximately 75% of NO 
from plasma-treated PBS diffused through the cell membrane into the cytoplasm. A 
maximum 1000 nM NO was detected in endothelial cells immediately following 240 
plasma pulses (Figure 58). The model closely predicted the experimental NO levels. 
However, since no losses were considered in the model, the theoretical NO levels were 
slightly higher than the experimental values.  
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While gas NO concentration saturated after 50 pulses, the NO level in liquid and cells 
continued to rise up to 240 pulses. This effect is likely related to diffusion time. NO 
diffusion through gas is relatively fast (Dgas = 0.3 cm
2
/s), however NO diffusion through 
water is significantly slower (DH2O = 2 x 10
-5
 cm
2
/s). Plasma NO had to travel through a 
50 mm tube filled with room air to reach the liquid surface, and it additionally traveled 
through 3 mm of PBS to reach the liquid bottom and the cells. While 240 seconds was 
inadequate to reach saturation, the model predicted that saturation would be reached after 
about 10 minutes. Lower NO concentration in cells as compared to PBS may be due to 
the short NO half-life in liquid, since NO diffuses freely across cell membranes. 
Similarly, while a maximum NO concentration of 1400 - 1600 nM was detected in PBS 
with the straight tube configuration, for the curved tube configuration, ~ 900 nM NO was 
detected in PBS for the same treatment duration. Decreased NO delivery with the curved 
tube was likely related to NO interaction with the tube surface. 
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Figure 58 NO concentration in gas, PBS, and the endothelial cell monolayer following PHD plasma 
treatment with the straight tube configuration; dotted lines show numerically calculated NO concentration 
in PBS and endothelial cells. 
 
Cell viability with plasma treatment  
Cell viability after plasma treatment was measured to ensure that plasma was non-toxic to 
cells. For cell counts, PAEC were treated with plasma in both PBS and serum-free media, 
employing the curved tube configuration. For both fluids, no significant cell loss was 
observed 24 hours after plasma treatment up to 240 plasma pulses (Figure 59(a)). A 
Live/Dead assay was carried out to confirm the results from cell counts. Approximately 
20% cell loss was observed for a treatment of 240 pulses in serum-free media in the 
straight tube configuration. No significant cell loss was observed for low treatment doses 
(Figure 59(b)). For similar treatment conditions employing the curved tube extension, no 
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significant cell loss was observed even at 240 pulses (Figure 59, (c)). Differences in cell 
viability between the straight and curved tube configurations may be related to NO dose, 
since the straight tube produced more NO. However the differences are more likely 
related to residual plasma UV reaching and killing the cells. These data suggest that 
plasma-derived NO and PHD plasma treatment are relatively non-toxic to endothelial 
cells. 
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Figure 59 Endothelial cell viability was maintained following PHD plasma treatment. Viable endothelial 
cell number 24 hours post plasma treatment using (a) cell count and, (b) Live/Dead assay. * p < 0.05 
compared to control, # p < 0.001 comparing straight and curved tube for 240 pulse plasma treatment. 
Live/Dead assay images (c) show that almost all plasma treated cells are alive (green) whereas few are dead 
(red). Scale bar is 200 µm. 
Intracellular cGMP in response to plasma-derived NO 
NO biological activity was measured indirectly in cells by determining cGMP 
concentration. cGMP inside endothelial cells following plasma treatment was measured 
up to 240 pulses using the curved tube extension. A linear increase in cGMP was 
observed with plasma dose (Figure 60). The endothelial cGMP concentration for the 
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highest plasma treatment of 240 pulses increased approximately 4 times compared to 
control.  
 
Figure 60 cGMP concentration increased linearly in response to plasma treatment. Plasma-induced cGMP 
decreased overall with addition of the ROS scavenger sodium pyruvate (10 mM), however levels continued 
to increase linearly with plasma dose. * p < 0.05 compared to control without sodium pyruvate, + p < 0.05 
compared to control with sodium pyruvate, and # p < 0.001 comparing  240 pulses plasma treated samples 
with and without sodium pyruvate. 
 
Hydrogen peroxide is known to increase NO-stimulated cGMP production [172]. Low 
production of H2O2, characteristic of hypoxia, decreases cellular cGMP level [173]. To 
determine the influence of plasma produced ROS on cGMP, the assay was carried out in 
the presence of the extracellular ROS scavenger sodium pyruvate. While plasma induced 
cGMP concentration decreased with addition of sodium pyruvate, the cGMP level 
continued to increase linearly with plasma dose. This suggests that NO produced by the 
PHD plasma resulted in endothelial cell cGMP production. 
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6.2.3. Conclusion 
In summary, it shown that a microsecond spark discharge ignited in a pin-to-hole 
electrode geometry effectively produced both reactive nitrogen (NO, ONOO
-
) and 
reactive oxygen (H2O2, O2
-
) species. In direct treatment mode, NO and H2O2 were 
delivered together with UV radiation. However, by adding a straight or curved tube 
extension to the plasma device, H2O2 was decreased 30 fold and UV was essentially 
eliminated. Since the curved tube also decreased NO delivery by a third, the plasma with 
the straight tube was used to directly and precisely deliver NO into cells and elicit a 
biological response. Although the discharge was designed to be thermal to produce a 
significant amount of NO, it was safely applied to cells without measureable viability 
loss. This plasma may therefore be used as a novel method for delivering NO locally and 
directly to wound sites. The different treatment configurations and consequent variation 
in delivered reactive species provide additional applications for this discharge. 
Simultaneous delivery of both NO and H2O2 may induce apoptosis in cancerous cells 
[174], inactivate bacteria  [175], and form biologically important singlet oxygen [176]. 
On the other hand, results of ―singlet‖ oxygen measurements are not conclusive, and this 
measurement technique should be significantly improved.  
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CHAPTER 7. A PHYSICOCHEMICAL IN VITRO MODEL OF TISSUE FOR 
STUDYING PLASMA PRODUCTION AND DELIVERY OF ACTIVE SPECIES 
 
In the previous chapter it was experimentally shown that plasma acts as a source of a 
number of reactive species which may be in a controllable fashion delivered into a liquid 
media. Obviously, this media in most cases plays role of an intermediate layer between 
gas phase (plasma itself) and wound being treated, while all biochemical processes take 
place in tissue. Therefore the focus of this chapter is measurement of delivery of plasma 
produced active species into tissue ex vivo. Based on the results of these experiments, a 
corresponding physicochemical in vitro model of tissue based on agarose gel phantom is 
proposed. 
7.1. Materials and methods 
In this study we used atmospheric pressure dielectric barrier discharge (DBD) plasma at 
room temperature in air. DBD plasma was generated using an experimental setup similar 
to the one previously described elsewhere [3,4,5,17,101].  In short, the discharge was 
generated by applying alternating polarity pulsed (1 kHz) voltage of ~20 kV magnitude 
(peak to peak) and a rise time of 5 V/ns between the insulated high voltage electrode and 
the sample undergoing treatment.  The powered electrode was made of a 1.5 cm diameter 
solid copper disc covered by a 1.9 cm diameter 1 mm thick quartz dielectric. The 
discharge gap was kept at 1.5 mm.  Current peak duration was 1.2 μs, and corresponding 
plasma surface power density was 0.3 W/cm
2
. In the case of ex vivo measurement in a rat 
tissue, a special pen-size electrode was used: one millimeter thick polished clear fused 
quartz (Technical Glass Products, Painesville, OH) was used as an insulating dielectric 
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barrier, where a handheld pen-like device with the quartz tip was used for treatment. In 
this case, the average power density for the active area of the high voltage electrode was 
kept at the level of approximately 0.74 Watt for 6 mm electrode diameter. 
Agarose gels were prepared using standard procedure with pure agar powder (Fisher) in 
either distilled water or phosphate buffered saline (PBS, Fisher). In order to determine the 
best concentration of agarose gels which would closely represent tissue, we have used 
agar at concentrations of 0.6%, 1.5% and 3% weight percentage. These values were 
chosen for the following reasons. Agarose gels at 0.6% concentration were reported to 
closely resemble in vivo brain tissue with respect to several physical characteristics [177]. 
4% agar phantoms are widely used as a tissue models for radiology studies [178]. The 
1.5% concentration of agar was chosen as a median point which is often used as a 
microbiological substrate. 
Measurements of H2O2 and pH penetration into agarose gels (0.6%, 1.5%, and 3% wt) 
and tissues were done using Amplex UltraRed reagent (Invitrogen, ex/em: 530/590 nm) 
and Fluorescein (Sigma Aldrich, ex/em: 490/514 nm) fluorescent dyes respectively. In 
the case of H2O2, 75μL PBS containing 100μM Amplex UltraRed with 200 U/μL 
horseradish peroxidase (MP Biomedicals) were placed in between 1 mm thick 4x4 cm 
agar slices and incubated for about 15 minutes before the treatment in order to provide 
presence of the dye in the agar volume; for the pH measurement, the agarose gels were 
prepared by adding fluorescein dye before its solidifying. In order to measure the H2O2 
and pH in tissue, the dyes were injected using a syringe into a 1 cm thick 4x4 cm skinless 
chicken breast tissue samples at various points to the depth of up to 1 cm. Ex vivo 
measurements were done in a rat tissue: animal (hairless Sprague-Dawley male rat) was 
120 
 
 
 
euthanized right before the procedure. A 200 l of dye solution (Amplex UltraRed) was 
injected subcutaneously using a sterile syringe, and the animal skin was treated with FE-
DBD plasma for various time points after 5 minutes incubation period (Figure 61). Right 
after the treatment, skin tissue samples were extracted and analyzed as follows. Treated 
samples were sliced in a vertical direction with thickness of 1 mm, and fluorescence was 
measured using an LS55 (Perkin Elmer) fluorescent spectrometer equipped with XY 
reader accessory (Figure 62-Figure 63). To obtain calibration curves for hydrogen 
peroxide in the plasma treated samples a standard stabilized 3% H2O2 (Fisher) water 
solution properly diluted to obtain various concentrations was used.  
 
Figure 61 Subcutaneous injection of the fluorescent dye (euthanized rat, top left), the rat skin after the 
plasma treatment (top right), and the skin sample cross-section just before measurement (bottom). 
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Figure 62 Chicken breast after plasma treatment with H2O2 fluorescent dye: photograph (top) and 
fluorescent images (bottom) from the top and side of the sample (arbitrary units). 
  
Figure 63 Agarose gel after plasma treatment with H2O2 fluorescent dye: photograph and fluorescent 
images from the top and side of the sample (arbitrary units). 
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7.2. Results  
The results of H2O2 measurements in dead tissue are shown on Figure 64: with longer 
treatment time depth of penetration as well as concentration of hydrogen peroxide 
increases. In general, several millimoles of H2O2 are produced in tissue after plasma 
treatment, while it diffuses 1.5-3.5 mm deep. About the same tendency is observed in the 
case of tissue acidity change which is shown on Figure 65 (florescence intensity of 
fluorescein decreases with lower pH, and the data are presented in arbitrary units), 
however effect of pH lowering penetrates deeper – up to 4.5-5 mm. 
 
Figure 64The profiles of H2O2 in tissue after the plasma treatment. 
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Figure 65 The profiles of pH in dead tissue after the plasma treatment. 
 
In order to develop a simple realistic in vitro model of tissue that would have simple 
physicochemical characteristics, first of all from the point of view of depth of reactive 
species penetration, three concentrations of agarose media were used. The measurement 
results for H2O2 produced by plasma treatment in agar gels together with the results for 
dead tissues for the same treatment doses are shown on Figure 66. Hydrogen peroxide 
concentration on the agar gel surface was different for different agar densities: 0.5 mM 
for 0.6%, 0.7 mM for 3% and 1.9 mM for 1.5% gels after 1 minute of plasma treatment. 
The results of hydrogen peroxide penetration measurements in a euthanized rat skin 
tissues are shown on Figure 67, and compared to the dead chicken breast tissue, depth of 
penetration appears to be very similar – up to 4 mm after 2 minute treatment (although 
concentration is almost an order of magnitude higher due to corresponding 8 times higher 
power of the discharge). Surprisingly, depth of H2O2 penetration for all types of agarose 
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media was about the same: Figure 68 shows depths at which the same level of 0.05 mM 
of H2O2 was detected in agar gels and tissue for different plasma exposure times.  
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Figure 66 The profiles of H2O2 in non-buffered agarose gels and dead tissues after the plasma treatment. 
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Figure 67 The profiles of H2O2 in euthanized rat tissue after the plasma treatment. 
 
Figure 68 Depth of H2O2 penetration at concentration of 0.05 mM: comparison for agarose gels and dead 
tissue 
In contrast to hydrogen peroxide, the dynamics of acidity change inside of agar gels was 
significantly different for different agar media compositions (Figure 69). Tissue appeared 
to have better buffer properties compared to non-buffered agarose gels. However addition 
of PBS into agar provides required similarities in terms of pH changes. 
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Figure 69 The profiles of pH in agarose gels and dead tissues after the plasma treatment. 
7.3. Discussion 
In this paper we address a problem of direct atmospheric pressure plasma interaction with 
tissues, particularly, delivery of neutral active components produced by plasma inside of 
tissues, and creation of a physical model of such interaction. Plasma is a complex 
chemically active medium, and a number of biomedical studies suggest that it can be 
successfully applied to various living tissues without damage [179,180,181], but 
providing a number of positive effects, such as blood coagulation [3,17,65,81], wound 
[17,65,69,182] and even cancer [5,183,184] treatment, for example. It was noticed that, 
for example in the case of experimental subcutaneous cancer tumor treatment in a mouse 
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model [184], the effect of plasma treatment is observed not only on the surface of treated 
tissue (skin), but also (and mainly) in volume, under the skin. In many cases, researchers 
report a significant change of pH of solutions and tissues after plasma treatment (see for 
example, [184,185]). On the other hand, hydrogen peroxide, which is almost always 
produced by plasma, is often considered to be important in bacteria inactivation 
[58,60,101,132,185] or wound healing processes [186]. Therefore, in the current study 
we focused on measurements of these two parameters – pH and H2O2 concentration, - as 
a function of treatment time and depth of penetration into a treated object.  
The evaluation of measuring techniques on the effects of plasma treatment on tissues is 
complicated in direct experiments on actual biological objects due to a wide variation of 
morphological and biochemical parameters that are beyond the control of the 
experimenter. Therefore, a stable and reproducible test objects that mimic tissue 
physicochemical characteristics are needed. In the current study, we have used a custom-
made agarose gel, similar to those used in microbiological studies, but modified to 
achieve certain similarities with dead tissue. Agarose phantoms are widely used as 
models of various tissues (see for example, [177,178,187,188]. 
The results we present in this paper show that, in the case of real tissue, active species 
produced by plasma on the surface may travel in tissue volume for up to several 
millimeters deep. Obviously, this depth of penetration is determined by diffusion and 
reaction rates, which would highly depend on type of tissue and its biochemical 
characteristics. A measurement of these parameters is extremely complicated task, and 
therefore creation of a simple model that would closely represent certain tissue is possible 
experimentally. We used agarose gels of various concentrations in order to mimic tissue 
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physical properties. For the case of hydrogen peroxide, as shown on Figure 66 and Figure 
68, depth of diffusion is about the same for all types of agar, but the concentration of 
H2O2 varies, being the closest for the 1.5% agar weight percent case, and about 3 times 
lower for both 0.6% and 3% wt agar gels. This behavior may be possibly explained by 
both diffusion properties and reaction rates of H2O2 in agar.  
Acidity of tissue, in contrast to the experimental in vivo data reported in [184] where 
authors observed a significant decrease of pH on the skin surface with a slight increase in 
subcutaneous tissue, in our experiments was measured to be consistently increased 
(lowering of pH) as a result of exposure to the discharge. Since the fluorescence of 
fluorescein highly depends not only on pH of a solution, but also on other parameters 
[189,190,191,192,193], we did not attempt to obtain calibration curves, and therefore the 
data are presented in arbitrary units. We show that tissue compared to agarose gels 
prepared in distilled water acts as a significantly better buffer, and the depth of pH 
changes inside such a gels is much greater. In fact, we observe significant drop in the 
whole volume of a phantom – up to a centimeter thick agar. This problem, as shown on 
Figure 69, may be addressed simply by adding a buffer into the agarose media – 1.5% wt 
agar was prepared in 1x PBS.  
In summary, we show that plasma effects may be transferred several millimeters deep 
inside a tissue, as measured in an ex vivo chicken tissue and rat skin models. We have 
detected a penetration behavior of two simplest active components, namely hydrogen 
peroxide and pH, but other species may be detected and measured using other fluorescent 
dyes or techniques. In addition, we have shown that a simple agar gel model may express 
130 
 
 
 
similar physicochemical properties as a real tissue, resulting in comparable penetration 
effects of active species.  
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CHAPTER 8. TOXICITY OF PLASMA TREATMENT OF LIVING TISSUE 
 
It is evident from the large number of recent reviews in the literature that there are many 
potential applications of non-equilibrium plasma discharges in biology and in medicine 
[66,67,137,138,140,142,194,195,196,197].  This is, in part, driven by the continued 
development of novel plasma sources and modification of existing ones 
[31,34,35,55,138,141,195,198,199,200,201,202,203] and by advances in modeling, 
simulation, and characterization of these sources, including characterization and 
quantification of biological effects 
[32,33,138,198,204,205,206,207,208,209,210,211,212,213,214]. The major focus in 
applications of plasma in medicine has been its antimicrobial effect, although some 
reports of wound healing applications have been presented [29,32,63,66,142,198,201]. In 
studying antimicrobial effects of plasma it is essential to evaluate the potential damage 
plasma can inflict on living tissues.  
This chapter investigates toxicity in the direct application of two different types of 
plasma to living tissue: (a) Floating Electrode Dielectric Barrier Discharge which is an 
inherently non-thermal discharge that generates a multitude of reactive oxygen species 
(ROS) and (b) Pin-to-Hole spark Discharge which is a thermal discharge that generates 
ROS together with reactive nitrogen species (RNS).  Both discharges have been 
considered before for antimicrobial treatment of living tissues. However, little work has 
been reported on the possible damage these discharges could inflict in the process.   We 
show that low doses of plasma (previously reported to be quite sufficient for sterilization, 
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see [94,137] for example) do not cause any visible or microscopic damage to live pig skin 
and wound tissue.  Higher doses do, in fact, cause damage and the damage appears to be 
related to the surface temperature of the tissue.  Thus, if the plasma temperature is 
reduced (through shorter pulses, for example) this heating and thus the damage may 
potentially be avoided. 
8.1. Materials and methods 
8.1.1. Floating Electrode Dielectric Barrier Discharge (FE-DBD) 
Non-thermal atmospheric pressure dielectric barrier discharge plasma was generated 
using an experimental setup similar to the one previously described by the authors 
[3,4,5,17,101].  In short, the discharge was generated by applying alternating polarity 
pulsed (500 Hz – 1.5 kHz) voltage of ~20 kV magnitude (peak to peak), 1.65 µs pulse 
width and a rise time of 5 V/ns between the insulated high voltage electrode and the 
sample undergoing treatment.  One mm thick, polished clear fused quartz was used as an 
insulating dielectric barrier covering the 2.54 cm diameter copper electrode.  The 
discharge gap between the bottom of the quartz and the treated skin or wound surface 
was fixed at 1.5 mm using a special electrode holder (Figure 70, a) or a modified planar 
electrode (Figure 70, b). Discharge power density was measured to be 0.13 W/cm
2
 (at 
500 Hz), 0.15 W/cm
2
 (at 800 Hz), 0.17 W/cm
2
 (at 1 kHz), and 0.31 W/cm
2
 (at 1.5 kHz). 
Rotational and vibrational temperatures were measured to be 313.5 ± 7.5K and 3360 ± 
50K respectively [25].  
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Figure 70.  General schematics and photographs of the FE-DBD electrodes: conventional (a), and modified 
planar (b). 
8.1.2. Microsecond Pin-to-Hole spark Discharge (PHD) 
Atmospheric pressure spark discharge was generated in a pin-to-hole electrode, and is 
described in the Chapter 2  
8.1.3. Animal model 
We evaluated the potential toxic effects of the FE-DBD and PHD plasmas on both intact 
and wounded porcine skin in 12 Yorkshire pigs.  Standard operative procedure included 
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the following: the pig was anesthetized and the dorsum of the pig was marked and 
divided for treatment areas (Figure 71, a).  When intact skin toxicity was studied, the FE-
DBD electrode was placed 1.5 mm above the skin, and plasma was applied for different 
doses by varying the power and time of treatment.  Spark discharge was applied at fixed 
power at a 5 mm distance from the skin for various amounts of time.  When wounded 
skin was studied, a dermatome knife was used to create a skin abrasion (Figure 71, b), 
removing about 2×3 cm of the epidermis and dermis (approximately 3 mm ± 1 mm deep), 
followed by plasma treatment.  Pigs were then sacrificed immediately or 24 hours after 
the treatment.  Tissue specimens from each treatment area were harvested and sent for 
histopathologic analysis. 
 
Figure 71.  Marked treatment areas of the pig skin (a), creation of skin abrasion with dermatome (b), and 
skin treatment with a high frequency desiccator Bovie®, positive control (c). 
 
For the intact skin model (3 pigs) of treatment with FE-DBD, we had a total of 85 
treatment areas on the three pigs that were harvested 24 hours after surgery.  One area of 
intact skin (n=3) was treated with a high frequency desiccator (positive control, Bovie
®
, 
Figure 71, c), and one area of intact skin (n=3) was left untreated (negative control).  The 
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remaining 80 areas were treated with 4 discharge frequency (power) settings for different 
time points: from 30 seconds, and up to 15 minutes (Table 5). 
Table 5.  Number of areas for intact skin FE-DBD plasma treatment and corresponding exposure dose (in 
J/cm2) 
Treatment time, 
min 
FE-DBD frequency, kHz (corresponding power density, W/cm
2
) 
0.5 (0.13) 0.8 (0.15) 1.0 (0.17) 1.5 (0.31) 
0.5 - - 3 (5.1 J/cm
2
) 3 (9.3 J/cm
2
) 
1 - 4 (9 J/cm
2
) 7 (10.2 J/cm
2
) 9 (18.6 J/cm
2
) 
2 2 (15.6 J/cm
2
) 4 (18 J/cm
2
) 5 (20.4 J/cm
2
) 7 (37.2 J/cm
2
) 
3 - 8 (27 J/cm
2
) 4 (30.6 J/cm
2
) 5 (55.8 J/cm
2
) 
5 - 5 (45 J/cm
2
) 2 (51 J/cm
2
) 5 (93 J/cm
2
) 
15 2 (117 J/cm
2
) 2 (135 J/cm
2
) - - 
 
For the wounded skin model (4 pigs) treated with FE-DBD, we had a total of 56 
treatment areas on 2 pigs harvested immediately after treatment, and 38 treatment areas 
on 2 pigs harvested 24 hours after procedure.  Animals were treated with two discharge 
power settings for various amounts of time (see Table 6) using planar DBD electrode, 
with a high frequency desiccator (n=8), or left untreated as control (n=7). 
For the intact and wounded skin model (5 pigs) treated with PHD, we had a total of 39 
(intact skin) and 36 (wounded skin) treatment areas on 4 pigs that were harvested 
immediately after the procedure, and 48 (intact skin) and 36 (wounds) treatment areas on 
4 animals that were harvested 24 hours after plasma exposure.  Skin was treated with 
spark plasma at 5 mm for 5 to 300 seconds (see Table 7). 
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Table 6.  Number of areas for wounded skin FE-DBD plasma treatment and corresponding exposure dose 
(in J/cm2) 
Treatment time, min FE-DBD frequency, kHz (corresponding power density, 
W/cm
2
) 
0.5 (0.13) 1.5 (0.31) 
0.5 6  (3.9 J/cm
2
) 6 (9.3 J/cm
2
) 
1 8 (7.8 J/cm
2
) 8 (18.6 J/cm
2
) 
3 9 (23.4 J/cm
2
) 9 (55.8 J/cm
2
) 
5 9 (39 J/cm
2
) 9 (93 J/cm
2
) 
15 6 (117 J/cm
2
) 7 (279 J/cm
2
) 
8.1.4. Histological analysis 
All specimens were analyzed with microscopic histological analysis.  Specimens were 
longitudinally sectioned and fixed for 24 hours in formalin.  Sections for histology were 
processed in a standard fashion and stained with hematoxylin-eosin.  The pathologists 
were blinded to all specimens and categorized each specimen into a burn grading system 
for the intact and wounded skin data analysis.  For intact skin, the specimens were either 
classified as normal, minimal change, epidermal damage, or full burn through the dermis.  
For wounded skin, the specimens were either classified as normal, presence of a clot or 
scab, and full burn through the dermis. 
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Table 7.  Number of areas for intact and wounded skin PHD plasma treatment  
Treatment time, s 5 mm, intact skin 5 mm, wounds 
5 2 (non-survival) 
4 (survival) 
2 (non-survival) 
2 (survival) 
15 2 (non-survival) 
4 (survival) 
4 (non-survival) 
4 (survival) 
30 2 (non-survival) 
4 (survival) 
4 (non-survival) 
4 (survival) 
60 2 (non-survival) 
4 (survival) 
4 (non-survival) 
4 (survival) 
90 2 (survival) - 
120 6 (non-survival) 
2 (survival) 
- 
180 5 (non-survival) 
4 (survival) 
4 (non-survival) 
4 (survival) 
240 2 (non-survival) - 
300 4 (non-survival) - 
 
8.1.5. pH and temperature analysis 
In order to check the change of skin temperature and pH of the skin sample after plasma 
treatment, fresh pig skin samples with average thickness of about 1 cm were placed on 
aluminum foil and kept at constant initial temperature of about 37°C.  Skin samples were 
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exposed to both discharges for the same amount of time as in in-vivo study.  These 
changes were monitored using infrared thermometer (OS53x-CR, Omega) and skin 
pH/temperature meter (HI 99181, Hanna). 
All procedures were performed in compliance with the animal welfare and protection act 
following the Drexel University‘s Institutional Animal Care and Use Committee 
(IACUC) approval, Protocols #17030 (intact skin) and #17335 (wounded skin). 
8.2. Results and discussion 
Endpoints for toxicity analysis consisted of recording both gross and histological 
examination of the intact skin and wounded skin specimens.  Gross observation was 
correlated with the histological grading system as mentioned previously. 
8.2.1. Treatment of intact skin 
FE-DBD plasma treatment was evaluated on 3 pigs with intact skin at 4 different 
frequency (power) settings, all harvested 24 hours after the procedure.  The results for 3 
discharge frequencies are shown on Figure 72 in terms of normalized number of 
observation of no or minimal changes in skin, epidermal damage, or burn after certain 
treatment dose.  Untreated skin appeared normal on gross histological observation. With 
minimal change, there was a small area of erythema on the skin.  With epidermal 
damage, there was mild erythema that resolved itself usually within 20 minutes.  With 
full burn through the dermis, there was diffuse erythema that remained until time of 
harvest.  Positive controls, i. e. samples treated with HF desiccator, all showed full 
thickness burn.  Representative photographs and histological images are shown in Table 
8. One can notice that resulting toxic effects (epidermal damage, burn) depends not only 
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on the exposure dose, but dose rate (frequency dependent): the higher the frequency, the 
lower dose required for skin damage to occur.  
The results of intact skin treatment with spark discharge plasma at 5 mm distance from 
the skin are shown in Figure 73. In this case a burn was observed after 3 minutes of 
treatment, while, for example, inactivation of bacteria in liquid requires an exposure time 
of several seconds [82,180]. 
Overall results of the skin toxicity trials on pigs are similar to those on human cadaver 
skin and on SKH1 mice [3,17] – only rather high doses of plasma, those far greater than 
needed for sterilization or blood coagulation, are able to damage skin; while doses 
required to achieve desired medically relevant therapeutic effect are significantly below 
the damage threshold. 
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Figure 72.  Results of the intact porcine skin treatment with FE-DBD plasma operated at 800 (a), 1000 (b) 
and 1500 (c) Hz frequency.  
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Figure 73.  Results of the intact porcine skin treatment with PHD plasma operated at 5 mm distance from 
the skin surface. 
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Table 8 Representative photographs and histological images of the intact skin after treatment with FE-DBD 
and PHD plasmas 
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8.2.2. Ex-vivo treatment of porcine skin samples  
In order to estimate the effect of global increase of temperature and pH of skin after the 
plasma treatment on induction of tissue damage, we have measured these parameters on 
skin samples ex vivo.  The results of temperature measurements (Figure 74, a) indicate, 
that after about 3 minutes of treatment by both plasmas, skin temperature increases by 
11-14 degrees, which is the critical temperature for skin burn [215,216], and is in good 
agreement with our experimental observations (see Figure 72 and Figure 73).  The effect 
of the decrease of pH due to plasma treatment is probably negligible for both discharges 
(Figure 74, b). 
144 
 
 
 
 
Figure 74.  The results of temperature (a) and pH (b) measurements of the porcine skin ex-vivo treatment 
with FE-DBD and PHD plasmas. 
8.2.3. Toxicity of wound treatment 
One of the potential applications of FE-DBD and spark plasma treatment is sterilization 
and healing of wounds and/or coagulation of bleeding capillaries.  We were able to test 
the efficacy and toxicity of such treatment on a superficial partial thickness skin wound 
similar to that of scraping one‘s knee.  Once the animal was anaesthetized the wound was 
made with a small hand-held dermatome knife (Zimmer, Franklin County, OH, USA) 
originally designed to remove precise-thickness skin grafts from a donor surface.  These 
are partial thickness wounds with the blade set to cut no deeper than a millimeter into the 
skin.  This exposes the top layer of skin and breaks capillaries located in the skin, but not 
the bigger vessels.  Thus, the bleeding is slow and manageable.  This is not a severe 
wound and the bleeding would normally self-terminate quickly.  Immediately after the 
wound is made we proceed with the selected treatment.  
Results of the various FE-DBD and PHD plasma treatments of wound surface and 
histological images of these skin samples are detailed in Table 9. Similar to the intact 
skin, treatment with Bovie
®
 knife quickly coagulates blood and desiccates the tissue but 
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causes quite significant damage (see Table 9).  Although the wound may be closed, there 
is a significant level of tissue damage which may prolong the wound healing process over 
that if the wound was simply left with no treatment in this case.  While the Bovie
®
 
electrosurgery knife causes significant tissue damage, both plasma treatments can be 
applied to the tissue for up to 15 minutes with no or minimal damage to this tissue (Table 
9).  One other observation is that even after a short treatment, the blood appears to be 
coagulated and (although this is not visible on the photograph below) the wound looks to 
be covered with a thin layer of clear coagulum.  We have seen such a thin transparent 
cork formation before with treatment of blood and blood plasma samples [3,17].  This 
film was claimed to be a thin layer of coagulated blood plasma – both FE-DBD and PHD 
seem to quickly form a layer of coagulated blood on the surface of the wound which 
protects the wound from further external disturbances.  
 
146 
 
 
 
Table 9.  Representative photographs and histological images of the wounded skin after treatment with FE-
DBD and PHD plasmas. 
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8.3. Conclusions 
The purpose of this work was to determine the toxic doses of cold plasma treatment of 
living tissue for both intact and wounded skin.  In this study we have used a well-
established method for evaluation of tissue toxicity, where a Yorkshire pig intact or 
wounded skin was exposed to a plasma source and macroscopic toxic effects were 
studied histologically.  In order to evaluate the possible source of plasma toxicity, we 
have used two plasma sources in which discharges are ignited and applied in completely 
different ways – direct non-thermal dielectric barrier discharge, and indirect thermal 
spark discharge.  The results of our study show that, despite the fundamental differences 
of these two discharges, toxic effects (epidermal damage and tissue burn) are related to 
global increase of temperature of the treated skin, and are highly dependant not only on 
the dose of plasma exposure, but also on the dose rate – the lower the frequency of a 
discharge, the higher plasma dose may be applied to skin without damaging it.  Plasma 
treatment of wounded tissue, on the other hand, did not result in any toxic effects to the 
tissue itself, but in effective and fast blood coagulation.  This blood clot, apparently, 
protected underlying wound tissue from plasma damage.  Overall, we have shown that 
plasma treatment is safe for living intact and wounded skin when applied for doses 
several times higher than required for effective inactivation of bacteria on surface of agar 
or in liquid.   
  
148 
 
 
 
CHAPTER 9. PLASMA WOUND HEALING AND PLASMA ASSISTED BLOOD 
COAGULATION: IN VIVO STUDIES 
 
One of the most exciting, important and promising direction in the field of Plasma 
Medicine is shaping up to be plasma-assisted wound healing. Recent studies in this 
direction of biomedical applications of cold atmospheric pressure plasmas have shown a 
great potential of plasma discharges to become a new, safe and effective tool for 
everyday medical practice. Although still there is a limited number of reports, mostly 
very much preliminary, that it is possible to indicate the most general mechanisms of 
plasma action on wounds, specifically, acceleration of wound healing processes. The goal 
of this chapter is to propose an initial model of such mechanisms. 
Wound healing is a complex and dynamic process of restoring cellular structures and 
tissue layers in damaged tissue as closely as possible to its normal state. Wound 
contracture occurs throughout the healing process, commencing in the fibroblastic stage 
whereby the area of the wound undergoes shrinkage.  It has 3 phases: 
inflammatory, proliferative and maturational, and is dependent upon the type and extent 
of damage, the general state of the host‘s health and the ability of the tissue to repair.  
We see three major effects of plasma treatment factors that affect healing efficiency: 
 Oxidative stress 
 Blood coagulation 
 Anti-inflammatory effect of so-called ―NO-therapy‖ 
 
Below we will discuss these effects in detail.  
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9.1. Plasma induced oxidative stress. 
Oxidative stress on mammalian cells may not be as detrimental as it initially seems.  
Indeed, ROS induce stress in mammalian cells and while in some cases it may lead to 
apoptosis in other cases this stress can actually promote or control angiogenesis, the 
growth of new blood vessels or repair/regeneration of existing ones [73,74,75].  
Kalghatgi et al. showed that plasma treatment increases proliferation of porcine aortic 
endothelial cells.  Fold growth, determined by counting attached cells seven days 
following the treatment, shows a two-fold increase in proliferation compared to untreated 
cells.  Initial results indicate that this phenomenon is due to release of fibroblast growth 
factor 2 (FGF-2) by these cells as was confirmed with FGF-2 inhibitors [76,77]. 
In this section an experimental study of microsecond spark discharge treatment of 
erythrocytes in solution is discussed. 
In order to investigate physiological and biochemical mechanisms of cold plasma 
affection changes in erythrocytes after plasma processing were studied in a series of in 
vitro experiments. Erythrocytes suspensions were prepared of human and mink blood. 
The concentration of red blood cells in the suspension was approximately 2•107 cells per 
ml. Cells were treated in suspension of 5 mm thickness at 3 mm distance from the plasma 
source. Treatment time varied from 5 to 60 s with constant mixing of the cell solution.  
The experiments with mink erythrocytes revealed hemolysis which was estimated by 
means of spectrophotometry. Percentage of destroyed cells was proportionate to 
exposition (Figure 75). Cell membranes are assumed to be damaged as a result of 
initiation of lipid peroxidation processes by ROS or directly in consequence of UV 
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irradiation. At the same time visible changes of hemoglobin in erythrocytes were not 
revealed. 
 
Figure 75 Hemolisys of mink red blood cells after spark plasma treatment. 
 
Hemolysis was not observed in the experiments with human blood, but oxidation of 
intracellular hemoglobin took place. The concentration of MetHb and OxyHb were 
measured by absorption at 560, 576 and 630 nm wavelengths after the treatment. 
Concentration of forming methemoglobin depends on expositon. Rates of the reaction 
differ for the investigated samples (different individuals – Figure 76). This fact is 
supposed to be explained by means of different cells antioxidant status. The influence of 
UV radiation of plasma has been showed to be negligible by placing a quartz glass 
between the plasma source and treated solution (Figure 77). 
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Figure 76 The concentration of MetHb and OxyHb in red blood cells in 2 samples after spark discharge 
treatment. 
 
Thus, the obtained results are a point in favor of membrane-acting process, but specific 
mechanisms can be various. Particularly O2
-
 is known to penetrate through cell membrane 
of a red corpuscle by anion channels or through lipidic double layer. O2
-
  can be a 
predecessor of more toxic oxygen metabolites: HbO2(Fe
2+
) + О2
-
 + 2H
+
  metHb(Fe3+) + 
O2 + H2O2. As a conclusion, these results show that plasma effect penetrates inside the 
cell causing oxidation, while no cell lysis is observed. 
 
Figure 77 Oxidation of OxyHb in human red blood cells in presence (left) and absence (right) of UV 
produced by spark discharge. 
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9.2. Blood Coagulation by Plasma 
Blood presents a challenging environment to every branch of science that studies it, from 
physiology [217] and biochemistry [218] of blood coagulation, to fluid dynamics of the 
process [219,220,221].  During the wound treatment process, for example, issues related 
to blood coagulation need to be addressed as blood provides the basis both for closing the 
wound and pre-forming matrix which is later used by cells and proteins to repair and 
close the wound, culminating in the re-formed tissue [222,223,224].  This section is 
concerned with the process of blood coagulation in a wound model where rat ear 
capillaries are cut and treated by cold plasma, promoting fast coagulation and closure of 
the wound.  It is of interesting note that electric plasma was so named after the blood 
plasma by Irving Langmuir owing to the complexity and ionic nature of both mediums 
[225].  While thermal plasma is well-known to coagulate blood through thermal 
desiccation [226], authors and other groups have previously reported on ability of cold 
plasma treatment to coagulate stationary blood in-vitro and in explanted organs and 
tissues [78,94,227].  Some elucidation to the mechanisms of blood coagulation was made 
showing plasma‘s ability to interfere with the coagulation cascade, serving as a source of 
charged species that may catalyze the process [142], crosslinking blood plasma polymers, 
and activating platelets [227].  Cold plasma, in general, was shown to be an effective new 
tool with potential of use in the medical setting.  Plasmas were shown to effectively 
sterilize various non-living surfaces such as medical instruments [28,51,53,56,103,228] 
as well as living human and animal tissues and cells [39,40,78,94,142,229].  Nitric oxide 
generated in plasma was shown to effectively promote wound closure and speedup 
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wound healing processes [78,84,89,140].  For these reasons it is important to show 
effective coagulation of capillary vessels in an in vivo model. 
9.2.1. Materials and methods 
Floating electrode dielectric barrier discharge, previously described [94], was used in this 
set of experiments and a standard rat ear bleeding model was modified for use of cold 
plasma as a treatment modality. 
Floating electrode dielectric barrier discharge 
In this study we have used a Floating Electrode Dielectric Barrier Discharge (FE-DBD) 
generated between the insulated high voltage electrode and the sample (FE) undergoing 
treatment.   This setup was previously described in detail [94] so only a brief description 
is given here.  One millimeter thick polished clear fused quartz (Technical Glass 
Products, Painesville, OH) was used as an insulating dielectric barrier.  The setup and 
high voltage electrode schematic are shown in Figure 78 where a handheld pen-like 
device with the quartz tip was used for treatment.  The discharge was generated by 
applying high voltage pulses with the following characteristics: 20 kV (p-p), 1.6 s pulse 
duration, 1 kHz frequency. The average power density for the active area of the high 
voltage electrode was kept at the level of approximately 0.74 Watt for 6 mm electrode 
diameter measured electronically by integrating current and voltage signals as was 
previously described [94].  Of course, in the case of a hand-held electrode, as shown in 
Figure 78, the actual surface power density is difficult to estimate as it changes 
depending on the angle of application and distance to tissue; for this reason in this 
manuscript we report plasma treatment dose in seconds rather than J/cm
2
 as the actual 
treatment area varies and is under the subjective control of the operator. 
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Figure 78.  Photograph and schematic of the cold plasma treatment for capillary blood coagulation. 
 
During the plasma treatment procedure operator was asked to hold the electrode steadily 
for a preset time interval.  Training time for the operator was no more than a few minutes.  
All procedures were performed in compliance with the animal welfare and protection act 
following the Drexel University‘s Institutional Animal Care and Use Committee 
(IACUC) approval. 
Animal model 
Thirty hairless Sprague-Dawley rats, weighing approximately 250 g, arrived and 
acclimated for 3-5 days in the facility.  Animals were transferred from the viviarium to 
the approved surgical suite.  Animals were continuously anesthetized with inhalational 
gas anesthetic, Isoflurane (Vedco, St. Joseph, MO) at 2-3% induction plus oxygen 
2L/min then 1.5-2% maintenance administered via a face mask for the appropriate length 
of time and placed in the supine position.  Animals received analgesia (Meloxicam, 
Boehinger-Ingleheim, Germany) at the onset of anesthesia but prior to surgery at 1 
mg/kg, subcutaneous.  A full thickness wound of the auricular vein was inflicted on 
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bilateral pinnas with a sterile blade.  One pinna served as the control experiment and 
coagulation allowed to occur naturally.  Bleeding time commenced upon incision until 
hemostasis was achieved with no rebleeding within 30 seconds.  FE-DBD plasma was 
applied to the opposing pinna upon onset of incision.  Two techniques were applied to 
control blood coagulation using plasma.  The first technique involved discharge treatment 
to the wound for 30, 20, 10 and 5 s increments.  Blood coagulation was monitored 
without removal of the clot formed as the result of FE-DBD treatment.  The second 
technique involved discharge treatment to the wound for 5 second increments during 
continuous removal of blood from the affected site until hemostasis was achieved.  
Control experiments were performed identical but without plasma treatment. 
All data is reported with 95% confidence interval (p < 0.05) and the number of samples 
in each experiment is identified. 
9.2.2. Results and discussion 
Expected bleeding time for the type of wounds inflicted in this model is in the 1-2 minute 
range [230,231,232].  In our experiments, as expected, in the control wounds we observe 
typical bleeding times of approximately 2 minutes (Figure 79).  As previously reported, 
there is no visible or microscopic adverse effect to tissue for long treatment times, over a 
few minutes [94,137,233] while blood clot formation was observed in vitro within 
approximately 15 seconds [94].  For this reason we have chosen 30 and 15 seconds as 
initial treatment points.  Following the treatment, in all of the animals studied (n = 4 for 
each experiment) we observe clot formation with the same result achieved after 10 
seconds of treatment both continuously and with 30 second intermission between 5 
second treatments (Figure 79). 
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Figure 79.  Results of observation of bleeding time in control groups and plasma treatment groups without 
continuous removal of blood clot. 
 
Two conclusions can be drawn from this experiment.  Either plasma significantly speeds 
up coagulation in bulk (as was previously suggested [94,227]) or there is a formation of 
solidified ―corque‖ or thin film which creates sufficient pressure to stop blood from 
further flowing.  This second possibility is less desirable in a medical setting since the 
formed solidified droplet of blood can be easily disturbed potentially leading to re-
opening of the wound and further bleeding.  Thus we have conducted a second set of 
experiments (Figure 80, here n = 16 for both control and plasma treatments).  In this 
experiment we remove the forming droplet of blood, blot it off, with sterile gauze every 5 
seconds.  Removal of the droplet takes less than a second and the treatment is continued.  
This treatment, visually, closer represent an actual clinical setting than the original 
model.  During surgery, excess blood is continually removed either by vacuum suction or 
by sterile gauze.  As can be seen from Figure 81, the blotting process does decrease 
bleeding time in the control group by a few seconds; although, this small difference may 
Plasma treatment without blotting
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be attributed to statistical variation (n = 4 for first set and n = 16 for the second).  Plasma 
treated wounds stopped bleeding, as before, in approximately 10 seconds (20 seconds 
was the highest, n = 1; and 5 or 10 seconds more typical, n5 = 4 and n10 = 7). 
  
Figure 80.  Results of observation of bleeding time with removal of blood clot every 5 seconds by sterile 
gauze. 
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Figure 81.  Summary of the results of observation of bleeding time with removal of blood clot every 5 
seconds by sterile gauze. 
9.2.3. Conclusion 
In this section the results of verification of cold plasma interaction in vivo where blood 
coagulation of a wound model was shown on a rat ear are presented.  These results 
further confirm a potential for cold plasmas to enter the medical field and serve as a new 
tool in treatment of wounds, in a surgical theatre, or possibly in treatment of diseases. 
9.3. Anti-inflammatory effect of so-called “NO-therapy” 
The Nobel Prize in medicine and biology was awarded in 1998 to R. F. Furchgott, L. J. 
Ignarro, and F. Murad for their work on the function of nitrogen oxide as a signal 
molecule. Today it is well known that in a human organism, NO serves a multitude of 
essential biological functions – it regulates blood vessel tone (via relaxation of flat 
epithelial cells) and blood coagulation, immune system and early apoptosis, neural 
communication and memory, relaxation of flat bronchial and gastrointestinal muscles, 
hormonal and sex functions, NO offers antimicrobial and anti-tumor defense, etc. In 
Plasma treatment with blotting
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pathology, NO plays a major role in adaptation, stress, tumor growth, immunodeficiency, 
cardiovascular, liver, gastrointestinal tract disease, etc. This explains wide possibilities of 
the plasma-generated exogenic NO in multiple medical applications. 
Importance of exogenic NO in infection and inflammation processes is also well studied 
and is linked with anti-microbial effects; stimulation of macrophages; induction of 
cytokines, T-lymphocytes, and many immunoglobulins; interaction with oxygen radicals; 
and influence on microcirculation, cytotoxic and cytoprotective role in different 
conditions. During inflammation, macrophages and some other cells (i.e., aibroblasts, 
epithelial cells, etc.) produce NO via inducible NO-synthase (iNOS) in quantities 
significantly greater (two orders of magnitude) than normal when NO is formed via 
constructional NOS: endothelial (eNOS) and neuronal (nNOS).  
Exogenic NO is also crucial in trauma wound processes. Activity of iNOS grows 
substantially in trauma wounds, burn wound tissues, bone fracture site tissues, and others 
in the inflammatory and proliferation phases of the healing process. Activation of iNOS 
was also discovered in the cultivation of wound fibroblasts. Macrophage activation in a 
wound, cytokine synthesis and proliferation of  fibroblasts, epithelization, and wound 
healing processes are all linked with the activity levels of iNOS. In animal models, 
injection of iNOS inhibitors disrupts all of these processes and especially the synthesis of 
collagen, while NO synthesis promoters increase the rate of these processes. 
Nitric oxide (NO) is a short-lived bioactive molecule critical to inflammatory and 
vascular processes, in particular wound healing. In the early wound, high NO levels are 
produced by inflammatory cells such as neutrophils and macrophages to fight infection 
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[16]. As the wound heals, endothelial cells, fibroblasts and keratinocytes produce lower 
sustained amounts of NO to stimulate angiogenesis and new tissue formation. The critical 
role of NO in wound healing is evidenced by poor wound healing in animals with 
decreased NO production, which can be abrogated by exogenous NO application [17]. 
Nitric oxide diffuses freely through biological membranes into the cytoplasm [18], where 
it stimulates soluble guanylyl cyclase (sGC) to convert guanosine triphosphate (GTP) 
into 3, 5-cyclic guanosine monophosphate (cGMP) [19]. The results of our study (see 
Chapter X) show that nitric oxide produced by microsecond spark discharge plasma may 
in direct and precise fashion be delivered into endothelial cells via liquid media with 
corresponding activation of cGMP production.  
9.4. Plasma assisted wound healing: in vivo rat model 
In this chsectionapter, a study where open wounds are treated with Floating Electrode 
DBD and microsecond spark discharge separately and in combination, and exogenous 
NO gas is presented. Rat is employed as the animal model.  
9.4.1. Materials and methods 
Plasma systems 
In this study we have used a floating electrode dielectric barrier discharge (FE-DBD) 
generated between an insulated high voltage electrode and the sample (FE) undergoing 
treatment. In the first stage of the experiment the same electrode with the same plasma 
parameters as described in Chapter 5 was used. For the second stage, the same electrode 
system described in this chapter, section 2 was used. The microsecond spark discharge 
(PHD) described in detales in Chapter 2 was used for treatment of wounds on both stages. 
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All procedures were performed in compliance with the animal welfare and protection act 
following the Drexel University‘s Institutional Animal Care and Use Committee 
(IACUC) approval. 
Animal model 
Thirteen hairless Sprague-Dawley rats, weighing approximately 250 g, arrived and 
acclimated for 3-5 days in the facility.  Animals were transferred from the viviarium to 
the approved surgical suite.  Animals were continuously anesthetized with inhalational 
gas anesthetic, Isoflurane (Vedco, St. Joseph, MO) at 2-3% induction plus oxygen 
2L/min then 1.5-2% maintenance administered via a face mask for the appropriate length 
of time and placed in the supine position.  Animals received analgesia (Meloxicam, 
Boehringer-Ingelheim, Germany) at 1 mg/kg, subcutaneous, Bupivicaine 25% (Hospira, 
Lake Forest, IL) 0.5 ml/site intradermally and Normosol R (Baxter, Deerfield, IL) 
crystalloid parenteral fluid therapy at 10ml/kg subcutaneous bolus at the onset of 
anesthesia but prior to surgery.  The ventral surface of the rat was prepared in sterile 
surgical fashion: the surgical area was gently washed and sanitized with chlorhexidine 
scrub solution; the area underwent an initial contact scrub of 5 minutes, rinsed with 
normal saline solution and repeated second time; a preparatory solution of diluted 
chlorhexidine with isopropyl alcohol (1:8) was lightly sprayed onto the surgical area.    
Approximately 2 cm incisions along the right and left side of the thoracic region were 
inflicted and plastic rings were inserted into the subcutaneous layer of the skin (ring size 
was equivalent to the size of the FE-DBD plasma probe) and restricted the bacteria to the 
affected area only, Figure 50.  Schematic of the FE-DBD plasma electrode that fits into 
the plastic ring sutured to the wound.). The skin was sutured with 3-0 nylon around the 
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ring in a continous suture pattern. Animals were recovered from anesthesia in a pediatric 
warming incubator and then plasma treated in the following fashion. Each rat had a 
control wound (untreated), and the other one was used as an experimental wound. 
Experimental wounds were treated according to the following scheme (2 wounds per 
experimental point): FE-DBD treatment for 30 and 60 s, PHD treatment for 15 and 30 s, 
combination of 15 s FE-DBD and 30 s PHD treatment, and 15 s of treatment with 8000 
ppm NO gas (balanced with N2, Airgas) from the tank at rate of 1 slpm. After the 
treatment, wounds were covered with Tegaderm® dressing. The treatment procedure was 
repeated daily for 14 days until animals were sacrificed.  
There were 2 stages of the study. On the first one, which last for 9 days, wounds were 
restricted from closure by rings (wounds on rats heal by contraction mechanism) covered 
with the Tegaderm® dressing every day in order to prevent their drying and access of 
oxygen, thus creating a chronic wound. On the 9
th
 day rings were removed and wounds 
were allowed to heal naturally or were treated with plasmas or gaseous NO. 
9.4.2. Results and discussion 
On the first stage of the study, a chronic wound model was created. Representative 
pictures of wounds are shown in Table 10. Comparing plasma treated wounds to control 
one, the ones that were exposed to DBD or PHD plasmas looked healthier, probably due 
to some antibacterial action of plasma treatment, and in control wounds there was 
accumulation of significant amount of fluid (up to 1.5-2 ml) with fibrin on the bottom of 
the wound. There was no significant difference between plasma and NO gas treated 
wounds. The wounds treated with combination of DBD and PHD plasmas also were not 
significantly different from other treatment cases. These results, although a little 
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difference was observed, may be indication of a somewhat positive effect of plasma and 
NO treatment. This may be related to the fact, that gas flows in the case of NO gas and 
PHD discharge, and slightly elevated temperature of the treated surface in the case of 
DBD and PHD plasmas, helped in removing the excess liquid from the wounds while 
providing more oxygen to the tissue.  
On the second stage of the study, rings were removed from the wounds (9
th
 day), and 
wounds were allowed to close. Again, the treatment (Figure 82) was administrated every 
day until animals were sacrificed. Wound surface area was measured every day before 
treatment. The pictures of wounds are shown in Table 11. On Figure 83 graphs showing 
the progress of wound healing process for all 4 types of treatment by each animal 
compared to controls are presented. Figure 84 summarizes the result by comparing the 
average wound area by type of treatment relatively to control wounds. We show, that 
plasma treatment, both FE-DBD and spark discharge, result in almost 2 times faster 
wound closure. It is interesting to notice, that NO gas treatment has almost the same 
efficiency compared to plasma. At the same time, the fact that both discharges have 
relatively the same effect, although the physical nature of these plasmas are completely 
different, may indicate that both oxidative stress (DBD) and NO therapy (PHD) may be 
successfully applied for acceleration of wound healing processes. However, the most 
surprising and interesting result is related to combine treatment method: when both DBD 
and PHD plasmas are used, wound healing process is significantly, in about 2.5 times, 
suppressed. This effect may be related to over production of reactive oxygen species in 
the tissue, or negative effect of simultaneous action of reactive nitrogen species (PHD) 
and significantly lower pH (as a result of DBD plasma treatment).  
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Table 10 Representative pictures of chronic wounds 
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Figure 82 Plasma treatment of wounds with FE-DBD (top left), PHD (top right) and NO gas (bottom). 
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Table 11 Photographs of wound healing progress by days 
 Day # 
 1 2 3 5 
DBD, 30s / Control 
    
 
    
DBD, 60s / Control 
    
 
    
PHD, 15s / Control 
    
 
 
 
 
 
PHD, 30s  
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Table 11 (continued) 
PHD, 30s  Control 
 
  
 
NO, 15s / Control 
    
 
    
DBD 30s  
+ PHD 15 s / 
Control     
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Figure 83 Progress of wound healing process for all 4 types of treatment by each animal compared to 
controls: FE-DBD 30 s treatment (a) and 60 second treatment (b), PHD 15 second treatment (c) and 30 
second treatment (d), NO gas 15 second treatment (e), and combination of 30 second FE-DBD and 15 
second PHD treatment (f). 
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Figure 84 Summary of the wound healing process by treatment method. 
 
9.4.3. Conclusions 
In this section the results of the first in vivo experimental study of cold plasma wound 
treatment are presented.  We show, that plasma treatment of chronic wounds do not cause 
adverse effects in general, and possibly may be beneficial. The effect of plasma treatment 
is shown to be positive: wound contracture was accelerated almost 2 times after treatment 
by either DBD of microsecond spark discharge, and was similar to the effect of NO 
treatment. Contrary, we show that effect of combined treatment by DBD and PHD 
plasmas is negative, resulting in 2 times slower wound healing. These results, although 
promising, are still very preliminary, and detailed careful study is required. The rat model 
used in this study must be further developed in in vivo studies involving larger animals 
(rabbits, pigs) where wound healing mechanisms are similar to those in humans.  
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CHAPTER 10. PLASMA TREATMENT OF GASTROENTEROLOGICAL 
DISEASES 
 
Recently, non-thermal atmospheric pressure plasmas have emerged as a promising new 
tool in medicine. Compared to conventional thermal plasma [80,234,235,236,237], cold 
plasma is selective in its treatment and is safe since it does not burn tissue. Non-thermal 
plasmas generate free radicals, charged species, and ultraviolet radiation, which may be 
used for targeted chemical modification and catalysis [238,239] unlike thermal plasmas 
which employ high temperature that causes significant thermal tissue desiccation, 
burning, and scar formation. An example of thermal plasma is the Argon Beam or Argon 
Plasma Coagulator (APC) developed mainly to cauterize wounds [240]. On the other 
hand, cold plasma discharges have many potential medical applications that include  
sterilization of living tissue without damage [65], blood coagulation [81], induction of 
apoptosis in cancer and other cells [5,241], and control of cell attachment [242]. Another 
promising field of cold plasma applications in medicine is gastroenterology, where strong 
antibacterial effect can be successfully combined with healing and anti-inflammatory 
effects.  Thus, the focus of this study is to evaluate whether cold plasma in vivo is 
detrimental to gastrointestinal tissue in health and disease conditions and whether cold 
plasma provides any therapeutic benefit in an animal model of murine experimental 
colitis.  The disease in this model produces experimental colitis reminiscent of human 
ulcerative colitis, which is a form of inflammatory bowel diseases. Inflammatory bowel 
diseases (IBD) consist of two major chronic, relapsing and debilitive forms of diseases 
known as ulcerative colitis and Crohn‘s disease that affect the gastrointestinal tract.   The 
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etiology of these diseases remains a mystery though genetic, environmental and 
immunological factors are found to play a major role in the induction, chronicity and 
relapses of these diseases.   Crohn‘s disease may appear in any part of the gastrointestinal 
tract from the mouth to anus and affects the entire thickness of the bowel wall.  On the 
contrary, ulcerative colitis is an inflammatory disorder affecting colonic mucosa and sub-
mucosa [243].   There are no known curative therapies for these diseases; however , 
recent advances in IBD therapeutics have shown that certain biological therapies have 
been successful in maintaining remission particularly in Crohn‘s disease [244,245]. 
This study was designed to evaluate the effects of cold plasma treatment of both healthy 
colon tissue and experimentally-induced ulcerative colitis disease in a live animal model. 
The goals of the study were to examine whether cold plasma treatment adversely affects 
the mucosa in normal condition, and to evaluate if cold plasma treatment results in 
acceleration or worsening of the disease during its induction phase.  Additional pilot 
experiments were conducted to study whether cold plasma discharges provide therapeutic 
effects, and whether these effects are comparable to a standard therapy, or cold plasma 
treatment enhances the beneficial effect of a standard therapy.    
10.1. Materials and methods 
10.1.1. Cold Pin-to-Hole Spark Discharge (PHD) Plasma 
Currently, the primary reason of gastroenterological inflammatory diseases, and 
particularly ulcerative colitis, is still unknown; however, two major candidates are 
bacterial infections and autoimmune disorders. In order to be able to address these 
problems using plasma, the treatment should meet several conditions, namely: 
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 average plasma temperature should be low, i.e. close to room temperature, when 
there is no or  minimal thermal damage due to contact of plasma with tissues; 
 have strong bactericidal effect; 
 be able to provide anti-inflammatory effect. 
Another set of criteria which are important in the present mouse model experiments refer 
to plasma system engineering problems:  
 electrode system (―plasma probe‖) should be small (maximum outer diameter is 
approximately 2 mm) in order to cause minimal mechanical damage to colon 
tissue of a mouse; 
 plasma should be easily ignited inside of a colon, and should not be sensitive to 
the distance between electrode and inner colon wall. 
All these conditions may be satisfied if one is using cold spark discharge plasma. Dr. 
Gostev and colleagues reported  that this cold discharge [82,180] (there, a large-scale 
system of about 10 times greater in size has been used) is extremely effective in 
sterilization of bacteria both in liquid [246] and on tissue surface [247], and due to 
production of significant amount of nitric oxide (NO) has pronounced ―healing‖ effect 
through faster tissue regeneration, and other beneficial effects [82,83,85,180]. The pin-to-
hole electrode configuration makes the discharge ignition process not sensitive to the 
presence of surrounding tissues in contrast to arc, dielectric barrier, or corona discharges. 
Also, PHD treatment allows operator to provide relatively high energy input resulting in 
shorter treatment time and less discomfort to an animal. 
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In this study we have used modified PHD system which consists of central copper needle 
covered by dielectric material which is inserted into a grounded stainless steel cylindrical 
electrode (Figure 85). In order to cause minimal mechanical damage to colon tissues 
external electrode is covered by polyethylene sleeve.  The discharge was ignited by 
applying high positive potential to the central electrode. In order to provide high 
discharge energy while keeping average gas temperature low, the electrode system was 
powered through a capacitor. This resulted in a formation of dense energetic spark which 
exists for about 3.5 µs. Due to low repetition frequency of about 7 Hz and short pulse 
duration, the average gas temperature did not exceed room temperature. 
 
Figure 85 Pin-to-Hole spark Discharge (PHD) plasma system general schematic and photograph of the 
discharge in operation. 
 
Main average PHD plasma characteristics are the following: 
 peak voltage: 3.2 kV; 
 pulse duration: 3.5 µs; 
 frequency: 7 Hz; 
 energy per pulse: 0.1 J; 
 plasma diameter: ~2 mm; 
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 typical waveforms are shown in Figure 86. 
 
Figure 86 Typical voltage and current waveforms of cold Pin-to-Hole spark Discharge (PHD) plasma. 
Lastly, it was necessary to check if miniaturized PHD plasma system indeed produces 
significant amount of NO, thus delivering the therapeutic effect (so-called, ―NO-therapy‖ 
[17,248,249,250]). The NO production was measured using gas chromatograph Agilent 
3000 MicroGC, calibrated with 700 ppm NO balanced with nitrogen. The discharge cell 
was inserted inside of a syringe tip, and plasma treated room air was collected with slow 
plunger pulling during plasma treatment. Then, collected air was analyzed 
chromatographically. The results of our measurements (see Figure 87) show that NO 
concentration is varied from 900 to 1200 ppm depending on plasma treatment dose, 
which allow us to expect that plasma treatment of colon ulcer may cause ―healing‖ effect.  
175 
 
 
 
 
Figure 87 Nitric oxide production by PHD plasma 
 
Although one can argue that plasma characterizations mentioned above were made in 
different atmosphere (room air), and therefore the results could differ from real 
experimental situation when plasma is ignited inside of intestine, we do not expect 
qualitative difference between these two conditions. This assumption is based on data on 
gas composition inside of a colon, which is mostly consists of air-like mixture (up to 80% 
of N2 and 2.3% of O2) with small additives of hydrogen, methane, and carbon dioxide 
[251]. Moreover, before the treatment procedure, the colon was cleansed with saline, and 
also room air was introduced into the colon during probe insertion. Therefore, air is 
expected to be a dominant plasma-forming gas.  
10.1.2. Dextran Sodium Sulphate (DSS)-induced experimental colitis in Mice 
The DSS model was used in the current study to produce ulcerative colitis in mice which 
is representative of human ulcerative colitis [33, 34]. The disease is induced in an animal 
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through a daily oral administration of 2.5% DSS dissolved in drinking water at 
concentration of 2.5%. Animal develops an acute form of inflammation beginning on the 
third day and they have a full blown colitis on the day of DSS feeding cycle. The primary 
characteristics of acute inflammation are the increased number of neutrophils in the 
mucosal layer, shortening of the epithelial crypts, hyalination in the lamina propria, 
accompanied by severe weight loss, diarrhea, and blood in the stool. This form of the 
disease gives an opportunity to use it as a model in efficacy studies of drugs and 
compounds [34]. The most striking feature of this model is that it works using a very 
simple pathway to produce the disease as DSS overcomes the barrier of the epithelium to 
expose the mucosa to the flora present in the intestine resulting in an inflammatory 
response; this in turn leads to activation of macrophages and monocytes. The model also 
shows close links to the disease in human beings and it is simple to induce and reproduce 
[33-35]. 
To quantify the disease induced by the DSS model a Disease Activity Index (DAI) have 
been used [252]. A scale of 0 to 4 is used to quantify the disease with 4 being the lethal 
stage of the disease. DAI is scored on the parameters of weight loss, consistency of the 
stool and presence of blood in the stool. This index has been shown to be in a linear 
correlation with the histology score based on changes in the architecture of the crypt [33]. 
10.1.3. Animal study design 
All experiments were done on live animals. The study consisted of 3 stages: 
1. Toxicity study of plasma treatment of a colon. 
2. Study DSS model disease progression after plasma treatment.  
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3. Comparison of effectiveness of plasma treatment with conservative therapy 
In all the experiments Female Swiss Webster mice approximately aged six to eight weeks 
of 25 to 30 grams in weight were used. Prior to plasma treatment animals were 
anesthetized with 0.4 ml Nembutal
®
. The effect of the anesthetic was checked using the 
toe relax by pinching. The colon was cleansed with saline before inserting the probe. 
10.2. Results and discussion 
10.2.1. Toxicity of plasma treatment of colon tissue 
The primary objective of the study was to ascertain if cold plasma treatment would cause 
any damage, to colon tissue or to the animal itself.  To ascertain this effect, 12 mice were  
divided into 4 groups of three animals in each group.   The first group was a control 
group which did not receive any treatment and the other three groups remained as 
experimental groups. In experimental groups a laparotomy was performed and the colon 
was exposed and kept moist covered with a saline gauze. The plasma probe was 
introduced through the anal verge up to 4 cm into the colon (Figure 88). Plasma treatment 
was administered for 0, 4, 30 and 60 seconds in the respective group. To check colon 
tissue damage, mice were intravenously injected with 30 mg/kg of Evans Blue (EB), ten 
minutes after the administration colon was washed with 1 ml physiological saline and EB 
presence was analyzed spectrophotometrically. Animals were euthanized with an over 
dose of Nembutal
®
 and colon tissue samples were surgically removed and were preserved 
in formalin for further histopathological analysis.  
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Figure 88 Photograph of cold spark plasma inside of the mouse colon: the colon here is not punctured and 
the light generated by plasma is seen through the thin tissue. 
 
Spectrophotometrical analysis of the saline fluid collected from the colon showed no 
traces of EB, indicating that plasma did not affect the tissue integrity. Histology analysis 
also showed that no damage was induced to the colon tissues by plasma treatment or 
probe manipulation (Figure 89).  
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Figure 89 Colon tissue histology shows no detectable damage 
10.2.2. DSS model disease progression after plasma treatment 
The next step was to check the response of the disease progression to plasma treatment; 
hence 24 animals were divided into 4 groups each receiving 0, 4, 30 or 60 seconds of 
plasma treatment every alternate day for 7 days. All animals were fed 2.5% DSS for 7 
days in parallel with plasma treatment. DAI was scored everyday to see which dosage of 
plasma was most effective in controlling the progression of the disease. For the plasma 
probe to be inserted and to go through the colon, the colon has to be cleansed of stool 
specks. To do so, the animals were fed a polyethylene glycol based laxative along with 
DSS one day before plasma treatment. However, the stool consistency on the next day 
was compromised as the laxative made the stool consistently loose. Hence, data extracted 
from the study were bifurcated and were analyzed using a three pronged approach 
considering: 
a. Weight, stool consistency, and presence of blood in the stool. 
b. Weight, and presence of blood in the stool (without stool data) 
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c. Mean hemoccult (visible blood in the stool)  
 
Figure 90 Progress of colitis, mean DAI: results of the second stage of the study (considering weight, stool 
consistency and hemmocult)  
 
Results of the experiment (Figure 90) show that, in the control group the DAI scored 
using weight, stool consistency, and blood visibility in the stool reaches a value of 2.3 by 
the end of 7 days. The group which received 60 seconds of plasma treatment reached a 
DAI of 1.6 on day 7. Hence, the disease is not controlled very well in the 60 second 
plasma group; on days 3, 4 and 5 one minute of plasma treatment stabilized the disease 
and prevented it from progression. However, as the severity of the disease increased the 
plasma treatment effectiveness ceased. 4 seconds of treatment resulted in disease 
reduction during the end stage of the study and it is comparatively better than the 60 
second treatment. Here the disease was well controlled through the course of the study. 
The most efficient dosage of plasma as shown by the study is 30 seconds exposure. This 
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group showed high resilience against the progression of the disease, and as compared to 
the control, showed great ability in stopping the progression of the disease even when 
DSS is being fed in parallel. The maximum DAI in this group was 1.2 as observed on day 
7, the day of maximum disease prevalence. 
 
Figure 91 Progress of colitis, mean DAI: results of the second stage of the study (considering hemoccult 
only) 
 
The laxative that was administered to the animals on days prior to plasma treatment 
might have compromised the score based on stool consistency as this makes the stool 
comparatively loose, and therefore on Figure 91 only hemoccult data have been 
considered as one of expected effects of plasma treatment is blood coagulation inside the 
inflammed colon. As the prime facet of tissue degradation of colitis is through bleeding 
out of the tissue which can be observed on the stool study. Hence this data is critical to 
check if plasma can actually clot and coagulate the blood inside the colon. Data shows 
that a statistically significant difference was obtained between untreated animals in 
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control group and animals treated with plasma for 30 seconds. On the final days of study 
hemoccult reached DAI of 4 in the control group while the ―30 seconds‖ group had a 
DAI of just over 0.5. It can be inferred from the data that the ―30 seconds‖ and ―4 
seconds‖ groups are showing blood coagulation inside the colon.  
10.2.3. Comparison of effectiveness of plasma treatment with conservative 
therapy of ulcerative colitis 
The goal of the last stage of the study was to investigate the effectiveness of plasma 
treatment as an adjuvant to conventional antioxidant drug (5-amino salicylic acid (5-
ASA)) treatment. Based on previous results, where it was shown that 30 seconds of 
plasma treatment gives the best results in controlling and reducing the disease 
progression compared to all other groups, this treatment dose was selected for the next 
step. In this set of experiments 24 animals were divided into 4 groups: control group 1, 
where no plasma or drug treatment was performed, and groups where mice were treated 
either with plasma alone (group 2), 5-ASA alone (group 3), or drug and plasma together 
(group 4). All four groups of animals were fed with DSS for six days. On days 2, 4, and 6 
they received 2.5 % DSS dissolved in water and for days 1, 3, and 5 (one day before 
plasma treatment) they received 2.5% DSS dissolved in 15% poly ethylene glycol based 
laxative to clean the colon. Plasma probe was introduced into the colon 4 cm from anal 
verge in groups 2 and 4, where group 2 received 30 second dose of plasma treatment 
only, while group 4 received same dose of plasma treatment in together  with 0.1 ml of  
5-ASA treatment. Animals in groups 3 and 4 were treated with 0.1 ml of 5-ASA. The 
DAI was scored everyday during the tenure of the study. On the seventh day of DSS 
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treatment and final plasma treatment DAI was measured and animals were euthanized 
with an over dose of Nembutal
®
.  
 
 
Figure 92 Progress of colitis, mean DAI: results of the third stage of the study (considering weight, stool 
consistency and hemmocult)  
 
The disease progression for all four experimental groups is shown on Figure 92. The 
control group showed a steady increase through the course of seven days with the DAI 
reaching an expected 2.7 on day 7. The plasma treatment group was administered 30-
second plasma treatment and obtained data are in direct correlation with the data acquired 
in the previous study and also show a constant increase of disease progression. However, 
the disease curtailed to near 1.8 on the DAI scale. The group 4 showed very positive 
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results as both in combination proved to be effective in controlling the disease and 
keeping the DAI on a level of 1.2 on the DAI scale. 
 
Figure 93 Progress of colitis, mean DAI: results of the third stage of the study (considering hemoccult only) 
 
Figure 93 is designed to express the mean hemoccult charted on a scale of 0 to 4 with 4 
being the advanced stage of the disease. The plasma treatment resulted in a significant 
drop on the hemoccult scale as compared to the control. This shows that plasma actually 
was working in clotting the blood that was being pumped out of the inflammed region in 
the colon. The combination treatment further reduced the hemoccult score as a two 
pronged approach is taken against the disease.  
The most important aspect of the study is to verify the hypothesis that plasma can be used 
as an add-on to the conventional drug treatment to cure the disease faster and with 
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renewed vigor. Experimental results show that in the group which received combination 
treatment, disease progression was further decreased as compared to the groups which 
received the drug or plasma alone. The bars show a statistical significance in the two 
groups as plasma and 5-ASA reduce the disease as compared to the control group on days 
5 and 7.  
10.2.4. Plasma Assisted Blood Coagulation and Antioxidant Effect of Plasma 
Treatment  
The results of our first invasive in-vivo experiments of cold plasma treatment of colon 
tissue in case of ulcerative colitis mouse model show that plasma can significantly reduce 
severity of the disease progression. In fact, while untreated (control) animals undergo 
weight loss, loss of stool consistency, and excessive bleeding, showing disease 
progression up to DAI number 3.1 (when 4 corresponds to lethal stage of the disease), 
plasma treated ones appeared to have significantly lover disease progression rate with 
reduced reaction to inflammation.  
Cold plasma treatment apparently has positive effect on inflammed colon tissue when 
applied for ulcerative colitis treatment. First, analyzing contribution of hemmocult level 
to the DAI, it is shown that plasma may cause effective blood coagulation in colon ulcers. 
Indeed, Fridman et al. have experimentally shown that treatment of normal whole blood 
both in in-vitro and in-vivo cases with floating electrode dielectric barrier discharge (FE-
DBD) plasma leads to initiation of natural coagulation cascade followed by fast, on the 
order of seconds, formation of blood clot [17,81]. However, contribution of various 
plasma species and detailed mechanism of this effect remain unclear. 
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Another possible effect of cold spark plasma is related to nitric oxide production. It is 
well known today, that NO plays an important role in wound healing and tissue 
regeneration by regulation of blood vessel tone and blood coagulation, immune system 
and early apoptosis, etc. [17] Exogenic delivery of NO-donors (compounds that contain 
and release or synthesize nitric oxide upon contact with tissue) to the wound promotes 
and speeds up healing processes [17].  
Additionally, the role of NO may be related to ―deactivation‖ of oxidants with formation 
of acidic environment. One possible explanation of pathogenesis of ulcerative colitis is 
given by so-called ―Radical Induction Theory‖, which suggests that the main cause of 
inflammation is excess un-neutralized H2O2 [253]. Hydrogen peroxide is produced within 
colonic epithelial cells, and then easily diffuses through cell membranes, and through 
formation of highly reactive hydroxyl radical extensively causes oxidative damage to the 
cells. In this situation, increased acidity may play an important role in process of 
inhibition of inflammation: currently used drugs, for example, 5-ASA, which is acid, 
probably acts as an ―antioxidant‖. To check this hypothesis, we have treated 100 µl of 
H2O2 water solution with initial concentration of about 30 mg/l with spark discharge 
plasma (Figure 94). In order to simulate closed environment of the treated colon, 
discharge cell and solution holder were incased using tygon tube. 
187 
 
 
 
 
Figure 94 Scheme of the experimental setup and the results of hydrogen peroxide PHD plasma treatment 
 
The result of the experiment shows that hydrogen peroxide was decomposed completely 
within 6 minutes of treatment. Possible mechanism of the destruction may be related to 
chemical reaction of H2O2 with NO with formation of nitric acid: 
                 
                   
10.3. Conclusions 
Major results may be summarized as follows: 
1. In the first stage of the plasma study, the primary goal was to understand the interaction 
of cold plasma with a living animal. The study showed that the cold plasma alone in 
graded doses did not cause any damage to the colonic tissue or the animal based on 
Evan‘s Blue extravasation and histological analysis.   
2. The second stage of the plasma study posed the challenge of ascertaining the graded dose 
at which the progress of the disease (ulcerative colitis) can be controlled. It is concluded 
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that plasma did not adversely affect the animals and did not increase the progress of the 
disease. Surprisingly, it reduced the disease from progressing rapidly as compared to the 
control. The exact mechanism by which cold plasma induced its beneficial effect   
remains unknown. 
3. The final stage of the plasma study was designed to evaluate and check the activity of 
plasma as an adjuvant to the industry standard drug 5-ASA in controlling the disease. 
Combination therapy of 5-ASA and cold plasma showed that there is a significant 
therapeutic relevance when it comes to adding plasma to the drug in controlling colitis in 
the DSS model during the induction phase. 
4. Possible explanations of observed positive effects of plasma treatment were proposed. 
First, it was noticed, that plasma treatment caused significant decrease of blood oozing 
from ulcerated colon tissues. Also, reduced progression rate of the disease may be related 
to ―antioxidant‖ and ―healing‖ effects of plasma produced nitric oxide.  
Although presented results are very promising, many questions remain unanswered and 
further development of the model and accurate extensive study are both needed. 
However, this study clearly demonstrates feasibility that the cold plasma treatment may 
be safely applied not only for sterilization of living tissues, but also to achieve a 
medically relevant therapeutic effect(s), which opens new possibilities of cold plasma 
applications in the field of medicine. 
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CHAPTER 11. OVERVIEW OF THE MECHANISMS OF PLASMA 
INTERACTION WITH LIVING OBJECTS 
 It is shown in previous chapters that cold atmospheric pressure plasmas can have not 
only physical (e.g. burning the tissue), but medically relevant therapeutic effects — 
plasmas can trigger a complex sequence of biological responses in tissues and cells.  To 
move ahead in further development of actual commercial tools that will enter the 
hospital, and in finding novel and perhaps even unexpected uses of these plasmas an 
understanding of mechanisms of interaction of non-equilibrium gas discharges with 
living organisms, tissues, and cells becomes essential.  The goal of this chapter is to 
propose an initial model of such mechanisms. 
Clearly, the interaction mechanisms depend on the way the plasma is generated, the way 
it is delivered, and the organism it is applied to; e.g. radiofrequency discharge in helium 
will likely have somewhat different mechanisms of interaction than afterglow from a 
nitrogen arc [9,42].  It is shown that not only reactive species generated in plasma are 
responsible for achieving a desired effect but also the charged species (electrons and 
ions) are.  Below, an attempt to classify different types of species created in plasma and 
to assess their importance in achieving bacterial inactivation and other biological effects 
is taken.   
The mechanism of interaction of plasma with living systems is complex owing partly to 
the complexity of plasma and mainly to the overwhelming complexity of biology.  In our 
current understanding, we see three distinct paradigms for plasma interaction 1) with 
bacteria, 2) with mammalian cells, and 3) with tissues.  In all three cases, mechanisms 
may and often prove to be significantly different.  Further complexity is added by 
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presence of liquid or physisorbed water which is always present in our treatment.  
Regardless of the overall complexity, below we proposed a general scheme of interaction 
of direct discharges with biological systems. 
A general schematic summarizing the plasma-cell interactions is shown on Figure 95.  
Here a direct cold plasma discharge, a Floating Electrode Dielectric Barrier Discharge, is 
considered as an example of direct cold plasma discharge.  We show that charges 
produced in plasma and coming in direct contact with the treatment target play a key role 
in the biological mechanisms through initiation and catalysis of peroxidation processes.  
Primary target of the direct plasma treatment is the cell membrane, the phospholipid 
(eukaryotes) or polysaccharide (prokaryotes) layer where we observe all initial effects.  
Past the membrane, plasma-related mechanisms cease and biochemistry takes over.  We 
show activation of complex biochemical pathways following plasma treatment, e.g. 
formation of malondialdehyde (MDA) which participates in formation of DNA adducts.  
MDA is a good example as it is also one of the examples of selectivity of plasma 
treatment as these DNA adducts are easily repaired by mammalian cells but not by 
bacteria.  Other examples of selectivity of plasma treatment include selective 
development of apoptosis in cancer cells, difference in cellular metabolism for eukaryotes 
and prokaryotes, etc. 
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Figure 95 Summary of key findings on plasma interaction with biological organisms. 
 
The key factors will now be examined in detail. 
A. Plasma ions play key role 
We show that plasma that comes in direct contact with a biological organism achieves the 
desired effect orders of magnitude faster than the same dose of indirect application where 
plasma is separated from treatment target even by a fraction of a millimeter.  We show 
that this effect can be primarily attributed to charged species in plasma.  Thus, the key 
role in plasma-cell interaction is played by ions, specifically: 
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 both positive and negative ions have relatively the same effect; 
 effect of charged species is chemical and not related to such physical phenomena as sheer 
stress, ion bombardment damage, or thermal effects; 
 ions catalyze peroxidation processes both inside and outside of the biological organism 
which explains why they are able to have greater effect than neutral active species; 
 presence of oxygen is necessary and reactive oxygen species play a crucial intermediate 
role. 
B. Primary target is cell membrane 
Careful investigation of the target of these charges reveals that most processes occur on 
the cell membrane, e.g. the phospholipid bilayer of a mammalian cell or the 
polysaccharide membrane of bacterial cell.  Key processes occurring on the membrane 
are: 
 peroxidation of lipids and polysaccharides catalyzed by charges; 
 effect is chemical and highly dependent on amount of water: 
o dry organism — low effect, 
o ―moist‖ organism (minute amount of non-liquid water) — highest effect, 
o and ―wet‖ organism (suspended in liquid) — diluted effect; 
 effect is strongly dependent on chemical composition of the medium surrounding 
the cells: complete inhibition or control over the plasma effects is possible, e.g. 
with addition of antioxidants to the media or intracellularly. 
C. Intracellular biochemistry 
The above mechanisms are related closer to plasma than to biology as they are 
biochemically controlled by plasma-generated species.  However, there are biological 
consequences of plasma treatment where plasma initiates, catalyzes, or helps sustain a 
complex biological response, e.g.: 
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 compromised membrane structure (e.g. peroxidation), or change in membrane-
bound proteins and/or enzymes (e.g. ion channel proteins) leads to complex cell 
responses and may affect many cells as the affected cell signal others; 
 plasma treatment may activate intracellular signaling pathways (e.g. turn on 
secondary messenger systems to amplify and transport plasma effect); 
 initiation of subtle secondary effects, like formation of malondialdehyde (MDA) 
which participated in DNA damage following lipid peroxidation, a process that is 
easily repaired by mammalian cells but not by bacteria. 
D. Selectivity 
Plasma effects can be quite selective, meaning tunable between damage to pathogenic 
organisms without damage to the host, or activation of different pathways in different 
organisms.  Selectivity discussed in this thesis can be summarized to: 
 sterilization of living tissue is achieved at two orders of magnitude lower plasma 
doses than required for damage as confirmed both visually and by histological 
stains; 
 bacteria are much smaller than mammalian cells and selectivity may be achieved 
simply though size/volume differences; 
 biochemical differences in the organisms, e.g. polysaccharides are easier to 
peroxidize than lipids; 
 difference in metabolic rates between, for example, cancer cells, normal cells, and 
bacteria may lead to difference in uptake rate of toxins generated by plasma; 
 cell cycle differences: frequently replicating cancer cells and bacteria have 
exposed DNA compared to static mammalian cells which do not, and thus in 
cancers and bacteria it is easier to get to the unfolded DNA. 
E. Effect of dose 
The effects of dose and dose rate is quite important: 
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 low plasma doses (< 1 J/cm2): inactivation/sterilization of bacteria, normal cell 
survival; 
 intermediate doses (2-6 J/cm2): repairable DNA damage, release of cell growth 
factors, increase in proliferation and migration, controlled development of 
apoptosis in cancers; 
 higher doses (> 7 J/cm2): normal cell death; 
 very high doses (> 10 J/cm2): cell necrosis. 
This concludes the general overview of interaction of non-equilibrium discharges with 
tissues, mammalian cells, and bacteria.    
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CONCLUDING REMARKS 
The main novel contributions of this thesis are: 
 Development and characterization of a cold microsecond spark discharge which 
can be safely and effectively  applied for biomedical applications; 
 Experimental study of the physical and chemical mechanisms of plasma 
interaction with microorganisms – bacteria and spores. A hypothesis of such 
mechanisms is proposed; 
 Experimental study of plasma production and delivery of reactive species into 
liquid media, tissues and cells; 
 Development of an in vitro physicochemical model of tissue based on agar 
hydrogel phantom; 
 Experimental study of plasma treatment toxicity of intact and wounded skin in 
vivo 
 Demonstration of high efficiency of plasma blood coagulation, wound 
decontamination and acceleration of wound healing in vivo; 
 Demonstration that cold plasma may be safely applied for treatment of 
gastroenterological diseases in vivo. 
Mechanisms of plasma interaction with living tissues and cells can be quite complex, 
owing to the complexity of both the plasma and the tissue. Therefore the physicochemical 
mechanisms of these interactions proposed in this thesis should be further investigated 
from the biochemical and biological stand points. A careful analysis of plasma treatment 
effects on cells, tissues and organs is required. Nevertheless, this work clearly 
196 
 
 
 
demonstrates the very basic effects of plasma on biological objects, and their relations 
with plasma parameters.  
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